Vessel stability in the Edinburgh model of retinopathy of prematurity : investigation of mural cell coverage & growth factor expression by Yaqoob, Zeenat
Vessel Stability in the EdinburghModel
ofRetinopathy of Prematurity:
Investigation ofMuralCell Coverage
& Growth Factor Expression
Zeenat Yaqoob
BSc (Hons)
Thesis for the Degree ofDoctor ofPhilosophy
The University of Edinburgh
2003
This thesis is dedicated to Ubbo and Umma,
7wantyou to know how much I admire and respectyou, and
how lucky Ifeel to have such good and caringparent,'
and to my sister, Saeema,
'thank-you foryour continued encouragement
and support over theyears.'
Declaration
The work presented in this thesis was conducted under the supervision of Professor
Neil Mcintosh and Dr. Kofi Sedowofia, Child Life and Health, Reproductive and
Developmental Sciences, University ofEdinburgh.
In accordance with the requirements of the University of Edinburgh, I hereby declare
that the contents contained herein are my own and that any assistance and advice has
been duly acknowledged.
This work has not been submitted for any other degree or professional qualification.
Child Life and Health








I would like to thank Professor Neil Mcintosh and Dr. Kofi Sedowofia for their
supervision, encouragement and constructive advice throughout the period of this
study.
My thanks also to Dr. Jan McColm for helping me to initiate this project. Particular
acknowledgment goes to Jean Wade who provided invaluable guidance and
encouragement in the laboratory, and to Linda Sharp for her much appreciated
assistance with the confocal microscope. My sincere gratitude to Helen Wilson and
Steve Mitchell who conducted the radiolabelled in situ hybridisation and electron
microscopy, respectively.
A big thank-you goes to the staff of the Medical Faculty Animal Facility and to the




Retinal blood vessels consist of endothelial tubules surrounded by a single layer of
smooth muscle cells or pericytes, collectively called the mural cells. Coverage of the
vessel with mural cells is suggested to signal their stability, and requires the actions
of several locally secreted growth factors including: platelet-derived growth factor,
which promotes mural cell migration and proliferation; transforming growth factor-/)1,
that induces the differentiation of precursors cells into pericytes and smooth muscle
cells; and the angiopoietins, for maintaining the interactions between endothelial
cells and pericytes.
Stability of blood vessels is believed to be compromised in retinopathy of
prematurity (ROP), a potentially binding eye disease characterised by the invasion of
the vitreous by proliferating retinal blood vessels. In the past the use of high oxygen
levels for the treatment of extremely premature infants was associated with the
incidence of this condition. However, it was recently suggested that rather than
absolute oxygen levels, the variability of the transcutaneous (blood) oxygen levels
within clinically 'safe' limits during the first two weeks of life may be more
important in ROP. Thus, a clinically relevant animal model of ROP was developed
(Edinburgh model). The first 14 days of the transcutaneous oxygen profile of an
infant who developed severe ROP was selected and converted into percentage
inspired oxygen levels to produce the equivalent arterial oxygen in a rat. The aims of
this thesis were to investigate mural cell coverage and the expression of the factors
suggested to participate in vessel stabilisation during normal retinal development and
in the Edinburgh model.
Rat pups were raised in room air or exposed to the oxygen regime of the Edinburgh
model from birth to postnatal days 2, 7 and 14. The pups were then killed, the eyes
enucleated and analysed for mural cell coverage and expression of platelet-derived
growth factor-B, transforming growth factor-/! i and angiopoietin-2 using
III
immunohistochemical, Western blotting, electron microscopy and in situ
hybridisation techniques.
In comparison to room air raised pups, the retinal vasculature of the pups raised in
the variable oxygen regime had reduced mural cell coverage; smooth muscle cell
coverage was only slightly reduced, however there was a marked and significant
reduction in pericyte coverage. The protein expression of both platelet-derived
growth factor-B and transforming growth factor-/?] were also reduced.
Unfortunately, the analysis of angiopoietin-2 mRNA expression was inconclusive
due to insensitive detection methods.
In conclusion, the reduction in mural cell coverage and in the expression of platelet-
derived growth factor and transforming growth factor-/?] suggest that blood vessel
stability is compromised in the Edinburgh model of retinopathy of prematurity.
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1.1 The Formation of Blood Vessels
Blood vessel development is a very complicated and delicate process which occurs
by vasculogenesis and angiogenesis [reviewed in Risau, 1997], In vasculogenesis,
endothelial cells spontaneously co-assemble into tubules to form a homogenous
primary vascular plexus which is later remodelled and encapsulated by support cells,
called mural cells. Angiogenesis, on the other hand, is the formation of new vessels
from existing ones. It is currently assumed that vasculogenesis is limited to early
embryogenesis, while angiogenesis occurs both during development and in postnatal
life.
1.1.1 Vasculogenesis
Vasculogenesis begins with the generation of angioblasts from mesoderm cells of the
embryo [reviewed in Risau, 1997], which appears to require the action of the
fibroblast growth factor family [reviewed in Flame and Risau, 1992], The
1
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angioblasts then differentiate into endothelial cells that proliferate and form de novo
vessels [reviewed in Risau, 1997], Vascular endothelial growth factor (VEGF) is
essential for inducing and maintaining the angioblast to endothelial cell
differentiation [Carmeliet et al., 1996], and for promoting the proliferation of
endothelial cells [Ferrara andHenzel, 1989],
During the later stages of vasculogenesis, the primitive vasculature is rapidly
remodelled into large and small vessels to become a mature network, and excess
endothelial cells generated during vasculogenesis regress due to the down-regulation
of VEGF [reviewed in Risau, 1997], As the vasculature is remodelled, the
endothelial tubules that remain are surrounded by a basement membrane [Croker,
Murad and Geer, 1970] and by mural cells, called pericytes and smooth muscle cells
[Rhodin, 1968], The coverage of the vessels with mural cells has been suggested to
signal their stability [Patz, 1968; Speiser, Gittelsohn and Patz, 1968], Several growth
factors are thought to be involved in regulating vessel stabilisation, including the
platelet-derived growth factors [Lindahl et al., 1997], transforming growth factor-/?
[Antonelli-Orlidge et al., 1989], and the angiopoietins [Suri et al., 1996], These
growth factors will be discussed in detail in subsequent chapters.
1.1.2 Angiogenesis
Angiogenesis is a process where new blood vessels develop by either sprouting
directly from a pre-existing vessel (sprouting angiogenesis) or by splitting from their
vessel of origin (non-sprouting angiogenesis or intussusception) [reviewed in Risau,
1997],
In the adult, the proliferation rate of endothelial cells is very low and the vasculature
essentially remains quiescent. The exceptions to this, during normal physiological
situations, are wound healing and menstruation where angiogenesis is tightly
regulated. Briefly, during the early stages of wound repair and tissue regeneration,
additional vessels (neovascularisation) develop at the edge of the wound to achieve
2
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rapid closure of the injury site. Once the skin has developed over the wound, the
wound edges contract and the microvessels regress [Wong et al., 1997], In females,
the ovaries and uterus are under hormonal control and are subjected to the formation
and breakdown of vessels on a regular basis. The vasculature of the uterus and
placenta undergo angiogenesis during pregnancy, but the new vessels regress after
the birth of the child [reviewed in Reynolds, Killilea and Redmer, 1992],
Occasionally, unregulated angiogenesis can cause pathologic conditions, including
tumours and ophthalmic diseases. Tumour growth is often a multi-step process that
begins with the rapid division of cancerous cells, in most cases forming a small
avascular mass. With time, this mass may grow further and make contact with a
nearby vessel or it may induce the formation of blood vessels into it. Once the
avascular mass establishes a blood supply, it then has the potential to invade the
surrounding tissue [Folkman, 1971], Ocular disorders resulting from uncontrolled
angiogenesis include diabetic retinopathy and retinopathy of prematurity. These
conditions are characterised by the profuse growth of retinal vessels and can result in
blindness if left untreated [Patz, 1980a].
1.1.3 Investigating Blood Vessel Development
The above is a general overview of vessel formation; the exact process differs
slightly from species to species and from organ to organ. One organ which has been
widely used to study vessel formation is the mammalian retina. For several reasons
it provides a good model:
• it is relatively small and vessels form rapidly over a short period of time
• the whole vascular bed can be easily investigated
• it utilises both vasculogenesis and angiogenesis in a temporally and
spatially segregated sequence
• the vascularisation in many species occurs either late in gestation or




• new vessel growth can be induced readily by manipulating environmental
conditions, such as oxygen exposure, to allow the investigation of
abnormal or pathologic vessels
• during development the vascular and avascular regions of the retina are





Human retinal development is similar to that of other mammals including rodents,
cats and dogs; it proceeds from the optic disc at the back of the eye towards the ora
serrata at the periphery, in two major gradients, vertical and horizontal [Carlson,
1999], For example, in humans at six weeks gestation the inner and outer walls of
the optic cup give rise to the neural and pigmented retina, respectively [Larsen, 1997;
Carlson, 1999], The neural retina undergoes extensive differentiation, and by about
32 weeks gestation forms several vertically aligned cell layers. The horizontal
spread of blood vessels, from the centre of the retina to the periphery, is initiated
around the 16th week of gestation [Ashton, Ward and Serpell, 1954; Ashton, 1966],
The vessels of the retina reach the ora serrata nasally by approximately 36 weeks,
and temporally by full term. While the retinal vessels are forming, a temporary
network of blood vessels supplies the front of the eye via the hyaloid artery
[reviewed in Avery and Glass, 1998], However, this system gives off no retinal
branches and normally disappears by 34 weeks gestation.
The embryonic vascular system in general arises from mesenchymal tissue. Since
the avascular retina lacks mesenchymal elements, the vessels develop from
undifferentiated spindle cells that enter the retina via the optic nerve [Ashton, 1966;
Henkind and de Oliveria, 1967], It is believed that these spindle cells differentiate
into angioblasts [Ashton, 1966] which undergo further differentiation to become the
endothelial cells. The endothelial cells then coalesce to form the solid vascular cords
which in turn give rise to patent vessels [reviewed in Risau, 1997],
1.2.1 Retinal Layers
Initially, the neural retina is divided into three layers: the nerve fibre layer, the inner
neuroblast layer, and the outer neuroblast layer [Larsen, 1997], As the retina
matures, the cells of both neuroblast layers differentiate, producing a retina that
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consists of six layers (Figure 1.1, page 7) [McDonnel, 1994; Larsen, 1997; Carlson,
1999],
The inner neuroblast layer gives rise to the ganglion cell layer (GCL), the inner
nuclear layer (INL) and the outer nuclear layer (ONL) [McDonnel, 1994; Larsen,
1997; Carlson, 1999], Ganglion cells make direct contact with bipolar cells of the
INL, which also contains amacrine and horizontal cells. The dendrites from both
horizontal and bipolar cells interact with the cell bodies of photoreceptors in the
ONL.
As cells within the outer neuroblast layer send out processes, the inner and outer
plexiform layers (IPL and OPL, respectively) become better defined [McDonnel,
1994; Larsen, 1997; Carlson, 1999], The IPL contains the dendrites of ganglion cells
and their synapses with amacrine and bipolar axons, whereas in the OPL bipolar and
horizontal cell processes make contact with the axons of the photoreceptors. The
eventual differentiation of the photoreceptor cells completes the horizontal
development of the retina.
6
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Figure 1.1 Layers of the rat retina.
10pm frozen section of the rat retina stained with hematoxylin and eosin. The retinal





1.2.2 Retinal Vessel Formation
Retinal vessel formation proceeds in a centrifugal fashion along a superficial layer
(within the GCL) and a deep layer (within the INL), and is essentially controlled by
oxygen and, as mentioned above, VEGF.
Control ofvesselformation
Oxygen
During early development, the retina is completely avascular and the entire retina
receives its oxygen supply from the choroidal vessels located on the outer aspect of
the retinal pigmented epithelium. As the retinal layers form and the thickness of the
retina increases, this oxygen supply becomes insufficient. As a result the superficial
vascular layer forms first followed by the deep vascular layer. These two layers meet
the oxygen demands of the inner layers of the retina. The ONL and the OPL remain
avascular and continue to consume most of the oxygen delivered by the choroid
[reviewed by Provis, 2001],
The importance of oxygen in blood vessel formation was first demonstrated by
Ashton and colleagues [Ashton, Ward and Serpell, 1954], In order to investigate a
retinal disorder called retrolental fibroplasia that affects ventilated preterm infants,
the researchers raised kittens in various oxygen environments and reported that
hyperoxia has an inhibitory effect on the growth of the kitten's retinal vasculature,
whereas hypoxia promotes faster spread of vessels into the avascular retina than
normoxia.
Almost thirty years later, it came to light that hypoxia is required for the controlled
growth of vessels during normal development [Weiter, Zuckerman and Schepens,
1982], Chan-Ling and colleagues then suggested that normal retinal vessel
formation depends on a transient period of hypoxia that is localised, induces the
division of retinal endothelial cells, and occurs at the edge of the spreading
vasculature [Chan-Ling, Halasz and Stone, 1990], Once the newly formed vessels
open, the oxygen carried in the blood relieves local tissue hypoxia and the
8
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proliferation rate of the endothelial cells is reduced. This hypoxia is termed
'physiological hypoxia' [Chan-Ling and Stone, 1993] because it occurs during the
normal process of development, and is well tolerated by the tissue. It now emerges
that oxygen is vital during blood vessel formation because it regulates the expression
ofmany growth factors essential to the process.
VEGF
The concept that the retina produces a 'chemical' or 'X factor' to control the
formation of its vessels was suggested by Michaelson [Michaelson, 1948], He went
on to suggest that the production of this angiogenic factor is driven by the local
metabolic needs of the retina, that it is essential in the development of the
vasculature, and that the same factor is involved in neovascular retinal diseases. A
series of studies were initiated to identify this all important chemical factor.
Fibroblast growth factor was the first retinal growth factor to be discovered [Arruti
and Courtois, 1978] and was immediately linked to Michaelson's 'X factor'.
However, since this growth factor is not induced by hypoxia [Brogi et al., 1993], it is
no longer believed to control vessel development. Later, another growth factor,
VEGF, was found to induce endothelial cell proliferation and migration [Ferrera and
Henzel, 1989; Millauer et al., 1993] by interacting with VEGF receptor-1 and VEGF
receptor-2 [Barleon etal., 1994],
Further evidence for a role of VEGF in vessel formation came from studies on
transgenic mice. The studies reported that in comparison to normal embryos, which
have a dense plexus of small vessels and larger connecting vessels, mouse embryos
lacking the VEGF gene [Carmeliet et al., 1996], or the gene for either of the two
VEGF receptors [Fong et al., 1995; Shalaby et al., 1995] display either an irregular
plexus of small vessels and lack of larger connecting vessels or fail to develop
functional blood vessels. Consequently, all three transgenic mice die at mid-
gestation, demonstrating that VEGF is crucial for early vascular development.
9
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However, what allows researcher to label VEGF as Michaelson's 'X factor' is the
finding that VEGF is up-regulated by hypoxia. VEGF mRNA levels are dramatically
increased within a few hours of exposing different cell cultures to hypoxia [Shweiki
et al., 1992; Aiello et al., 1995; Stein et al., 1995], Its expression eventually returns
to background levels when a normal oxygen supply is resumed [Shweiki et al.,
1992], but is down-regulated in response to hyperoxia [Stone et al., 1995, 1996],
Therefore, VEGF is the vaso-formative growth factor that acts in both normal and
abnormal retinal vessel formation.
The vascular layers
Superficial plexus
The optic disc is the first region of the retina to experience 'physiological hypoxia'
[Chan-Ling and Stone, 1993], Astrocytes, which act as oxygen sensors, migrate
from the optic nerve head into the retina [Ling and Stone, 1988; Watanabe and Raff,
1998] and arrange themselves into an array to form a template for the initial retinal
vessels [Stone et al., 1995], Detecting the hypoxia of the avascular retina, astrocytes
increase their expression ofVEGF [Stone et al., 1995] which promotes the migration
and growth of endothelial cells, to form a network of vessels [Ferrara and Henzel,
1989], Once the area is vascularised and the vessels carry oxygenated blood, the
hypoxia is relieved and astrocytes reduce their production of VEGF, limiting vessel
growth [Chan-Ling and Stone, 1993; Stone et al., 1995], Astrocytes then continue to
form an array just peripheral to the edge of the growing vasculature [Ling and Stone,
1988], where 'physiological hypoxia' is presumably maximal [Chan-Ling and Stone,
1993], This entire process of astrocytes invading the avascular areas, secreting
VEGF, and then decreasing VEGF production continues until the vessels reach the
peripheral edge. Once the astrocytes have fulfilled their role in vessel formation, by
providing a scaffold for the endothelial cells, they then function to maintain the




The capillary network is then remodelled to again meet the metabolic demands of the
tissue, and spaces (called capillary-free zones) develop by the retraction or atrophy of
some immature capillaries that are no longer required [Ashton, 1966; Henkind and de
Oliveria, 1967], These spaces are larger on the arterial side and diminish towards the
venous side of the capillary circulation [Ashton, 1966], The vessels that remain are
then encapsulated by mural cells [Rhodin, 1968] which may contribute to the
stabilisation of the vasculature [Patz, 1968; Speiser, Gillelsohn and Patz, 1968],
The deep plexus
At a later stage, a second vascular layer develops by the blood vessels of the
superficial plexus within the GCL extending downwards into the INL of the retina
[Chan-Ling, Halasz and Stone, 1990], This layer is referred to as the deep plexus
and in many ways develops in a similar manner as the upper layer. Instead of
astrocytes, Muller cells (another class of glial cells) act as a template for new vessels
[Flower et al., 1985], The Muller cells, like astrocytes, detect hypoxia, up-regulate
their expression ofVEGF and recruit endothelial cells [Stone et al., 1995], However,
the Muller cells do not migrate as the blood vessels form; the vessels grow in a strict
radial pattern, following the radial processes of the Muller cells [Flower et al., 1985],
The oxygen brought by these vessels later down-regulates VEGF expression, limiting
the growth of the plexus [Stone et al., 1995],
Like the superficial layer, the vasculature of the deep layer first forms centrally and
then peripherally; vessels of the superficial plexus at the centre first form the deeper
plexus and then the vessels of the superficial layer further out extend into the deep
layer and so on until the deep layer finally reaches the periphery. Unlike the
superficial layer, however, the vessels of the deep layer seem to form more precisely
to the retina's need; there is little evidence of overproduction and retraction among
these vessels [Stone and Maslim, 1997],
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1.3 Retinopathy of Prematurity
Retinopathy of prematurity (ROP) is an eye disease that principally affects ventilated
preterm infants. In threshold ROP, normal vasculogenesis of the retina is interrupted
and abnormal vessels invade the vitreous. If the disease progresses, retinal scarring
can develop followed by retinal detachment, resulting in the loss of vision [Flynn,
1987],
1.3.1 History
The disease was first described by Terry in 1942 who found a greyish-white opaque
membrane behind each lens of a six-month old infant that was born at around 32
week gestation. This disease was named retrolental fibroplasia [Terry, 1942] and
was soon associated with the supplemental oxygen treatment that premature babies
received to increase their chance of survival [Campbell, 1951],
To find out whether high or low concentrations of supplemental oxygen induced
retrolental fibroplasia, Campbell compared the clinical set-up of three nurseries with
different therapeutic oxygen regimes [Campbell, 1951], She found that the disease
usually developed in premature babies and that high oxygen treated infants
developed the disorder more often than those who received low oxygen treatment.
These results were confirmed by Patz and colleagues [Patz, Hoeck and Cruz, 1952],
Consequently, oxygen therapy was restricted to 40% or less in the late 1950s and
early 1960s, resulting in a significant decrease in the incidence of retrolental
fibroplasia [Crosse and Evans, 1952; Ryan, 1952; Guy, Lanman and Dancis, 1956],
Unfortunately, this restrictive use of oxygen also caused an increase in neurological
mortality and morbidity as well as respiratory mortality [Avery and Oppenheimer,
I960], Thus, in the 1970s and early 1980s, the use of oxygen was again liberalised
with the reappearance of the disease [reviewed in Weakley and Spencer, 1992; and in
Ziavras and Javitt, 1995],
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The term 'retinopathy of prematurity' replaced retrolental fibroplasia in the 1980s to
stress the importance of neonatal immaturity in causing the disease [Flynn, 1987],
The current disease differs from the original disease because, unlike in the 1950s-
1970s, infants are no longer exposed to continuing high oxygen concentrations;
instead their blood oxygen levels are monitored and controlled within clinically
'safe' limits [Cunningham et al., 1992, 1995],
1.3.2 Risk Factors
In humans, the retina is not completely vascularised until approximately 40 weeks
gestation [reviewed in Avery and Glass, 1988]; hence, all preterm babies are bom
with some degree of retinal avascularity. The size of the peripheral avascular zone at
birth is directly related to the degree of prematurity; the more premature an infant,
the larger the retinal avascular area at birth. Although the central retinal area of
preterm babies is vascularised, it consists of many delicate capillaries that are still
growing and lack the support of more mature vessels. Consequently, these vessels
are susceptible to injury. Thus, neonatal immaturity is the single most determining
risk factor for ROP [Palmer et al., 1991],
In the 1950s, the survival rate of infants with a birthweight of lOOOg or less was very
low, but by the late 1980s (with the development of modem intensive care,
ventilators and other technology) smaller, more premature infants were surviving. It
is now reported that a preterm baby bom at or beyond 25 weeks gestation, or with a
birthweight of 700g or more, has a 50% chance of survival [Hack and Fanaroff,
1989], Multicenter clinical trials report that 65% of infants bom weighing less than
125 lg develop some degree of ROP [Cryotherapy for Retinopathy of Prematurity
Cooperative Group, 1990], The incidence rises to over 80% and 90% in those
preterms weighing less than lOOOg and 750g, respectively. Hence, ROP is associated




As mentioned above, high oxygen levels have a toxic effect on the premature retina.
In the 1950s, ROP was not seen to affect those infants who received limited oxygen
treatment (concentrations of less than 40%) [Crosse and Evans, 1952; Ryan, 1952;
Guy, Lanman and Dancis, 1956], In addition, the longer a premature infant was kept
in an oxygen-enriched environment, the greater was its chance of developing ROP
[Kinsey, 1956], Therefore, next to immaturity, prolonged treatment with high
oxygen levels is an important factor.
The incidence of ROP rose in the late 1980s due to the survival of more premature
infants; however supplemental oxygen therapy was not considered to play a
significant role because continuous transcutaneous oxygen monitoring and blood gas
analysis allowed better control of oxygen delivery. So, if infants are no longer
exposed to excess oxygen, why do some still develop this disease? A recent study
suggests that small fluctuations in oxygen levels within clinically 'safe' limits can
cause severe ROP [Cunningham et al., 1995], It is possible that in these infants
hyperoxic episodes or absolute oxygen levels are not the determining factors, but the
frequent switching between relatively high and low oxygen levels within clinical
limits is more important. As a consequence, there has been a renewed interest in the
role of oxygen in the pathology and management ofROP.
A small proportion of infants develop ROP despite never receiving oxygen
treatment. Conversely, many infants who receive oxygen therapy never develop the
condition. Thus, it is believed that ROP is a multifactorial disease and although
numerous risk factors have been implicated, including hypercarbia, hypocarbia,
vitamin E deficiency, and metabolic acidosis [reviewed in Avery and Glass, 1988;
and in McColm and Fleck, 2001], their role in inducing or promoting the disease are
still debated. Only early gestational age, low birthweight and excess oxygen therapy
have been consistently associated with the disease. Hence, extremely premature
babies of low birthweight that receive supplemental oxygen therapy have the highest
incidence as well as the greatest severity of ROP [Campbell, 1951; Patz, Hoeck and
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Cruz, 1952; Cryotherapy for Retinopathy of Prematurity Cooperative group, 1988,
1990],
1.3.3 Pathogenesis
The first clinical and animal studies to provide an insight into the pathogenesis of
ROP were conducted by Patz [Patz, Hoeck and Cruz, 1952] and by Ashton [Ashton,
Ward and Serpell, 1954], respectively. They demonstrated that the disease consists
of two clinical phases. During the first phase, called vaso-obliteration, supplemental
oxygen therapy interrupts normal vasculogenesis and causes the occlusion and
obliteration of existing blood vessels. Once the infant is returned to normal oxygen
levels, the disease either regresses naturally, or progresses to the vaso-proliferative
phase which involves the formation of new pathologic blood vessels into the
vitreous.
Effects
The initial response of the vasculature to elevated oxygen levels is suppression of
new vessel formation [Patz, Hoeck and Cruz, 1952; Ashton, Ward and Serpell, 1954;
Chan-Ling et al., 1992], and constriction of the most immature vessels, those near the
peripheral vanguard of the advancing vasculature [Ashton, Ward and Serpell, 1954],
This is followed by narrowing of the arterioles and venules (causing a decrease in
retinal blood flow) and obliteration of the vessels, starting with the capillaries
[Ashton, Ward and Serpell, 1954; Chan-Ling et al., 1992], If the insult continues,
the arterioles and venules close and the retina appears avascular [Ashton, Ward and
Serpell, 1954],
When an infant or an animal is returned to room air after excess oxygen exposure,
the obliteration is reversible in a majority of the affected vessels, and normal
vascularisation may resume from the centre of the retina to the peripheral avascular
retina [Ashton, Ward and Serpell, 1954], The likelihood of this depends on the
extent of damage, which is determined by the concentration and duration of oxygen
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exposure. If, however, the retinal vessels have been extensively obliterated, they are
prevented from reopening adequately [Ashton, Ward and Serpell, 1954],
Vasculogenesis is initiated, but the abnormal proliferation of the cells causes a large
number of vessels to bud either from the disc or from pre-existing vessels into the
retina and then burst into the vitreous [Ashton, Ward and Serpell, 1954], This
profuse growth of new vessels is termed neovascularisation and is the critical step in
the chain of events that can cause retinal detachment and blindness in the months or
years that follow.
Mechanism
The high oxygen environment of ventilated premature babies makes the avascular
portion of the retina hyperoxic (which during normal development is hypoxic).
Astrocytes, which usually move into the avascular area and produce VEGF, instead
decrease their production of VEGF in response to the increased oxygen levels [Stone
et al., 1995], As a result, spindle cells fail to enter the avascular area and
differentiate into the endothelial cells that form the tubules, and the process of
vasculogenesis is halted. Normally, once the vasculature is formed, VEGF continues
to be expressed in small quantities in order to prevent vessel regression [Stone and
Maslim, 1997], However in ROP, VEGF production is decreased to the extent that
many existing vessels undergo regression.
As a result of the oxygen induced vaso-obliteration, on transfer to air the retina
suffers an acute lack of oxygen which causes astrocytes, that are present on the
retinal surface, to degenerate; but it promotes the migration of new astrocytes into
the retina [Stone et al., 1995], In response to the relative hypoxia the astrocytes
produce vast amounts of VEGF and this overproduction of VEGF causes excessive
growth of blood vessels [Stone et al., 1995; Pierce et al., 1995a], In cases where the
retina experiences severe hypoxia, astrocytes can degenerate [Chan-Ling and Stone,
1993; Stone et al., 1996], and VEGF is instead expressed by the neurones of the GCL
[Stone and Maslim, 1997], Without astrocytes to serve as a template, the vessels
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break through the inner limiting membrane of the retina into the vitreous humour,
forming pre-retinal vessels [Zhang and Stone, 1997].
These early animal studies were in line with the clinical practise at the time. High
levels of oxygen were used during the first days and weeks of life, followed by return
to room air. This produced a vaso-obliterative followed by vaso-proliferative form
of retinopathy. Whilst these are adequate to describe the pathogenesis of the old
disease, the pathogenesis of the disease seen today cannot be understood by these
studies.
1.3.4 Classification
In 1984, a new and precise classification system for ROP was introduced which
defines five stages of the disease and fully describes the active retinal changes that
occur. Furthermore, it takes into account the location of the disease in the retina and
the extent of the vasculature involved [The Committee for the Classification of
Retinopathy of Prematurity, 1984],
Location
The retina is divided into 3 circular zones, each centred on the optic disc. Zone I is
the most posterior zone and has a radius of twice the distance from the disc to the
centre of the macula. Zone II extends from the peripheral edge of Zone I to the ora
serrata nasally and to an area near the temporal equator. If the nasal retina is fully
vascularised, the limit of vascularisation temporally is considered to be in Zone III.
Because Zone III is the last zone to be vascularised, it is most frequently involved in
ROP.
Extent
The extent of the disease is specified as clock hours with each hour representing a





Stage 1, the first of the acute phases of retinopathy, is characterised by a distinct
demarcation line separating the avascular retina anteriorly from the vascular retina
posteriorly. During stage 2, the line of stage 1 develops into a ridge and has height,
width, volume and extends out of the plane of the retina. In most cases of stage 1
and 2 disease, the retinal lesions spontaneously regress, leaving no residual scars. In
stage 3 new vessels (or neovascularisation) project upwards from the ridge into the
vitreous. This stage is, therefore, characterised by extraretinal fibrovascular
proliferation. During stage 4, the fibrous proliferating blood vessels contract causing
tractional retinal detachment which may or may not involve the detachment of the
macula. The final stage is stage 5, formerly referred to as retrolental fibroplasia,
where total retinal detachment occurs.
Progressive vascular incompetence is characterised by increasing dilation and
tortuosity of the central retinal vessels, as well as iris vascular engorgement with
pupillary rigidity. These vascular changes can occur at any time and when they do, a
'plus' is added to the ROP stage number.
1.3.5 Treatment
In a high number of infants affected by acute ROP (stages 1 and 2), the disease
spontaneously regresses and the retina appears normal. If, however, the disease
progresses to stage 3, ophthalmologic treatment is necessary. If the retina is still
attached then retinal cryotherapy, and more recently diode laser photoablation
therapy is used [reviewed in Phelps, 1993], These therapies make use of lasers
focused through the pupil, or supercold probes applied to the outside of the eye, to
destroy the avascular peripheral retina that is ischaemic. It is believed that the
destruction of the ischaemic tissue prevents the continued production of growth
factors and therefore continued vessel growth, while preserving the retina already
vascularised. By producing extensive chorioretinal scars, cryotherapy is expected to
reduce or halt fibrovascular proliferation. While this therapy is often successful, it
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none-the-less destroys the peripheral retina irrevocably and can limit the vision of the
child. If the retina detaches from the sclera, then a scleral buckle procedure is used in
combination with cryotherapy. The aim is to bring the sclera close to the retina and
then to 'weld' the retina to the underlying choroid with cryotherapy or laser burns
[reviewed in Phelps, 1993],
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1.4 Models ofOxygen-Induced Retinopathy
Several animal models of ROP have been generated which have provided invaluable
insights to the pathogenesis of the disease. These models depend on extreme levels
of oxygen to induce retinal vascular changes in neonatal animals, and are therefore
more representative of the old disease, retrolental fibroplasia. Although many
models parallel the early stages of the human disease, the exact disease has never
been reproduced in animals. Conversely, some models develop abnormal features
that are not described in human ROP.
1.4.1 Dog
Flower and Blake exposed two day old puppies to 95-100% oxygen for three days
and reported a significant constriction of the retinal blood vessels [Flower and Blake,
1981], These results were later confirmed by McLeod et al. who maintained
newborn puppies in 100% oxygen for four days [McLeod, Brownstein and Lutty,
1996; McLeod, Crone and Lutty, 1996], In this model, the progressive constriction
of the developing retinal vasculature resulted in vaso-obliteration, and upon return to
room air, the abnormal proliferation of the blood vessels progressed into the vitreous.
Advantages /disadvantages
Retinal vessels of both the newborn dog and the premature infant exposed to
hyperoxia share many morphological features: vaso-obliteration [McLeod, Crone and
Lutty, 1996]; dilation and tortuosity of the posterior pole vessel, known as plus
disease in infants [McLeod, D'Anna and Lutty, 1998]; severe overgrowth of the
capillaries, producing an elevated ridge of vessels at the border of the vascular retina
[McLeod, D'Anna and Lutty, 1998]; and neovascular lesions [McLeod, D'Anna and
Lutty, 1998], However, the optic nerve head neovascularisation and posterior
vascular tufts that are somewhat common in hyperoxic dogs are not usually




Ashton and colleagues were the first to mimic ROP in an animal by exposing kittens
to 70-80% oxygen and reported the effects of various oxygen concentrations (25%
up to 80%) and duration of exposure (three to 26 days) on the development of the
feline retina at different ages [Ashton, Ward and Serpell, 1954], They found that
constant hyperoxia caused vaso-constriction of the growing vessels followed by
vaso-obliteration. The capillary bed slowly disappeared and soon the retina appeared
avascular, but if the insult was severe enough the vasculature could be completely
destroyed. When the kittens were returned to room air, vaso-proliferation was
observed at the optic disc of the retina and in the vitreous [Ernest and Goldstick,
1984; Chan-Ling et al., 1992], After relief of this relative hypoxic phase, the retina
revascularised from the optic disc outwards [Ashton, Ward and Serpell, 1954], This
final stage was called normalisation [Chan-Ling et al., 1992].
Advantages /disadvantages
Retinal vascularisation in a newborn kitten is similar to a 25-30 week human fetus
[Patz, 1968], and is completed by postnatal day eight (P8) [Ernest and Goldstick,
1984], Similarities between the cat and human forms of ROP are: the growth of
proliferative intraretinal vessels; leakiness of both the pre-retinal and peripheral
intra-retinal vessels; and normalisation of the proliferative vasculature, termed
regression in humans [Chan-Ling et al., 1992], The closure and obliteration of the
retinal vessels during hyperoxia are not well described in premature infants, but it is
assumed that this is due to the cloudiness of the optics of the eye. The features have,
however, been reported in post-mortem human retina [Ashton, 1966], Therefore, the
cat provides a relatively accurate model of human ROP.
1.4.3 Rat
In one of the earliest animal experiments investigating oxygen-induced retinopathy
rats (age not stated) were exposed to 40-50% oxygen which resulted in vaso¬
constriction of the retinal vessels [Patz et al., 1953], However, when rats were raised
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in 70-80% oxygen, complete obliteration of the vessels was observed within four
days and by 12-15 days, capillary tufts (abnormal neovascularisation) were noted on
the surface of the retina.
Ashton and Blach exposed rats at various ages, from birth to Pll, to high oxygen
levels (concentrations not stated) and found that hyperoxia alone caused partial
obliteration of the retinal vessels [Ashton and Blach, 1961], When the rats were
returned to room air much of the retina remained permanently obliterated and no
abnormal vaso-proliferation occurred.
Rat models of ROP have been widely used by Penn and colleagues [Penn, Tolman
and Lowery, 1993; Penn, Tolman and Henry, 1994; Penn, Henry and Tolman, 1994;
Penn et al., 1995], Their first study involved exposing newborn rats to a constant
oxygen concentration of 80% for up to 14 days. This regime produced the first stage
(vaso-attenuation) of the disease, but failed to produce the subsequent phases of
abnormal proliferation and pre-retinal neovascularisation [Penn, Tolman and
Lowery, 1993], Instead, newborn rats exposed to alternating 40% and 80% oxygen
followed by relative hypoxia (by placing them in room air) developed pre-retinal
neovascularisation [Penn, Tolman and Lowery, 1993], The group then investigated
the retinal changes induced by various oxygen cycling regimes, and determined that
alternating between 50% and 10% inspired oxygen every 24 hours for 14 days
followed by a four day period in room air produced the highest incidence (100%) and
the greatest severity of neovascularisation [Penn, Henry and Tolman, 1994],
Advantages /disadvantages
The rat retina at birth is avascular and normally vascularisation is completed by day
14 [Penn, Tolman and Lowery, 1993; Holmes, Duffner and Kappil, 1994], Thus,
formation of the retinal vessels in rats can be observed at various time points.
Although there are some developmental differences, the rat oxygen-induced
retinopathy model closely resembles the vascular changes seen in the human disease.




The most widely used mouse model of oxygen-induced retinopathy was developed
by Smith and colleagues. From day seven (when the hyaloid vessels had regressed
and the retina resembled that of the premature infant) to day 12 (at which point
normal vascularisation was near completion) mice were exposed to 75% oxygen.
The mice were then returned to room air and sacrificed between PI7 and P21. The
initial response of the mice to high oxygen was central vaso-constriction followed by
non-perfusion. The larger vessels became tortuous and engorged, and between PI7
and P21 maximum neovascularisation was observed. With a longer recovery period
in room air, the neovascularisation regressed and the vascular pattern normalised
[Smith etal., 1994],
Newborn mice raised in 90-95% oxygen for five days, followed by room air recovery
also developed retinopathy [Browning, Wylie and Gole, 1997], This regime
produced reliable and consistent results and the extent of neovascularisation could be
quantified. By day 20, the rate of vessel growth was similar to control animals,
however a peripheral avascular area still remained.
Advantages /disadvantages
Like rats, the vascular development of newborn mice occurs postnatally and
resembles that of the infant. The mouse models are reproducible, inexpensive and
reflect the retinal neovascularisation and the proliferative neovascular phase of ROP.
The drawback to the model developed by Smith et al. is that the vascular changes
occurred only centrally and the peripheral vasculature is spared from any damage
[Smith et al., 1994], Although Browning's model produces quantifiable
neovascularisation and an increase in peripheral capillary density, adult mice are
very vulnerable to extreme levels of oxygen, and the mortality rate of the mothers in
these experiments is high [Browning, Wylie and Gole, 1997], Nevertheless, because
the mouse retina responds rapidly to hyperoxia, it is an excellent model for the study
of angiogenesis and inhibition of vessel growth [Browning, Wylie and Gole, 1997],
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1.5 A Clinically-RelevantModel of ROP
1.5.1 Basis for a New Model
The current animal models of oxygen-induced retinopathy use large swings in
oxygen concentration to produce the retinal vascular changes observed in human
ROP. One criticism is that these models are characteristic of the disease seen in the
1950s and 1960s, when supplemental oxygen therapy was neither monitored nor
controlled, and therefore, are not reflective of the oxygen environment experienced
by present-day premature babies.
Ventilated neonates in the Simpson's Maternity Pavilion, Edinburgh have their
transcutaneous oxygen (TCO2) levels recorded every second by a cotside monitor and
stored as an average each minute [Cunningham et al., 1992], Over a period of almost
three years, the recorded data of preterm infants from birth to 21 days of age was
analysed; 69 babies were included ofwhich 38 had no, stage 1 or 2 ROP and 31 had
stage 3 or greater ROP. The study found that although there was no difference in the
average blood oxygen levels between the two groups, preterm infants who developed
severe ROP experienced a greater number of small fluctuations in blood oxygen
levels within clinically 'safe' limits than those with no or acute ROP [Cunningham et
al., 1995], The study also showed that greater variability in TCO2 during the first two
weeks of life was particularly significant in inducing the disease.
Taking this cohort study into consideration, a computer controlled oxygen delivery
system was developed that produced minute-by-minute changes in oxygen
concentration within an animal chamber, by injections of oxygen or nitrogen gas,
mimicking the changing oxygen environment of this cohort of ventilated preterm
infants [McColm and Cunningham, 2000],
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1.5.2 The Edinburgh Model
A 14-day profile of the oxygen data from a preterm infant who developed stage 4
ROP was translated into percentage inspired oxygen levels for the rat (diagram
below) since the relationship between blood oxygen level and inspired oxygen is
linear [Penn et al., 1995], Rats exposed to this clinically relevant oxygen profile, that
had a mean oxygen concentration of 21.3%, developed features of ROP; the retinas
had a significantly reduced vascular area and capillary density compared to the
controls (details ofmeasuring avascularity and capillary density are given in Chapter
6) [Cunningham et al., 2000], The retinal vasculature of the experimental pups was
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Figure 1.21 The 14-day minute variable oxygen profile.
The oxygen profile of a preterm infant translated into equivalent oxygen levels for the
rat.
In summary, by exposing rat pups to small frequent fluctuations, rather than large
swings in oxygen levels every 12 or 24 hours, this model induced the early stages of
ROP. Thus, the Edinburgh model is more comparable to the retinal disorder that can
occur in present-day ventilated extremely premature infants.
Clinically the lower and upper TCO2 limits for infants are set to 6kPa and lOkPa,
respectively [Cunningham et al., 1995], therefore neonatal staff attempt to maintain
the babies at a mean of 8kPa. In the original animal study, the oxygen profile also
1
Taken, with permission, from McColm and Cunningham, 2000.
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had a mean of 8kPa, termed normoxia [Cunningham et al., 2000], Next the relative
contribution of hypoxia (6kPa) and hyperoxia (lOkPa) with fluctuating oxygen on the
rat retina was investigated [McColm et al., 2004], The data was again translated into
inspired oxygen levels for the rat with a mean of 6kPa (17.9% O2) and lOkPa (24.7%
O2). This study showed that pups raised in the lOkPa regime, where they spent 90%
of their time above 21% inspired oxygen, had a larger avascular peripheral area and a
higher capillary density than those raised in the 8kPa regime, where only 50% of
their time was spent above 21% oxygen. In contrast, retinas of rats exposed to the
6kPa profile, spending 90% of their time below 21% oxygen, appeared relatively
normal. Thus, pups exposed to the hyperoxic variable regime developed the most
severe disease.
Although no neovascularisation was observed, abnormal dilated terminal vessels
were noted at the vascular/avascular interface in 21% and 43% of the normoxic and
hyperoxic retinas, respectively [Cunningham et al., 2000; McColm et al., 2004],
These abnormal vessels could be precursors of pre-retinal vessels. In other models
of oxygen-induced retinopathy, a period of room air recovery is needed to induce
neovascularisation [Penn, Tolman and Lowery, 1993; Penn, Tolman and Henry,
1994; Penn, Henry and Tolman, 1994; Smith et al., 1994] and this model might also
have done, however, the research group did not allow rats this period in room air
because in the clinical setup preterm infants do not experience a switch from a high
oxygen to a relatively low oxygen environment; the infants progress to threshold
ROP whilst they are receiving supplemental oxygen therapy and are gradually
reintroduced to room air.
1.5.3 The Species of Choice
The rat was the species of choice in developing this model for several reasons.
Compared to the kitten and dog, the rat model has low cost, low animal maintenance,
large litter sizes, and short gestation. More importantly, the rat retina takes 14 days
to completely vascularise, allowing the investigation of vessel growth at any stage of
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development. Although, the mouse is an excellent model for the general study of
angiogenesis, and has the added advantage of investigating the effects of oxygen on
various transgenics, the mouse retina proliferates only centrally after hypoxic




1.6 Aims and Hypothesis
A vast body of literature is available on the processes and mechanisms of early
vasculogenesis, including endothelial cell production, migration and proliferation. In
comparison, less attention has been directed towards the later stages of
vasculogenesis, especially maturation and stabilisation of the vasculature by
investment of mural cells and production of basement membrane. In an infant born
at 24 weeks gestation, only about half the retina is vascularised [Phelps, 1992], and
without the support of basement membrane, pericytes and smooth muscle cells of the
more mature vessels, the capillaries are particularly susceptible to injury from
hyperoxia [Patz, 1968],
The purpose of the work described in this thesis was first to investigate the
stabilisation of retinal blood vessels in normal development by studying:
• the cell-to-cell interactions between endothelial cells, pericytes and
smooth muscle cells
• the expression patterns of the principle regulators of vessel stabilisation,
which include platelet-derived growth factor, transforming growth factor-/?
and the angiopoietin/Tie-2 system;
and second, to determine if the expression of these stabilising factors were altered in a
clinically relevant model ofROP (Edinburgh model).
As discussed above retinal blood vessels are particularly vulnerable to changes in
inspired oxygen levels. Thus, it is proposed that the cell-to-cell contacts in the
retinas of the Edinburgh model would be compromised. It is also expected that the
expression of growth factors that promote and maintain retinal blood vessel stability
would be altered by the oxygen regime, since other growth factors, such as VEGF,
have been shown to be directly regulated by oxygen [Shweiki et al., 1992; Aiello et
al., 1995; Stein et al., 1995; Stone et al., 1995, 1996],
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Chapter Two
Mural Cells Of The Retinal Vessels
2.1 Introduction
2.1.1 The Vascular Network of the Retina
The vasculature is composed of two distinct cell types: endothelial cells which
assemble into a network of blood vessels; and mural cells which encapsulate the
vessels [reviewed in Risau, 1997], There are two types of mural cells; smooth
muscle cells which densely cover larger vessels [Bloom and Fawcett, 1968], and
pericytes that form a non-continuous layer around smaller vessels [Rhodin, 1968],
In comparison to endothelial cells, relatively little is know about the mural cells.
There are several hypothesises regarding mural cell origin, their functions,
mechanisms of action and recruitment during blood vessel development. These
hypothesises will be discussed in this chapter, followed by a detailed account of
mural cell coverage of the rat retinal vasculature.
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The vessel system feeding the retina begins with the central retinal artery within the
optic nerve that resembles other small arteries of the circulatory system [Wise,
Dollery and Henkind, 1971], When the artery enters the retina, it divides into
several intraretinal branches (arterioles), where the endothelial cells are orientated
parallel to the vessel axis and are surrounded by smooth muscle cells. The central
vein also divides into intraretinal branches (venules) that are larger than the
arterioles, but have a much thinner wall. The capillary network connecting the
arterioles and venules are classified into pre-capillaries, true-capillaries and post-
capillaries [Zimmermann, 19231j. As retinal arterioles split into pre-capillaries, the
smooth muscle cell coverage is decreased and the microvessels begin to develop a
pericyte coating that extends onto the venules.
Although both types of mural cells will be examined in my studies, more attention
will be directed towards pericytes for two reasons. Firstly, the main vessels of the
retina resemble other small arterioles and venules in the circulatory system,
therefore smooth muscle cell coverage is expected to be limited to these larger
vessels. Secondly, in animal models mimicking retrolental fibroplasia, hyperoxia
causes the retinal arterioles to contract resulting in the regression of the capillary
network [Ashton, Ward and Serpell, 1954], It is possible that in these animals,
vessel regression is due to delayed or loss of pericyte coverage.
2.1.2 Identification ofMural Cells
Microvascular mural cells were first identified in 1873 and described by Rouget as
'non-pigmented adventitial cells' present in the vasculature ofmany species2. Since
their discovery, these cells have been called Rouget cells [Clark and Clark, 1925; de
Oliveria, 1966], pericapillary cells [Battig and Low, 1961], undifferentiated cells,
perivascular cells, and intramural pericytes [Ashton and de Oliveria, 1966; de
1 The original paper was written in German and a translation was not available. This is taken from
the review by Darland and D'Amore, 2001b.
2 The original paper was written in French and a translation was not available. This is taken from the
review by Ashton and Oliveria, 1966.
30
Chapter Two: Mural cells ofthe Retinal Vessels
Oliveria, 1966], However, the most widely used term today is pericyte ('peri'
meaning around and 'cyte' meaning cell), as suggested by Zimmermann .
Mural cells can be distinguished from other cells of the vasculature, such as
endothelial cells and fibroblasts, by their location within the vascular network, by
their morphology, and more recently by their expression of certain protein markers.
However, differentiating pericytes from smooth muscle cells is more difficult, firstly
because some mural cells of smaller vessels lack the typical structure of either a
pericyte or a smooth muscle cell, and secondly, because studies investigating the
expression of protein markers by pericytes and smooth muscle cells have produced
conflicting results.
Morphology
Using electron microscopy, the complete structure of blood vessels was gradually
revealed. It was found that the relative frequency and distribution of mural cells
varies among species and within different organs, and that coverage differs
depending on the type and location of the vessel [Tilton et al., 1985],
Smooth muscle cells are elongated, spindle shaped cells with fine tapered ends and a
wider central region which contains the elongated or ovoid nucleus. The length of
these cells depends on the location, from about 20pm in diameter in smaller arteries
to 500pm in larger vessels [Weiss, 1988], Smooth muscle cells can be found
arranged in small bundles surrounding large arteries, or as sheets of
circumferentially orientated individual cells around arterioles. Veins also have a
smooth muscle cell covering, but it is considerably reduced in comparison to
arteries. All smooth muscle cells are arranged offset with respect to one another so
that the nuclear region of one is adjacent to the tapered ends of its neighbours
[Bloom and Fawcett, 1968; Leeson and Leeson, 1976],
3 Reviewed in Sims, 1986.
31
Chapter Two: Mural cells of the Retinal Vessels
In 1923, Zimmermann4 investigated pericytes in many vertebrates, including fish,
amphibians, reptiles, birds and mammals, and reported that the cell bodies of
pericytes are often elongated with multiple, long and slender cytoplasmic processes
that run parallel to the axis of capillaries or encircle the capillary wall. The pre¬
capillary pericyte processes are mainly wrapped around the vessel, with a few lying
along the axis [Zimmermann, 19234; Fujiwara & Uehara, 1984], True capillaries are
encircled by few widely scattered pericytes with many primary and secondary
branches [Rhodin, 1968] that are arranged longitudinally and circumferentially,
respectively [Zimmermann, 19234; Fujiwara & Uehara, 1984], Post-capillaries have
the greatest number of pericytes [Rhodin, 1968], The cells are more branched with
shorter processes [Zimmermann, 19234], and appear not to be confined to a
particular orientation [Fujiwara & Uehara, 1984], In addition, Zimmermann5 found
that pericytes of pre- and post-capillaries display a gradual transition to smooth
muscle cells and termed them 'transitional' pericytes, and called the cells of the mid-
capillaries 'true' pericytes.
Whereas smooth muscle cells are separated from endothelial cells by a thick layer of
extracellular matrix, pericytes and endothelial cells of capillaries are separated by a
thin layer of basement membrane [Steinberg, 1963], So, in comparison to smooth
muscle cells, pericytes lie in close proximity to endothelial cells with occasional
points of direct contact [Rhodin, 1968; Fujiwara and Uehara, 1984], but the
processes of one pericyte rarely contact those of a neighbouring pericyte [Rhodin,
1968],
Protein markers
a-smooth muscle actin (a-SMA)
Actin is a major cytoskeletal protein expressed in mammals as six isoforms, four of
which are markers ofmuscle tissue [Owens and Thompson, 1986], The expression
of a-SMA (muscle-specific actin) by pericytes has been reported by several
4 Reviewed in Sims, 1986.
5 Reviewed in Nehls and Drenkhahn, 1993; Darland and D'Amore, 2001b.
32
Chapter Two: Mural cells ofthe Retinal Vessels
researchers [Skalli et al., 1989; Mitchell et al., 1990; Newcomb and Herman, 1993;
Nicosia and Villaschi, 1995], Herman and D'Amore, for example, found from in
situ and in vitro labelling of endothelial cells, pericytes and smooth muscle cells,
that a-SMA stained both pericytes and smooth muscle cells whereas /ESMA (non-
muscle specific actin) positively stained pericytes and endothelial cells, but not
smooth muscle cells [Herman and D'Amore, 1985], Some researchers, however,
argue that pericytes do not express a-SMA. Nehls and Drenckhahn found that
capillaries of the retina and mid-capillaries of the mesentery artery were devoid of
a-SMA [Nehls and Drenckhahn, 1991], The pre-capillary and post-capillary
pericytes of the mesentery artery, however, stained positively for a-SMA. They
suggested that the a-SMA positive mural cells that covered vessels were in fact
smooth muscle cells. This, to some extent, agrees with Zimmermann6 who stated
that pre-capillary and post-capillary pericytes display a gradual transition to smooth
muscle and that only the mid-capillary pericytes are 'true' pericytes.
Myosin
Myosin, like smooth muscle actin, consists of several isoforms, and is an essential
component of the contractile system present in muscle and non-muscle cells.
Studies of cultured pericytes and tissue sections demonstrated that pericytes
expressed both the a and f isoforms of myosin [Joyce, Haire and Palade, 1985;
Ehler et al., 1995], though ^-myosin was more predominant in small capillaries
[Joyce, Haiie and Palade, 1985], Myosin was also expiessed by endolhelial cells
[Joyce, Haire and Palade, 1985; Ehler et al., 1995], but not by vascular smooth
muscle cells [Mitchell et al., 1990],
Desmin
Desmin is one of the two principal intermediate filament proteins present in muscle
and muscle-like cells [Debus, Weber and Osborn, 1983], Many researchers agree
that smooth muscle cells express desmin [Mitchell et al., 1990; Nehls, Denzer and
Drenckhahn, 1992; Nicosia and Villaschi, 1995] however, their opinion regarding
6 Reviewed in Darland and D'Amore, 2001b.
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the expression of desmin by pericytes differ. In one study the desmin antibody
stained fine processes running along the mid-capillaries; the authors suggested that
these processes belonged to the youngest pericytes in the vasculature [Nehls, Denzer
and Drenckhahn, 1992], By that account, it is possible that desmin was the first
marker to be expressed by pericytes. In contrast, another study reported that during
the early stages of angiogenesis, pericytes cultured from rat aorta were desmin
negative and became weakly positive later in development [Nicosia and Villaschi,
1995],
Other markers
Vimentin is another intermediate filament protein expressed by muscle cells. As
well as staining endothelial cells, vimentin also stained pericytes of various tissues
[Mitchell et al., 1990; Ehler et ah, 1995], Observations showed that as the
mesenchyme cells matured, their expression of vimentin also increased, but the
expression was down-regulated as the cells differentiated towards the smooth
muscle lineage [Ehler et ah, 1995],
3G5 (a ganglioside-like antigen) labelling was continuous and limited to the external
margins of retinal capillary walls [Nayak et ah, 1988], Unlike the markers
mentioned above, 3G5 only stained pericytes and not other vascular cells, such as
endothelial cells or smooth muscle cells [Nayak et ah, 1988; Schlingemann et ah,
1990], thus the 3G5 antibody may be the most specific marker for pericytes within
the microvasculature.
NG-2 is a high molecular weight melanoma-associated antigen [Schlingemann et ah,
1990; Grako and Stallcup, 1995] which has been suggested to be a specific marker
for activated pericytes during angiogenesis [Schlingemann et ah, 1990], Yet, NG-2
may not be a suitable marker for in situ detection of pericytes because it has also
been reported to stain immature smooth muscle cells [Burg et ah, 1999] and
proliferating endothelial cells [Pagan-Mercado et ah, 2002].
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In summary, a marker specific to any one of the two mural cells is currently
unavailable, since much of the published data is contradictory. Be that as it may,
there are several reasons for the discrepancies between the reports. Firstly, the
anatomy of the capillary system differs from tissue to tissue and no two studies have
investigated the exact same vasculature from the same species. Secondly, in studies
involving cell cultures the pericytes were obtained from different sources and
instead of being from true capillaries, they may be of vascular smooth muscle origin.
Thirdly, it is possible that the expression of the markers differs depending on the
stage of pericyte differentiation or on the maturity of the pericyte.
2.1.3 Origin and Recruitment of Pericytes
One of the biggest controversies surrounding mural cells is their embryonic origin.
There are three hypothesises, and it has been suggested that all three are correct and
all contribute to pericyte differentiation.
Kuwabara and Cogan thought that pericytes stemmed from a layer of
undifferentiated cells called the mesenchyme [Kuwabara and Cogan, 1963], Their
theory was soon backed by Shakib and de Oliveria [Shakib and de Oliveria, 1966],
Furthermore, Hirschi and colleagues grew 10T1/2 cells (presumptive mesenchymal
cells or mural cell precursors) on their own and as co-cultures with endothelial cells
and found that in the presence of endothelial cells, the 10T1/2 cells underwent
dramatic shape change from polygonal to spindle-shaped (typical structure of mural
cells) [Flirschi, Rohovsky and D'Amore, 1998], In addition, when endothelial cells
and 10T1/2 cells were grown in three-dimensional co-cultures, the cells were
organised and orientated similar to vessels in vivo; the endothelial cells became
tightly associated in cord like structures and the 10T1/2 cells either stretched along
or wrapped around the endothelial cells [Darland and D'Amore, 2001a],
35
Chapter Two: Mural cells ofthe Retinal Vessels
In 1873, Rouget7 described pericytes as less differentiated smooth muscle cells,
which implies that pericytes and smooth muscle cells are somehow related. Since
Rouget's statement, a body of evidence has gathered confirming that pericytes and
smooth muscle cells are indeed related:
• pericytes react with both muscle and non-muscle isoactin
• in culture the morphology of pericytes is very similar to smooth muscle
cells
• both cells are similar in their location (external margin of the
endothelium).
Over a century later this theory was developed further and it was suggested that
pericytes might be derived from nearby vascular smooth muscle cells that
'dedifferentiate', proliferate and then associate with new sprouts [Nicosia and
Villaschi, 1995; Lindahl et al., 1997; Hellstrom et al., 1999],
The third hypothesis is that pericytes are at least partly differentiated from stromal
fibroblasts. Nehls and colleagues reported that desmin positive pericytes were
fibroblast-like in morphology and found that once endothelial cells and fibroblasts
established a contact, the fibroblasts differentiated into periendothelial cells and
began to express desmin. The pericytes of the small capillaries then acquired
smooth muscle-like features [Nehls, Denzer and Drenckhahn, 1992],
The method by which pericytes and smooth muscle cells cover the vasculature is
unclear. It is proposed that the cells migrate systematically from the root to the tip
of microvessels using pre-existing parent vessels as a guide and as a surface for
attachment [Crocker, Murad and Geer, 1970]. However, Benjamin and colleagues
observed that mural cell coating (identified using a-SMA) lagged significantly
behind the formation of the blood vessels [Benjamin, Hemo and Keshet, 1998], and
suggest that although retinal vessel formation proceeds radially from the optic disc
outwards [Stone et al., 1995], vessel coverage proceeds in the arteriole to venule
7 Reviewed in Darland and D'Amore, 2001b.
36
Chapter Two: Mural cells ofthe Retinal Vessels
direction. Another mechanism may involve the in situ differentiation of mural
precursor cells similar to differentiation of angioblasts into endothelial cells during
vasculogenesis [Carmeliet and Collen, 1998], It is also suggested that in the adult
vasculature pericytes may sprout from a pre-existing parent vessel at sites of
angiogenesis [Nehls and Drenckhahn, 1993],
2.1.4 Roles of Pericytes
A number of functions have been ascribed to pericytes, and since smooth muscle
cells and pericytes are so closely related, the most obvious pericyte function is
contraction, which was first suggested by Rouget8. This has been supported by
studies showing that pericytes express many contractile proteins, including a-SMA
[Herman and D'Amore, 1985; Herman et al., 1987; Skalli et al., 1989], myosin
[Joyce, Haire and Palade, 1985; Ehler et al., 1995] and desmin [Mitchell et al., 1990;
Nehls, Denzer and Drenckhahn, 1992], Yet, this role is greatly debated since there
is no direct evidence for pericyte contractility in the retina [Friedman et al., 1949],
Other general attributes of the pericytes are phagocytosis during inflammatory
response [Majno and Palade, 1961] and maintenance of a selective permeability
barrier for plasma constituents [Hirschi and D'Amore, 1996], The latter function is
supported by the varied pericyte distribution according to the needs of different
tissues [Frank, Dutta and Mancini, 1987; Shepro and Morel, 1993],
Regarding blood vessel formation, the main role of pericytes is suggested to be
stabilisation of the vessel wall and, therefore, maintenance of vascular integrity
[Kuwabara and Cogen, 1963; Orlidge and D'Amore, 1987; Suri et al., 1996], It is
believed that the pericytes stabilise the vasculature by providing support for the
endothelial tubules, by transforming a 'plastic' tubule into a 'static' structure and
possibly by protecting the tubules from damage:
8 Reviewed in Diaz-Flores et al., 1991, and in Nehls and Drenkhahn, 1993.
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• endothelial tubules which lack a coating of mural cells are leaky and
prone to rupture [Suri et al., 1996]
• loss of retinal capillary pericytes in diabetic retinopathy may be linked to
the occurrence ofmicroaneurysms reported in the disease [Kuwabara and
Cogen, 1963]
• vessels with the slowest endothelial cell turnover have the highest extent
of pericyte coverage [Tilton et al., 1985]
• in cell cultures, when endothelial cells and pericytes come into contact,
endothelial cell proliferation is inhibited [Orlidge and D'Amore, 1987],
The exact mechanism by which pericytes promote vessel stability is unclear. There
are, however, a number of factors involved: firstly, endothelial cells and pericytes
must interact with each other by at least coming into close proximity; secondly, the
production and secretion of basement membrane proteins by the pericytes; and
thirdly, the release of vascular growth factors by both cells. These factors are
described in further detail below.
2.1.5 Regulation of Pericyte Growth and Differentiation
Like all cell types, pericytes are affected by changes in the surrounding
environment, for example, the increased or decreased expression of growth factors.
During vessel development, the actions of pericytes are dependant on three main
growth factors secreted by the pericytes themselves or by other cells in close
proximity.
Platelet-derived growth factor-B, secreted by endothelial cells [Collins et al., 1985],
binds to its receptor expressed on the cell surface of undifferentiated mesenchymal
cells [Bernstein, Antoniades and Zetter, 1982], PDGF-B is reported to induce the
migration of undifferentiated mesenchymal cells towards endothelial cells [Hirschi,
Rohovsky and D'Amore, 1998],
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As discussed earlier, one of the functions of pericytes is to inhibit endothelial cell
proliferation [Orlidge and D'Amore, 1987], It is believed that this effect is mediated
through transforming growth factor-/?, which is activated when endothelial cells and
pericytes make contact (or came into close proximity) [Antonelli and Orlidge, 1989;
Sato and Rifkin, 1989], Although this growth factor suppresses endothelial growth,
it promotes the differentiation of mesenchymal cells into pericytes [Hirschi,
Rohovsky and D'Amore, 1998] and promotes the proliferation of the pericytes
[Hellstrom et al., 1999],
Transgenic mice lacking either the gene for angiopoietin-1 [Suri et al., 1996] or the
gene for its receptor (Tie-2) [Dumont et al., 1992] share many phenotypic
abnormalities including the lack of endothelial cell encapsulation by mural cells.
Consequently, the vessels of these mice are fragile and prone to rupture and leakage.
In addition, the angiopoietin-1/Tie-2 system also inhibits endothelial cell apoptosis
[Kwak et al., 1999; Papapetropoulos et al., 1999],
It has been suggested that pericytes and smooth muscle cells are capable of
producing basement membrane [Shakib and de Oliveria, 1966] and extracellular
matrix components [reviewed in Owens, 1995], respectively, which in turn have
profound effects on cell behaviour including migration, proliferation and
differentiation. The basement membrane covering endothelial cells is mainly
composed of collagen and has several functions, the most important of which is
support; acting as a framework for the endothelial cells and pericytes and as an
anchor for the vessel to the surrounding tissue.
Thus, the current theory with regard to how a mesh of unremodelled vessels
becomes a mature network can be described in the following way. Once the
endothelial tubules are formed and before smooth muscle cell or pericyte coverage
begins, there is a time interval (or window of plasticity) during which the
vasculature remodels and adjusts to the physiological needs of the tissue [Benjamin,
Hemo and Keshet, 1998], The endothelial cells then secrete platelet-derived growth
39
Chapter Two: Mural cells ofthe Retinal Vessels
factor-B, which binds to the receptor on undifferentiated mesenchymal cells, and
promotes their migration towards the endothelial cells [Hirschi, Rohovsky and
D'Amore, 1998], As these mesenchymal cells come into close contact with
endothelial cells, both cells begin to release transforming growth factor-/)1 promoting
the differentiation of mesenchymal cells into mural cells [Antonelli-Orlidge et al.,
1989; Sato and Rifkin, 1989], and suppressing vascular growth by inhibiting
endothelial cell proliferation [Orlidge and D'Amore, 1987], Pericytes then
synthesise and secrete new basement membrane [Diaz-Flores et al., 1994], while
smooth muscle cells produce extracellular matrix components [reviewed in Owens,
1995; and in Hungerford and Little, 1999], at which point the proliferative phase
comes to an end. Vessel regression is inhibited by the interaction of angiopoietin-1
with the tie-2 receptor; however, the exact role of angiopoietin-1 in this process is
yet to be fully elucidated.
2.1.6 Pericytes in Postnatal Life
The adult vasculature, although mature, still undergoes changes in physiological
situations such as wound repair and menstruation. Thus, it is hypothesised that
pericytes are involved in sprouting angiogenesis [Nehls, Denzer and Drenckhahn,
1992; Hirschi and D'Amore, 1997], Briefly, pericytes are activated by a number of
angiogenic stimuli and the basement membrane is degraded [Diaz-Flores et al.,
1994], As a result, the contact between the pericytes and endothelial cells is thought
to be loosened, but the pericytes guide the migrating endothelial cells and continue
to regulate their proliferation [Hirschi and D'Amore, 1997], The endothelial cells
form a connection between new sprouts [Nehls, Denzer and Drenckhahn, 1992] at
which point angiogenesis comes to an end and the pericytes reoccupy their position,
synthesise new basement membrane and stabilise the vasculature again. To date,
however, there is little evidence for pericytes or smooth muscle cells directly
regulating angiogenesis, although one report found desmin-positive pericytes at and
in front of the advancing tips of endothelial sprouts, and suggested that pericytes
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participate in angiogenesis from the earliest stages of capillary sprouting [Nehls,
Denzer and Drenckhahn, 1992],
Pericyes are also thought to play a significant role in vascular diseases. For
example, an increase in pericyte number has been reported in hypertension; vessels
of the spontaneously hypertensive rat contained four times as many a-SMA positive
pericytes than normal rats [Herman and Jacobson, 1988], Pericytes are suggested to
have a contractile function and are implicated in controlling vessel diameter
[Rouget, 18739; Kuwabara and Cogan, 1963], Thus, a microvessel with increased
pericyte coverage may have the potential to contract more than a microvessel with
normal coverage, and thereby contribute to hypertension.
In contrast, Spieser and colleagues determined the ratio of endothelial cells to
pericytes in non-diabetic and diabetic patients, and reported that prior to retinal
neovascularisation, there was a selective loss of pericytes on the retinal capillaries
(termed pericyte drop-off) [Spieser, Gittelsohn and Patz, 1968], The reduction in
pericyte number may cause a loss of support and stability of the capillaries, and may
therefore underlie the formation of microaneurysms often seen in this condition.
The exact mechanism which underlies the degeneration of the pericytes has not been
established.
9 Reviewed in Diaz-Flores et al., 1991, and in Nehls and Drenkhahn, 1993.
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2.2 Aims and Hypothesis
As discussed earlier, studies investigating the expression of biochemical markers by
pericytes and smooth muscle cells have produced conflicting results with regard to
localisation and marker expression during development. Therefore, the purpose of
the work in this chapter was:
• to compare the distribution of two mural cell markers in the rat retina
• to determine the extent ofmural cell coverage during development of the rat
retina using the protein markers
• to determine if the retinal vessel coverage by mural cells was affected by the
fluctuating oxygen regime of the Edinburgh model of retinopathy of
prematurity (ROP).
The extent ofmural cell coverage is of course expected to increase as the vasculature
forms, however it is expected that both smooth muscle cell and pericyte coverage
will only extend to the remodelled vasculature, thus the central vessels are expected
to establish a mural cell coating before the peripheral vessels.
Literature on mural cell coverage in animal models ofROP is very limited, however,
it is thought that there may be a loss of pericytes in this disease, as many growing
vessels of the incompletely vascularised retina lack mural cell coverage [Hirschi and
D'Amore, 1997], Because the Edinburgh model results in reduced vascular
remodelling, it is proposed that there shall be a reduction in the extent of pericyte
and/or smooth muscle cell coverage.
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Approval for these studies was given by the UK Home Office and all animals were
cared for in accordance with UK Home Office legislation.
Sprague-Dawley rats were supplied by Bantan and Kingman, UK and mated in the
Medical Faculty Animal Facility. Two groups of animals were studies, room-air
controls and oxygen treated, and three litters were analysed per group. It has been
previously shown that an increase in litter size induces a greater incidence and
severity of disease due to postnatal growth retardation [Holmes and Duffner, 1996],
Therefore, litters with a minimum of 12 pups were used in order to induce a
significant change in the retinal development of the oxygen treated pups. Pups from
litters born on the same day were used to supplement any litters of fewer than 12
pups. Within four hours of the final pup of each experimental litter being delivered,
the pups and their mother were transferred into an oxygen chamber and raised in the
oxygen profile. The rats were exposed to a 12-hour light: 12-hour dark cycle. The
chambers were cleaned every seven days at which point the profile was paused and
restarted about ten minutes later. The build-up of carbon dioxide was prevented
through the flow of injected gases and by placing soda lime chips (Medisorb) in a
corner of the animal chamber.
Control litters were raised in room air and sacrificed on postnatal day 2 (P2), P7,
P14 and P21. Experimental litters were exposed to the minute-to-minute variable
oxygen profile set at lOkPa (described in Chapter One and in McColm et al., 2004).
Pups were anaesthetised and killed immediately upon removal from the oxygen
profile on P2, P7 and PI4.
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Termination ofexperiment
The rat pups were weighed and anaesthetised by intraperitoneal injection of
ketamine (2.5mg/kg bodyweight) and xylazine (lmg/kg bodyweight). The chest
cavity was then opened and, depending on the weight of the pup, 1.5 - 2.5mls of 1M
phosphate buffered saline (PBS) was injected slowly into the left ventricle followed
by 1.5 - 2.5mls 0.5% paraformaldehyde. The animals were then euthanised by
intracardiac injection of 0.5mls pentobarbitone. Both eyes were enucleated; the
right eye was taken for immunohistochemistry and the left for Western blotting.
2.3.2 Immunohistochemistry
Fixation
Without taking any factors, such as pup weight, into consideration, the right eyes
were randomly divided into two groups; one group was stained for lectin and a-
SMA, the other for lectin and desmin. Eyes for a-SMA staining were fixed whole in
2% paraformaldehyde for 2 hours before being washed in 1M PBS. Eyes for desmin
staining were first pierced by a needle and then fixed whole in 75% acetone in 1M
PBS for approximately 30mins. To directly compare the expression of the two
mural cell markers, some day 14 control retinas were double-labelled with a-SMA
and desmin. These retinas were fixed in 75% acetone.
Retinal wholemounts
Under a dissecting microscope a scalpel incision was made in the cornea just above
the ora serrata. Scissors were then used to cut round the junction between the cornea
and sclera until the cornea could be completely removed after which the iris and lens
were removed easily. For the eyes fixed in paraformaldehyde (a-SMA staining), the
retina was gently eased from the sclera using fine forceps, taking care to leave the
ora serrata intact as it defined the edge of the retina. The retinal cup was then
transferred onto a glass slide. For the eyes fixed in acetone (desmin staining), the
retina and sclera were so strongly attached that separating the two was very difficult,
and so the retina was mounted onto a slide with the sclera still attached. Four
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incisions perpendicular to the outer edge of the retina were made, which divided the
retina into four equally sized quadrants. At this stage the retina was flattened onto
the slide and as much vitreous as possible was removed by gently plucking the
retinal surface using forceps.
Double staining: a-SMA/desmin and lectin
The flattened retinal wholemounts fixed in paraformaldehyde were further fixed in
cold 70% ethanol (-20°C) for 20mins. All retinal wholemounts were then
permeabilised in 1M PBS/1% Triton X-100 for 30mins and blocked using 5%
normal rabbit serum (Diagnostic Scotland) diluted in 1M PBS/Triton X-100 for
20mins. The retinas were incubated overnight at 4°C in primary antibody prepared
in the serum solution: a-SMA (Sigma) at 1:400; and desmin (Dako) at 1:50. The
following day, the tissues were washed in 1M PBS/1% Triton X-100 (each wash
stage in the protocol consisted of three lOmins incubation with this solution), and
then incubated (with gentle shaking) for 2 hours at room temperature in biotinylated
rabbit anti-mouse secondary antibody (Dako) diluted to 1:200 in 1M PBS/1% Triton
X-100. The retinas were washed and Texas red streptavidin (1:100, Vector
Laboratories) was applied for 2 hours at room temperature with gentle shaking.
After washing, the retinas were blocked using avidin and biotin for 20mins each
(Vector Laboratories) before incubating with biotinylated G. simplicifolia
(Bandeiraea) isolectin B4 (1:50, Vector Laboratories) overnight at 4°C. The
following day the washes were repeated and the retinas incubated in fluorescein
streptavidin (1:100, Vector Laboratories) for 2 hours with gentle shaking at room
temperature. The wholemounts were washed for the final time and mounted in
PBS:glycerol (1:1) and the coverslip sealed with nail varnish.
Double staining: a-SMA and desmin
Once the day 14 control eyes were fixed in acetone and dissected, the retinas were
stained using a protocol similar to that described above. Briefly, the wholemounts
were permeabilised in 1M PBS/1% Triton X-100 for 30mins and blocked in 5%
rabbit serum (Diagnostic Scotland) for 20mins. The retinas were first incubated in
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desmin antibody (1:50) overnight at 4°C. The retinas were then washed and
incubated for 2 hours in biotinylated secondary antibody (anti-mouse, 1:200). The
washes were repeated and Texas red streptavidin (1:100) was applied to the tissues
for another 2 hours. The retinas were then washed again and blocked using avidin,
biotin and 5% rabbit serum for 20mins each, after which a-SMA antibody (1:400)
was applied overnight at 4°C. The following day, the washes were repeated and the
wholemounts were incubated in secondary antibody (anti-mouse 1:200) for 2 hours,
followed by 2 hours in flourescein streptavidin (1 TOO). The wholemounts were then
washed for the final time and mounted.
Triple staining: a-SMA, lectin and TO-PRO-3
A few eyes were fixed in 2% paraformaldehyde, the retinas dissected and stained for
a-SMA and lectin as described above. The cell nuclei were then labelled using a
nuclear marker, TO-PRO-3 iodide (Molecular Probes); TO-PRO-3 was prepared in
1M PBS at a concentration of 1:500 and applied to the wholemounts for lOmins.
The wholemounts were briefly rinsed in 1M PBS and mounted.
Negative controls
For the a-SMA and desmin negative controls, fixed retinal wholemounts were first
incubated in 5% serum solution overnight at 4°C and then in rabbit anti-mouse
secondary antibody (1:200) for 2 hours. Texas red streptavidin (1:100) was then
applied for a further 2 hours. For the lectin negative controls, the retinas were
incubated in 1M PBS/1% Triton X-100 overnight at 4°C followed by flourescein
streptavidin (1:200) for 2 hours.
Analysis
The retinal flatmounts were viewed using a Leica TCSNT confocal system with a
mixed gas argon/krypton laser (Leica Microsystems, Germany). Cells stained using
fluorescein were labelled green and excited at 488nm (filter BP 525/50), and cells
stained with Texas red were labelled red and excited at 568nm (filter LP 590).
TO-PRO-3 stained cell nuclei blue and was excited at 647nm. Representative
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images at x5, xlO, x20, x40 and x63-oil magnification were taken and digitally
stored for later analysis. To eliminate cross-talk between the flurochromes which
can give rise to false results, the retinas were scanned by sequential scanning; first
the retinas were scanned for fluorescein, followed by Texas red, and where
applicable for TO-PRO-3. The images were then overlaid.
2.3.3 Western Blot Analysis
Protein extraction and assays
Retinas from each control and experimental litter were dissected fresh in 1M PBS,
pooled and stored at -70°C. At a later stage, the proteins were extracted from the
retinas using the following method. The retinas were first homogenised in
extraction buffer containing 50mM Tris-HCl, 4mM EDTA, 0.1% Tween and a
mammalian cell and tissue proteinase inhibitor cocktail (Sigma). The samples were
then centrifuged at 14,000g for lOmins after which the supernatant was removed and
spun for a further 30mins. The supernatant was then transferred into eppendorf
tubes and stored at -70°C.
The protein content of the samples was measured using the BCA protein assay
method (Perbio) according to the manufacturer's instructions. Briefly, 5pi of each
sample was added to the extraction buffer, followed by 95 pi BCA protein assay
reagent. All samples were incubated at 37°C for 30mins after which the OD562 of
each sample was measured. Bovine serum albumin was used as standard.
Protein separation and transfer
75pg of total retinal protein for each control and experimental timepoint were loaded
onto a 12% acrylamide gel along with a biotinylated molecular weight marker
(Biorad). The proteins were then separated by SDS-PAGE electrophoresis for
around 2 hours and transferred onto PVDF membranes (Bio-Rad Laboratories) using
the semi-dry transfer cell (Bio-Rad Laboratories) according to the manufacturer's
instructions.
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Blotting
The membranes were washed twice (1M PBS/0.1% Tween) for 5mins while shaking
gently and blocked overnight at 4°C in 5% non-fat dry milk prepared in the wash
solution. The next morning, the membranes were washed twice with gentle shaking
for 5mins each, and incubated in primary antibody (a-SMA at 1:1000 (Sigma) or
desmin at 1:500, 1:200 and 1:100 (Santa Cruz and Dako)) prepared in the blocking
solution for 1 hour at room temperature with gentle shaking. The membranes were
then washed three times for 5mins followed by two 15mins washes, and incubated in
horseradish peroxidase conjugated secondary antibody (for a-SMA, rabbit anti-
mouse (Dako) and for desmin, rabbit anti-goat (Dako), both at 1:5000) prepared in
the blocking solution. Additional horseradish peroxidase (Amersham Bioscience) at
1:2000 was added to the secondary antibody solution for detection of the molecular
weight marker. The membranes were again washed several times and incubated for
5mins in ECL-Plus Western blotting developer (Amersham Bioscience). The
membranes were then exposed to X-ray film for around 2mins.
To ensure that any difference in expression between control and experimental litters
was not due to loading errors, each membrane was stripped and reprobed for actin.
Briefly, the membranes were first stripped for 15mins at 37°C using Restore
Western Blot Stripping Buffer (Pierce), washed and blocked in 5% non-fat milk
overnight. The following morning, the membranes were incubated in actin primary
antibody (1:100, Santa Cruz) and then in anti-goat secondary antibody containing
horseradish peroxidase. After the washing stage, developer solution was applied to
the membranes which were then exposed to X-ray film.
Analysis
An image of the X-ray film was captured using software called 'Quantity One' (Bio-
Rad Laboratories). Individual bands that had developed on the X-ray film were
manually selected and the software calculated the quantity of a-SMA protein
expression in each sample by taking its area and intensity into consideration.
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2.3.4 Threshold Analysis for Desmin Expression
Desmin labelling of the retinal vasculature was measured in the retinas of pups
raised in room-air and the lOkPa regime of the Edinburgh model by threshold
analysis. Images of the central and peripheral retina from each quadrant were taken
using the confocal microscope, the offset and gain of which were adjusted to
eliminate background signalling. Images for lectin staining and desmin staining
were stored separately. Later, using data analysis software called 'Image Tool'
(designed by The University of Texas, Health Sciences Centre, San Antonio), the
threshold for each lectin and desmin image was manually set, and the software
calculated the number of black and white pixels. The extent of desmin coverage was
then expressed as a percentage of the lectin staining.
2.3.5 Transmission Electron Microscopy
Only two P14 control and two P14 experimental retinas were processed for electron
microscopic analysis to establish whether pericytes made direct contact with
endothelial cells. In addition, the electron microscopic analysis allowed me to
determine if the association between the two cell types was compromised as a result
of oxygen exposure.
Fixation
The retinas were dissected fresh in 1M PBS, but the sclera was not removed as it
provided support for the retina when it was cut into quadrants. Once the retina was
flattened onto a slide, they were fixed using 3% glutaraldehyde in 0.1M sodium
cacodylate buffer for around 2 hours.
Sectioning and staining
The tissue processing, sectioning and staining were carried out by Steve Mitchell in
the electron microscope suite within the Royal Dick Vet School.
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All processing was carried out with a constant rotation of the tissues. The tissues
were washed in 0.1M sodium cacodylate buffer for an hour followed by post-
fixation in 1% osmium tetroxide for 45-60mins. The wash was repeated and the
tissues were dehydrated through a graded series of acetone solutions (50%, 70%,
90% and 100%). The tissues were infiltrated in a 50:50 mix of araldite and acetone
for 30mins at room temperature and then at 60°C overnight. The next morning the
tissues were infiltrated further in araldite/acetone mix for 3 hours, with a solution
change every hour. The tissues were then infiltrated in araldite/acetone mix with
Acclerator for 2 hours and embedded in the araldite/acetone mix with Acclerator for
48 hours at 60°C.
60-80nm serial sections of the retinal quadrants were obtained using an ultra-
microtome and the sections mounted onto formvar-coated copper slots grides. Once
the sections were dried, they were stained by an LKB ultrostainer using uranyl
acetate and lead cirtrate.
Analysis
The retinal sections were viewed using the Philips CM12 transmission electron
microscope and high-power images were obtained.
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2.4 Results
2.4.1 Spread of the Superficial Vasculature
The spread of the retinal vessels during normal development was briefly studied
(Figure 2.1) before investigating their coverage by mural cells. On P2, the
endothelial tubules had spread from the optic nerve area to around a third of the
retinal surface, but the vasculature was only a dense immature mesh which had
undergone very little remodelling. By P7, about two-thirds to three-quarters of the
retinal surface was vascularised and many of the small vessels seen on P2 had
withdrawn around the arterioles to produce capillary-free zones; the leading edge of
the vasculature was still developing, thus was immature in appearance. Formation
of the retinal vascular bed was complete by PI4; the endothelial tubules had reached
the ora serrata and the vasculature had undergone considerable remodelling.
Between P14 and P21 there was no appreciable difference in the appearance of the
vasculature.
2.4.2 Effects of Variable Oxygen Exposure on Endothelial Tubule Formation
The oxygen regime of the Edinburgh model caused abnormalities in the formation of
the endothelial tubules that resembled the early stages ofROP in that retinal vascular
development was delayed (called vaso-obliteration). As mentioned above, pups
raised in room-air, had a fully formed superficial retinal vasculature by P14. In
comparison, retinas of pups exposed to the lOkPa oxygen profile from birth to P14
had a less remodelled and mature vasculature (indicated by an increase in the
number of capillary branches) and a significant peripheral avascular area (Figure
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Figure 2.1: Formation of the retinal vasculature.
The endothelial cells were labelled using lectin followed by fluorescein streptavidin.
P - postnatal day.
Scale bar: (P2) 400pm; (P7) 500pm; (P14) 400pm.
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Figure 2.2: Rat pup retinas after exposure to the Edinburgh model of ROP.
Retinas were stained using lectin and fluorescein streptavidin. (A) Retinal quadrant of
P14 control pup. (B) Retinal quadrant ofP14 oxygen treated pup. (C) Retinal capillary
density of control pup. (D) Retinal capillary density of oxygen treated pup.
Scale bar: (A) 400pm; (B) as A; (C) 200pm; (D) as C.
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2.4.3 Defining a-SMA and Pesmin Staining
To begin the investigation of mural cell coverage, the labelling of both markers was
first determined.
a-SMA labelled a single layer of closely packed spindle-shaped cells with tapered
ends and a wider central region which contained the nucleus (Figure 2.3 A, page 54).
The cells were arranged perpendicular to the axis of the vessel and in a manner so
that the nuclear region of one cell lay next to, and possibly in contact with, the
tapered ends of the adjacent cells. The cells were located on the external surface of
the vessel and covered the entire circumference of the arteriole (Figure 2.3 B).
Desmin stained very fine, elongated cells along the arteriole and its branches (Figure
2.3 C). Like a-SMA, desmin positive cells were located on the external surface of
the lectin stained endothelial cells and were wrapped around the arteriole; but unlike
a-SMA, the coverage of desmin stained cells was non-continuous. The extent of
labelling was markedly greater with desmin than a-SMA, as shown in Figure 2.4
(page 55). a-SMA labelling was confined to the arteriole, its branches and, to a
lesser degree, the venule; no staining was observed within the deep capillary bed nor
on the branches of the venule. In comparison, desmin coverage was seen across the
whole vasculature, although it appeared to be most predominant around the venule.
At a higher magnification the structure and distribution of cells positive for a-SMA
and/or desmin could be further established. As mentioned above, a-SMA and
desmin predominantly stained the arterioles and venules, respectively. Although
desmin staining was sparse on the arteriole, it followed the same pattern as a-SMA;
the few fine processes of the cells were wrapped around the vessel. As illustrated in
Figure 2.5, some cells stained positively for both markers. These cells either had the
typical structure of smooth muscle cells (elongated spindle shaped cells with tapered
ends, arrow b) and expressed very little desmin, or were strongly positive for desmin
(arrow a), but lacked the typical shape of a pericyte or smooth muscle cell.
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Figure 2.3: Arterioles of P14 control retinas double-labelled with lectin and
«-SMA or desmin
(A) Double-stained using lectin (green) and a-SMA (red). Projected focus stack of 5
optical sections at 0.85pm. (B) Cross-section of image A. The side panels are
orthogonal slides through the Z-stack (C) Double-stained using lectin (green) and
desmin (red). Projected focus stack of 9 optical sections at 1.06pm. (D) Cross-section
of image C. The side panels are orthogonal slides through the Z-stack.
Scale bar: 32pm.
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Figure 2.4: Comparison of «-SMA and desmin staining of P14 control retina.
Retinal flatmount double-labelled with a-SMA (green) and desmin (red). (A) The
central area containing an arteriole (a) and venules (v). (B) Enlargement of the venule
in image A. (C) Enlargement of the arteriole in image A.
Scale bar: (A) 200pm; (B) 100pm; (C) as B.
Figure 2.5: Comparison of «-SMA and desmin staining of an arteriole.
Some cells stained for both markers, a few were predominantly stained with desmin
(red, arrow a), and others were predomiantly stained with a-SMA (green, arrow b).
Projected focus stack of 7 optical sections at 0.98pm.
Scale bar: 32pm.
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2.4.4 Retinal Expression of a-SMA in Normal and Oxygen Exposed Pups
Postnatal day 2 (Figure 2.6, page 59)
The vasculature of the P2 retina was very immature in appearance, although
capillary-free zones were beginning to form centrally. a-SMA labelling was present
only on the arteriole, however this coverage lagged behind the outgrowth of the
vessels; labelling was strong near the optic nerve, but progressively decreased
towards the advancing peripheral edge of the vasculature. At a higher magnification
the labelling appeared as a sheath over the lectin stained endothelial cells; the
marker did not appear to label cells that had the structure typical of smooth muscle
cells.
The retinas of pups exposed to the variable oxygen regime had around the same
extent of a-SMA labelling as the control retinas; coverage was only present on the
arteriole, but had not progressed very far. In comparison to the image of the control
retina (Figure 2.6 E), the image of the experimental retina (Figure 2.6 F) was taken
closer to the optic disc. As mentioned above a-SMA staining of the arteriole was
strongest at the optic disc region and weakest at the periphery. This could explain
the greater extent of staining observed on the arteriole of the experimental retina.
Postnatal day 7 (Figures 2.7 and 2.8, pages 60 and 61)
By P7 capillary-free zones had formed in the central area, but the capillary network
had undergone limited remodelling. a-SMA coverage of the arterioles was now
more obvious and had progressed further peripherally than on P2. Further analysis
(Figure 2.8) showed that the staining of the arteriole was weakest at the periphery
(almost background levels) and strongest towards the centre of the retina, where the
primary arteriole branches were also beginning to express a-SMA. The coverage,
however, ended very abruptly, at the point where the capillary network had so far
been remodelled. In comparison to P2, when a-SMA-positive cells appeared
flattened, at P7 the cells were adopting the typical structure of smooth muscle cells.
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The retinas of pups exposed to the variable oxygen profile had also established
considerable a-SMA coverage. However, the coverage had not progressed as far as
it had done in the control retina and appeared more as a flattened sheath rather than a
layer of tapered cells; in comparison to the control retinas, the number of cells with a
smooth muscle cell appearance was reduced. Surprisingly, a-SMA staining was
observed on the venules in the central area; this labelling was significantly greater
than the background labelling observed on the venules of the controls.
Postnatal day 14 (Figures 2.9 and 2.10, pages 62 and 63)
By this stage of normal development, the arterioles, in the central area, were
encapsulated by a closely packed layer of cells that resembled smooth muscle cells.
Acquisition of the a-SMA coating within the central area had taken place on the
primary arteriole branches and had advanced onto the secondary branches, but as in
P7 retinas, the coverage ended abruptly and the cells of the branches were not fully
differentiated. Coverage of the arterioles peripherally and the venule however, was
still very limited; only background levels of labelling were observed. Thus, the
staining pattern of a-SMA on the arterioles seemed to differ along its length. This
was investigated by taking several high-power images of an arteriole from the centre
to the periphery (Figure 2.10). Centrally, the arteriole and all its primary branches
were encapsulated by a dense layer of smooth muscle cells. At a mid-point between
the optic nerve and the peripheral edge of the vasculature, the arteriole was still
strongly positive for a-SMA, the cells were arranged around the circumference of
the arteriole, but the number of cells resembling smooth muscle cells had greatly
reduced. At this point coverage continued on to the primary branches, but did not
progress to the very edge. Further towards the periphery, the staining levels of
a-SMA had markedly reduced; levels slightly above background were observed, and
the cells had no distinct structure.
As illustrated in Figure 2.9, a-SMA labelling of the experimental retinas was
observed on the arterioles, its primary branches and on the venules. On the
arterioles of the central area, the cells had differentiated into smooth muscle cells
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and were arranged in a similar manner to those of the control retinas. As previously
mentioned, the vasculature of these retinas was not fully formed, which may explain
the lack of a-SMA labelling on the secondary branches. Another difference between
the control and experimental retinas was that in the former, labelling of the
peripheral arteriole and of the venule was very weak, however in the latter, moderate
labelling was noted on both vessels, though the structure of the cells that stained
could not be determined.
Postnatal day 21 (Figure 2.11, page 64)
Although there was not much difference in the lectin staining of P14 and P21
retinas, a-SMA expression had increased; centrally, the primary and secondary
arteriole branches were completely labelled, and peripherally the staining was
intense. In addition, labelling was also present on the central venules. As on P14,
a-SMA positive cells of the peripheral arteriole did not have any distinct shape.
Likewise, the venules were positive for a-SMA, however the staining was weak and
appeared as a thin layer of flat undifferentiated cells.
Western analysis
The immunohistochemical staining of the flatmounts showed that retinas of pups
exposed to the Edinburgh model expressed less a-SMA than those of room-air raised
pups. To establish if this was indeed the case, the retinal proteins from both groups
were extracted and Western analysis performed. As illustrated in Figure 2.12 (page
65), in normal development no a-SMA protein was detected on day 2. Slight
expression was observed on day 7, which increased markedly by day 14. The
expression was still strong at day 21. In the oxygen-treated tissues, the expression
on both day 7 and day 14 was slightly reduced in comparison to the controls. This
was further confirmed by quantitative analysis.
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Control Oxygen treated
Figure 2.6: «-SMA labelling of P2 control and oxygen treated retinas.
Labelled with lectin (green) and a-SMA (red). (A) Overview of the central retina in a
control pup. (B) Oxygen treated equivalent of image A. (C) The arteriole and capillary
bed in a control pup. (D) Oxygen treated equivalent of image C. (E) Enlarged image
of arteriole in image C. (F) Enlarged image of arteriole in image D
Scale bar: (A) 400pm; (B) as A; (C) 100pm; (D) as C; (E) 32pm; (F) as E.
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B
Figure 2.7: Overview of a-SMA labelling at P7.
























Figure 2.8: «-SMA labelling of P7 control and oxygen treated retinas.
Labelled with lectin (green) and a-SMA (red). (A) The central vasculature, containing
an arteriole and venule of a control retina (B) Oxygen treated retina comparable to
image A. (C) The arteriole close to the peripheral edge of the control retina.
(D) Oxygen treated retina comparable to image C. (E) Projected focus stack of 10
optical sections at 0.44pm of the same arteriole as in image A where the a-SMA
staining ends abruptly on the branch (arrow). (F) Enlarged image of an arteriole in the
oxygen treated retina. (G) Enlarged image of venule in image A. (H) Enlarged image
of the venule in image B.
Scale bar: (A) 100pm; (B), (C) and (D) as A; (E) 32pm; (F), (G) and (H) as E.
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Figure 2.9: «-SMA labelling of PI4 control and oxygen treated retinas.
Labelled using lectin (green) and a-SMA (red). (A) The central network of the blood
vessels in a control retina. (B) Oxygen treated retina equivalent image A. (C) The
central arteriole in control. (D) Oxygen treated retina equivalent to image C. (E) The
peripheral arteriole in control. (F) Oxygen treated retina equivalent to image E.
(G) Enlarged image of a control arteriole; projected focus stack of 7 optical sections at
0.94pm. (H) Oxygen treated retina equivalent to image G. (I) Enlarged image of a
control venule. (J). Single labelled oxygen treated retina equivalent to image G.
Scale bar: (A) 200pm; (B) as A; (C) 100pm; (D), (E) and (F) as C; (G) 32pm; (H)
50pm; (I) and (J) as G.
Figure 2.10: Arteriole of a P14 flatmounted control retina labelled with «-SMA.
Double-labelled with lectin (green) and a-SMA (red). (A) Central image of a projected
focus stack of 7 optical sections at 0.93pm. (B) Midperipheral image of a projected
focus stack of 8 optical sections at 0.90pm (C) Peripheral image.
Scale bar: 32pm.
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Figure 2.11: a-SMA labelling of P21 control retina.
Flatmounts double-labelled with lectin (green) and a-SMA (red). (A) Overview of the
vasculature. (B) The arteriole, centrally; projected focus stack of 15 optical sections at
0.49pm. (C) The arteriole, peripherally. (D) The venule, centrally; projected focus
stack of 7 optical sections at 1.10pm. (E) The venule, peripherally;.projected focus
stack of 7 optical sections at 0.93 pm.
Scale bar: (A) 400pm; (B) 32pm; (C), (D) and (E) as B.
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Figure 2.12: Western blot of retinal a-SMA expression in control and oxygen
treated rat pups.
The lower blot shows actin (43kDa) expression as a loading control. The densitometric
values were obtained using a computer software called 'Quantity-One'.
C - control litter; 02 - oxygen treated litter; P - postnatal day.
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2.4.5 Retinal Expression of Desmin in Normal and Oxygen Exposed Pups
Postnatal day 2 (Figure 2.13, page 69)
In the normally developing retina, desmin positive labelling occurred across the
entire vasculature that had so far formed, however peripherally the labelling was
much stronger. On arterioles, most of the stained cells were long, fine and wrapped
around the vessel, but did not resemble pericytes or smooth muscle cells. On all
capillaries, the cells lay across the axis of the endothelial tubules and were long,
thin, and thread-like. In comparison, the cells of the venules had multiple processes
and appeared as typical pericytes, but were not arranged in any particular
orientation.
Cells present on many of the capillaries seemed very loosely attached; for example
on the arterial branches (Figure 2.13 E) and at the advancing peripheral edge of the
vasculature (Figure 2.13 I). Some retinal capillaries were negative for desmin
expression. These capillaries may have been very immature and, therefore, had not
yet been invested by support cells. Alternatively, these capillaries lacked a pericyte
coverage because they were destined to regress.
With variable oxygen exposure, the desmin staining was reduced; desmin positive
cells were visible at the peripheral edge, thus the extent of desmin was not affected,
rather the number of cells stained in the vasculature seemed to have decreased. The
cells present on the surface of the arterioles and capillaries were very similar to
those of the control with respect to structure and orientation, but those of the venule
were markedly different; the cells did not have the typical appearance of pericytes,
but were long, lacked processes, and were lying longitudinal to the venule.
Postnatal day 7 (Figures 2.14 and 2.15, pages 70 and 71)
With further development it became apparent that the venules had considerably
more coverage of desmin than the arterioles. The capillary network had also
developed a significant amount of desmin coverage compared to P2, but the mid-
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capillaries did not express desmin. The structure of the cells differed considerably
from the arteriole to the venule (Figure 2.15). Centrally, the arteriole and pre¬
capillaries consisted of cells with several fine and short processes whereas those of
the venule had longer processes. Regarding their orientation, the cells of the venule
did not follow a distinct pattern, they lay in several directions, but those of the post-
capillaries were arranged along the length of the vessels. Towards the peripheral
vasculature the cells of all major vessels were similar; single long strands that lay
longitudinal to the vessels.
As in the controls, desmin was observed through the entire vasculature of the
oxygen treated retinas with more intense labelling of the venule than arteriole.
However, the overall coverage appeared reduced in comparison to the controls. On
the venules, the cells appeared to lack the typical pericyte shape; the cells were
single strand-like structures that lay along the axis of the vessels. The arteriole, in
contrast, was very similar to that of the control. A noticeable difference in these
retinas was that the desmin positive cells were finer than those of the control retina.
Postnatal day 14 (Figure 2.16, page 72)
On day 14 in the room-air raised retinas, the entire vasculature, from the centre to
the periphery, had established a coating of desmin staining. In Figure 2.16 A, it
appeared that now the arteriole had stronger expression for desmin than the venule,
however this could be due to poor focusing. Desmin labelling of the central retinal
vasculature was similar to P7; the desmin positive cells were wrapped around the
arteriole and its branches. Peripherally, cells on the arteriole were also beginning to
appear as those in the centre. The cells on the venules had now formed multiple
processes and were arranged in all directions, although those of the post-capillaries
were lying along the axis of the vessels. All cells now appeared to be in close
proximity to the endothelial cells; no cells were loosely attached as in early retinal
development.
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In the retinas of the oxygen raised pups, the desmin staining was present to the very
edge of the peripheral vasculature. As was the case at other timepoints, the coverage
of the venule continued to be stronger than the arteriole. Centrally the coverage of
the arteriole was barely detected, and peripherally the cells were long, thin and lying
along the axis, similar to those of the peripheral venules in controls. Although cells
on the central venule were very similar to those of the control, peripherally the cells
were finer (barely visible), longer and less branched than those in the control.
Overall, the coverage was again qualitatively reduced in comparison to the controls.
Postnatal day 21 (Figure 2.17, page 73)
By day 21, most desmin stained cells had established their shape and were now fully
developed. The coverage of the arteriole and its primary branches near the central
area was distinct; the elongated cells had few branches all of which were wrapped
around the circumference of the vessel surface. Coverage was not increased at the
branching points, a feature observed with a-SMA. Further from the centre, the
number of cells on the arterioles was reduced and the pattern of the cells was very
similar to that of the centre, but on the primary branches the cells were arranged in
several directions, not just circumferentially. Towards the periphery the number of
desmin stained cells was further reduced and the cells now had several processes
although most were still encircling the vessel. Moving onto the venule, near the
central point, the processes of the cells were short and wrapped mostly around the
vessels. Peripherally the processes were longer and although they were not lying
longitudinally they were also not encircling the vessel.
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Figure 2.13: Desmin staining of P2 control and oxygen exposed retinas.
Flatmounts double-labelled with lectin (green) and desmin (red). (A) Central retinal
vasculature of control pup. (B) Experimental retina comparable to image A.
(C) Peripheral retinal vasculature of control pup. (D) Experimental retina comparable
to image C. (E) Enlarged image of an arteriole, central area of control retina. Some
cells had the typical structure of pericytes (arrow). (F) Experimental retina comparable
to image E. (G) Enlarged image of a venule, central area of control retina.
(FI) Experimental retina comparable to image G. (I) Enlarged image of an arteriole,
peripheral area of control retina (J) Experimental retina comparable to image I.
Scale bar: (A) 100pm; (B), (C) and (D) as A; (E) 32pm; (F), (G), (FI), (I) and (J) as E.
Control Oxygen treated
Figure 2.14: Desmin staining of P7 control and oxygen exposed retinas.
Flatmounts double-labelled with lectin (green) and desmin (red). (A) Central retinal
vasculature of control pup. (B) Experimental equivalent to image A. (C) Arteriole of
the peripheral retinal vasculature of control pup. (D) Experimental equivalent to image
C. (E) Venule of the peripheral retinal vasculature of control pup (F) Experimental
equivalent to image E.
Scale bar: 100pm.
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Figure 2.15: Desmin staining of P7 control and oxygen exposed retinas at higher
magnification.
Flatmounts double-labelled with lectin (green) and desmin (red). (A) Arteriole of
central vasculature of control pup; projected focus stack of 8 optical sections at
0.49pm. (B) Experimental retina comparable to image A. (C) Venule of central retinal
vasculature of control pup; projected focus stack of 15 optical sections at 0.49pm.
(D) Experimental retina comparable to image C; projected focus stack of 5 optical
sections at 1.35pm. (E) Arteriole of peripheral vasculature of control pup; projected
focus stack of 5 optical sections at 0.89pm. (F) Experimental retina comparable to
image E. (G) Venule of peripheral vasculature of control pup; projected focus stack of
10 optical sections at 0.45pm. (H) Experimental retina comparable image G.
Scale bar: 32pm.
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Figure 2.16: Desmin staining of PI 4 control and oxygen exposed retinas.
Flatmounts double-labelled with lectin (green) and desmin (red). (A) Central
vasculature of control pup. (B) Experimental retina comparable to image A
(C) Arteriole of central retinal vasculature of control pup; projected focus stack of 19
optical sections at 0.45pm (D) Experimental retina comparable to image C; projected
focus stack of 8 optical sections at 1.34pm. (E) Arteriole of peripheral vasculature of
control pup. (F) Experimental retina comparable to image E; projected focus stack of 6
optical sections at 0.5pm. (G) Venule of central vasculature of control pup.
(H) Experimental retina comparable to image G; projected focus stack of 6 optical
sections at 1.69pm. (I) Venule of peripheral vasculature of control pup; projected
focus stack of 5 optical sections at 0.94pm. (J) Experimental retina comparable to
image I; projected focus stack of 6 optical sections at 1.69pm.




Figure 2.17: Desmin staining of P21 control retina.
Flatmount double-labelled with lectin (green) and desmin (red). (A) Central image of
an arteriole; projected focus stack of 9 optical sections at 0.94pm. (B) Midperipheral
image of an arteriole; projected focus stack of 10 optical sections at 0.94pm
(C) Peripheral image of an arteriole; projected focus stack of 7 optical sections at
0.89pm. (D) Central image of a venule. (E) Peripheral image of a venule projected
focus stack of 16 optical sections at 0.50pm.
Scale bar: 32pm.
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Western analysis
As with a-SMA, it appeared that the expression of desmin on the retinas of the
oxygen treated pups was reduced in comparison to controls. Thus, Western analysis
was conducted. Two different antibodies to desmin, were used at various
concentrations (1:500, 1:200 and 1:100), but no positive labelling was observed on
the blots. Despite increasing the concentration of the secondary antibody and
lengthening the incubation times, positive results for the expression of desmin
protein were not achieved. An alternative method for calculating and comparing the
expression of desmin in control and oxygen treated retinas had to be used.
Extent ofdesmin coverage ofthe vasculature
Using the flatmounted retinas stained for endothelial cells (lectin) and pericytes
(desmin), the extent of pericyte coverage of the vasculature was measured by taking
images of the central and peripheral retina at PI4. The amount of lectin and desmin
staining was calculated by applying a threshold to the images and counting the black
and white pixels. The desmin coverage of the vasculature was then expressed as a
percentage:
Endothelial cells Pericytes % coverage
Control Retina 1 1754922 612521 34.90
Retina 2 1437603 503121 35.00
Retina 3 1369544 478906 34.97
Retina 4 650095 236981 36.45
Retina 5 652096 244198 37.45
Mean 35.75
02 treated Retina 1 1503427 359282 23.90
Retina 2 1402541 321220 22.90
Retina 3 1759933 370425 21.05
Retina 4 646473 141983 21.96
Retina 5 1085005 275143 25.36
Mean 23.03 *
Table 2.1: Extent of pericyte coverage in retinas of P14 control and experimental
rat pups.
*
- p value was calculated as <0.000 using the unpaired t-test.
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In controls it was calculated that around 35% of the vasculature was covered by
desmin positive cells, whereas in the oxygen treated retinas, the extent of coverage
had decreased significantly, to around 23%.
2.4.6 Electron Microscopy
Finally, using transmission electron microscopy, the relationship between
endothelial cells and pericytes was briefly investigated to establish whether the two
cell types made direct contact with each other or if they were just in close proximity
to one another.
As illustrated in Figure 2.18 (page 77), an electron micrograph showing a retinal
capillary of a normal rat at PI4, pericytes have larger and lighter nuclei than
endothelial cells, and lie within the basement membrane. This retinal capillary was
relatively well invested with pericytes and appeared to have a 1:1 endothelial
celhpericyte ratio as previously suggested by others [Shepro and Morel, 1993], The
endothelial celhpericyte ratio of the arterioles and venules was also 1:1 (Figure 2.19,
page 77). The pericytes of all three types of vessels were either lying very close to
the endothelial cells, or parts of their processes were in contact with the
endothelium.
The micrographs of the retinal vessels of oxygen exposed pups (Figure 2.20, page 78
and 2.21, page 79) were difficult to interpret because some retinal vessels appeared
relatively normal while some presented with quite marked degenerative features.
The most common defect of the oxygen exposed retinas was the degradation of the
basement membrane; in all electron microscope images of these retinal blood
vessels, the basement membrane had lost the characteristic structure associated with
the extracellular matrix proteins and, therefore, was very difficult to identify.
Another difference was that the nuclei of the pericytes of the experimental retinas
were much darker than the control retinas. The structure of some pericytes and
endothelial cells were also altered, for example, in Figure 2.20 B, the pericyte had
no processes, the endothelial cell cytoplasm was degraded and the two cell types no
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longer appeared to lie within close proximity. In some cases the capillaries had
collapsed, although pericytes were still in direct contact with the endothelium
(Figure 2.21, A).
Thus, the loss of pericyte and endothelial cell association and the incomplete or
degraded extracellular matrix in retinal capillaries of the experimental pups suggests
that the oxygen exposure resulted in abnormal interactions between the endothelial
cells and pericytes.
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Figure 2.18: Electron micrograph of a P14 control retinal capillary.
EC - endothelial cell; P - pericyte; RBC - red blood cell; asterisk - possibly a pericyte
process; arrows - indicate the basement membrane.
Magnification: x8,000.
Figure 2.19: Electron micrographs of P14 control retinal vessels.
(A) Arteriole. (B) Venule. Arrow indicates cytoplasm ofendothelial cell.
EC - endothelial cell; P - pericyte.
Magnification: (A) x5,000; (B) x3,000.
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Figure 2.20: Electron micrographs of P14 retinal vessels of pups exposed to
variable oxygen.
(A) Venule. The cells are relatively similar to those of a control vessel (B) Capillary.
Arrow indicates remains ofbasement membrane.
EC - endothelial cell; P - pericyte.
Magnification: (A) x3,800; (B) x8,000.
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Figure 2.21: Electron micrographs of P14 oxygen exposed retinal capillaries.
Arrow indicates intact basement membrane
EC - endothelial cell; P - pericyte.
Magnification: (A) x8,000; (B) x3,000.
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2.5 Discussion
2.5.1 Mural Cells of the Retinal Vasculature
The retinal vasculature consists of the smallest sized arterioles and venules [Wise,
Dollery and Henkind, 1971] that are connected by an intricate network of pre-, mid-
and post-capillaries [Zimmermann, 192310]. The entire retinal vasculature, like that
of any tissue, is associated with a layer of mural cells, called smooth muscle cells
and pericytes. Smooth muscle cells are elongated, spindle shaped cells with fine
tapered ends and a large nucleus in the centre. These cells encapsulate arterioles and
to a lesser extent the venules [Bloom and Fawcett, 1968; Leeson and Leeson, 1976],
Capillaries, on-the-other-hand, are invested by pericytes that are elongated cells with
multiple, long processes [Zimmermann, 1923n]. Some cells are without a doubt
identified as mural cells (by their location and orientation), however their
morphology does not appear to be either of a true pericyte or a smooth muscle cell.
As a result many researchers prefer to group the two cell types and refer to them as
pericytes/smooth muscle cells [Antonelli-Orlidge et al., 1989; Benjamine, Hemo and
Keshet, 1998; Darland and D'Amore, 2001a],
There is a great body of evidence supporting the theory that stabilisation of the
vessel wall and maintenance of vascular integrity are important functions of the
pericytes [Crocker, Murad and Geer, 1970; Tilton et al., 1985; Orlidge and
D'Amore, 1987; Suri et al., 1996], In proliferative retinal disorders, such as diabetic
retinopathy, it is suggested that both the stabilisation and integrity of vessels may be
compromised due to a loss of capillary pericytes [Kuwabara and Cogan, 1961;
Speiser, Gittelsohn and Patz, 1968], Similarly, it is suggested that the
neovascularisation which develops as a complication of ROP arises from immature
microvessels that have not yet established a pericyte coverage [Patz, 1968], Perhaps
for this reason pericyte coverage in animal models of ROP has never been studied.
10 Reviewed in Darland and D'Amore, 2001b.
11 Reviewed in Nehls and Drenkhahn, 1993 and in Darland and D'Amore, 2001b.
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Therefore, retinal mural cell coverage was investigated in the Edinburgh model of
ROP.
2.5.2 Selecting the Markers
Over the years, several protein markers including a-SMA, myosin, desmin and
vimentin have been used for the labelling of mural cells. But, because published
data on these markers is contradictory and markers specific for either smooth muscle
cells or pericytes are currently unavailable, selecting a marker for the
immunohistochemistry was difficult. a-SMA and desmin were selected for several
reasons:
• labelling of the mural cells by a-SMA and desmin has been reported by
several researchers [Skalli et al., 1989; Mitchell et al., 1990; Nehls,
Denzer and Drenckhahn, 1992; Newcomb and Elerman, 1993; Nicosia
and Viallaschi., 1995]
• other markers are not strictly specific to mural cells; myosin [Joyce,
Haire and Palade, 1985; Ehler et al., 1995], vimentin [Mitchell et al.,
1990; Ehler et al., 1995] and NG-2 [Pagan-Mercado et al., 2002] are all
reported to be expressed by endothelial cells.
• 3G5, which may be a good marker for pericytes, is not available
commercially and literature on this marker is limited.
2.5.3 Labelling and Specificity of the Markers
a-SMA
In the fully formed vasculature, a-SMA labelled elongated, spindle-shaped cells; the
cells had a large round central area, which presumably contained the nucleus, and
had tapered processes. The cells had a tendency to be arranged perpendicular to the
axis of the arterioles and pre-capillaries. Thus, a-SMA stained the smooth muscle
cells. These results are in agreement with previous studies where a-SMA was
detected on the arterioles and venules, but not on the capillaries of the bovine retina
[Nehls and Drenkhahn, 1991], In addition, vessels of the human brain, like the
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retina, are mainly covered by pericytes and it was found that a very small number of
the mural cells contained a-SMA [Verbeek et al., 1994], Therefore, the use of this
marker for the identification of pericytes is limited, instead it should be considered
as a marker for smooth muscle cell differentiation.
Desmin
Desmin labelling was dependent upon the fixative used during tissue processing.
The retinas did not stain when the eyes were fixed in 2% paraformaldehyde or 70-
100% ethanol. Positive results were obtained using acetone at a 3:1 dilution with
1M PBS. The drawbacks to using acetone as the fixative were that the outer tissue
of the eye became very rigid, making dissection difficult, and that despite piercing
the eye prior to fixation, the retinal tissue remained fragile and damage to the surface
occurred easily.
Unlike a-SMA, desmin expression was associated with all vessels of the retina and
labelled long slender cells with numerous processes. The structure of the pericytes
was different depending on their location; on the venular vessels the cells were
highly branched and not arranged in any particular manner, but on the capillaries the
cells were slightly less branched and lay across the axis of the capillaries. Their
structure altered further on the arterioles where the cells were long and thin, and
encircled the wall of the vessel.
The background labelling of the flatmounts stained with a-SMA and desmin was
considerably high. Figure 2.22 A (page 84) shows that this high background was
not a result of antibody labelling, but that of Texas red streptavidin, which stained
the ganglion cells and the retinal pigmented epithelium. This problem may be
overcome by using a different detection system, such as Alexa Fluor 568.
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Lectin
Lectin has been widely used for staining vessels as it is suggested to be very specific
for endothelial cells. Hence, G. simplicifolia (Bandeiraea) isolectin B4 was used in
this study for visualising the vessels.
The negative control (Figure 2.22 B, page 84), where the retinal flatmounts were
incubated in wash solution instead of lectin, showed that background labelling of the
lectin antibody was minimal. However, in the lectin labelled tissues, a bed of large
round cells beneath the vasculature were also stained; these cells were the ganglion
cells. In addition, at earlier stages of development, lectin also stained small fine
cells in the avascular areas of the retina. These cells were the microglia, which have
previously been reported to stain with lectin [Hughes, Yang and Chan-Ling, 2000],
Although lectin has been used extensively in studies of the retinal vasculature
[Benjamin, Hemo and Keshet, 1998; Hughes, Yang and Chan-Ling, 2000], none of
these studies have evaluated its staining pattern at high magnification. During the
initial analysis of the retinal vasculature, it seemed that lectin stained the endothelial
cells, however doubts of lectin specificity arose after viewing the vessels at high
magnification. Lectin did not label elongated cells that lay in the direction of the
vessels, but fine fibres wrapped around the vessels (Figure 2.23, page 85). Some of
the lectin positive cells were clearly on the external surface of the vessel.
Further examination was conducted by using TO-PRO-3 to stain the nuclei of the
vascular cells. Figure 2.24 (page 85) shows that large round nuclei were protruding
from the surface of the vessel wall, and that under this layer elongated nuclei were
indeed running along the direction of the vessel; these nuclei belonged to the
endothelial cells. Thus, lectin did not stain endothelial cells, but rather appeared to
stain the membrane of the entire vessel. Perhaps lectin was staining the basement
membrane that splits whilst it approaches the mural cell, and therefore provides a
layer on both sides of the cell to enclose it completely.
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Figure 2.22: Negative controls.
(A) a-SMA and desmin labelling. (B) Lectin staining.
Scale bar: 100|im.
84




Figure 2.23: Flatmounted retina stained with lectin only.
On the arteriole lectin outlined cells that were protruding from the vessels (arrows).
These cells may be mural cells.
Scale bar: 32pm.
Figure 2.24: Retinal flatmount labelled with lectin, a-SMA and TO-PRO-3.
The nuclei were visualised using a nuclear marker, TO-PRO-3 Iodide.
(A) An arteriole labelled with lectin (green), a-SMA (red) and TOPRO-3 (blue);
projected focus stack of 8 optical sections at 0.76pm. (B) Cross section of image A
showing optical section number 3.
Scale bar: 32pm.
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Other markers considered to be specific to endothelial cells are Von Willebrand
factor and VE cadherin. However, Von Willebrand factor failed to stain the
endothelial cells in vitro [Ehler et al., 1995] and the smallest capillaries of the
vasculature in vivo [Hughes, Yang and Chan-Ling, 2000], Although VE cadherin
may be suitable for labelling endothelial cells in culture [Lampugnani et al., 1992;
Breier et al., 1996], to date this marker has not been used for in vivo work.
2.5.4 Mural Cell Coverage of the Vessels in Normal Development
The frequency, distribution, orientation and structure of the mural cells varied
depending on the type and location of the vessel. As mentioned above, it appeared
that rt-SMA stained smooth muscle cells and desmin stained the pericytes. There
were however several cells, on the arteriole in particular, that stained positively for
both markers.
a-SMA expression on the retinal vessels increased progressively from P2 to P21 and
was limited to the vasculature that had undergone complete remodelling. On P2, the
arteriole near the optic disc was labelled and by P21 the labelling was observed
along the whole length of the arterioles, the pre-capillaries and the venules, but other
retinal vessels (the mid-capillaries and the post-capillaries) remained negative for
a-SMA. These results are very similar to those reported by Benjamin and
colleagues who also stained rat retinal flatmounts with lectin and a-SMA [Benjamin,
Hemo and Keshet, 1998], They reported staining of the artery on P2 which, by P10,
progressed onto the primary branches and by PI8 on to the secondary and tertiary
branches. They referred to these cells as pericytes. However, there is evidence to
suggest that these cells were not pericytes; 1) the labelling was only observed on the
arteriolar vessels and not across the capillary bed which has been previously
1 9
reported to have pericyte coverage [Zimmermann, 1923 ; Kuwabara and Cogan,
1963; Rhodin, 1968; Fujiwara & Uehara, 1984; 2) the cells positive for a-SMA were
closely packed along the vessels, whereas it is well established that pericytes do not
12 Reviewed by Sims, 1986.
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13form a continuous layer along vessels [Zimmermann, 1923 ; Rhodin, 1968] nor do
pericytes make contact with each other [Rhodin, 1968]; and 3) a-SMA is a poor
marker for pericytes.
During early development, a-SMA positive cells were flat and lacked distinct
structure. By P7, the labelled cells had a very different appearance; the cells were
bulging from the vessels, and by PI4 these cells had differentiated fully into smooth
muscle cells. These findings suggest that a-SMA labelled the precursors of smooth
muscle cells and that differentiation of these cells was a slow process. At P21, the
peripheral arteriolar vessels and the venules also stained for a-SMA, but the cells
were undifferentiated precursor cells. It is likely that these cells may also
differentiate into smooth muscle cells at a later stage; this could be easily
investigated by staining retinas of older rats.
In comparison to a-SMA, desmin staining was widely distributed and dispersed
across the whole vasculature including the advancing peripheral edge. On P2,
desmin labelled very fine and long strands on the surface of the retinal vessels; many
vessels near the arterioles lacked these cells, probably because these were vessels
that would eventually regress to form capillary free zones. By P7, the cells on the
vessels of the central region had thick multiple processes, and had gained the
structure of pericytes. Peripherally the cells were very similar to those observed on
the vessels at P2. By PI4, most of the pericytes of the vasculature were fully
formed; those of the arteriole had few processes, whereas those of the venule had
many processes (primary and secondary). The pericytes of the peripheral retinal
area had also completely differentiated by P21.
The fine long unbranched cells observed in the central retina on P2 and the
peripheral edge on P7 and P14 were most likely the pericyte precursor cells; thus
desmin was expressed very early in the process of pericyte differentiation. This is in
agreement with Nehls et al. who suggested that desmin antibody labelled fine
13 Reviewed in Darland and D'Amore, 2001b.
87
Chapter Two: Mural cells ofthe Retinal Vessels
processes belonging to the youngest pericytes [Nehls, Denzer and Drenckhahn,
1992], However, these researchers also stated that true pericytes only existed on the
mid-capillaries, but the post-capillaries and the venules of the retinas in my study
were also covered by desmin stained cells that had the typical structure of pericytes.
The orientation of the pericytes differed on the vessels during development. On P2,
the cells were wrapped around the arteriole near the optic disc, but towards the
periphery, and on all arteriolar branches, they lay across the axis of the vessel. The
cells of the venule, at this stage, were not arranged in any distinct pattern. By day
14, the cells were encircling the walls of the central arterioles and the pre-capillaries,
but towards the periphery the cells did not appear to be positioned in any particular
manner. The pericytes were arranged both parallel and perpendicular to the walls of
the venules and the post-capillaries. The facts that the orientation of the cells
differed during development and that some precursor cells appeared to be very
loosely attached to the vasculature in early development suggest that, unlike smooth
muscle cells, pericytes display a high degree of plasticity, agreeing with Clark and
Clark who described pericytes as non-static structures [Clark and Clark, 1925],
Another difference between the two mural cells is that the pericytes appeared to
differentiate rather rapidly in comparison to smooth muscle cells.
Figures 2.3 to 2.5 (pages 54 and 55) which contain images of retinal flatmounts
double-labelled with ot-SMA and desmin antibodies, show that some differentiated
cells surrounding the arterioles expressed both markers. Some of these cells had the
typical structure of smooth muscle cells with only two processes, whereas other cells
had three or four processes. There are several possible explanations for this staining
pattern. Firstly, smooth muscle cells expressed desmin along with a-SMA which
has been previously suggested [Nicosia and Villachi, 1995], This seems unlikely
since only some, not all, of the smooth muscle cells stained for desmin. Secondly,
desmin expression depended on the state of cell differentiation, i.e. as the smooth
muscle cells matured their expression of desmin decreased. This could be easily
determined by double-staining retinal flatmounts of younger and older animals with
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a-SMA and desmin; if expression levels of desmin were lower in the older animals
then perhaps desmin is expressed by immature smooth muscle cells. Thirdly, some
pericytes had the potential to differentiate into smooth muscle cells on demand,
which may be interpreted from the findings of previous studies: (1) Rouget14
described pericytes as less differentiated smooth muscle cells; (2) Zimmerman15
found that pericytes merged into smooth muscle cells on the arteriolar and venular
sides; (3) transforming growth factor-/?, which is reported to induce mesenchymal
cell to pericyte differentiation [Hirschi, Rohovsky and D'Amore, 1998], was also
found to increase a-SMA expression of cultured human brain pericytes, suggesting
that the pericytes differentiated into smooth muscle cells [Verbeek et ah, 1994]; and
(4) pericytes have been suggested to be derived from nearby smooth muscle cells
that 'dedifferentiate' [Nicosia and Villaschi, 1995; Lindahl et ah, 1997; Hellstrom et
ah, 1999], Earlier I suggested that a-SMA may be an early marker for smooth
muscle cell differentiation, hence it may also be expressed at the earliest stages of
pericyte to smooth muscle cell differentiation. Thus, two distinct types of pericytes
may indeed exist; true pericytes that remain static once formed and transitional
pericytes that have the potential to undergo further differentiation. But what induces
the differentiation of a pericyte into a smooth muscle cell? Perhaps the formation of
the surrounding precursor cells into smooth muscle cells is a signal for these
pericytes to differentiate further and become smooth muscle cells.
In summary, a-SMA and desmin were very early markers for smooth muscle cells
and pericytes, respectively. Transitional pericytes, however, expressed both
proteins, although desmin expression may decrease as these cells differentiate into
mature smooth muscle cells. Thus, further investigations on more suitable and
specific markers for both types ofmural cells are still required.
14 Reviewed in Darland and D'Amore, 2001b.
15 Reviewed in Kuwabara and Cogan, 1963.
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2.5.5 Mural Cell Coverage of Vessels in the Edinburgh Model of ROP
As previously reported retinal vessel formation of pups exposed to variable oxygen
was retarded and abnormal; the peripheral edge of the vasculature, which reached
the ora serrata by PI4, was still a significant distance from the ora serrata, and the
central capillary network had not undergone extensive remodelling [McColm et al.,
2004],
Immunohistochemically stained flatmounts showed that coverage of the vessels by
both smooth muscle cells and pericytes was affected by the oxygen regime. a-SMA
labelling on all days examined did not progress as far as it did on the control days;
the extent of coverage along the length of the arteriole and its branches appeared
slightly reduced. In addition, the differentiation of the precursor cells into smooth
muscle cells seemed delayed; less fully formed smooth muscle cells were observed
on the arterioles of the experimental retinas. Surprisingly, expression of the marker
was increased on the venules; during normal development a-SMA expression was
low on P14 and more intense on P21, but in the oxygen treated retinas, the venules
stained as early as P7 and continued on P14. These cells surrounding the venules
did not appear to be smooth muscle cells. Although difficult to interpret, two
possible explanations are offered. First, in response to the variable oxygen regime
the venules may have acquired coverage by a layer of smooth muscle cell precursors
which may differentiate to provide a form of protection for the venule; these cells
would probably differentiate on demand i.e. if the insult continued. Second, the
pericytes of the venules may have differentiated into smooth muscle cells in
response to the oxygen. In support of this is the report by Meyrick and Reid who
found that under hypoxic stress pericytes of the lung microvasculature had the
potential to develop into smooth muscle cells [Meyrick and Reid, 1978],
Western analysis confirmed that in comparison to control retinas, a-SMA expression
was marginally reduced in the experimental retinas. As discussed above, a-SMA
coverage was only seen on arteriolar vessels once the surrounding vasculature had
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undergone complete remodelling, indicating maturation and stabilisation of the
vessels. It is possible then that the reduction of a-SMA expression and coverage of
smooth muscle cells in the oxygen exposed retinas was the result of the
delayed/reduced remodelling of the vasculature.
Regarding pericytes, it has been suggested that there cannot be a loss of pericytes in
ROP since the vessels are too immature for coverage [Patz, 1968], however, in my
studies desmin positive pericytes were visualised at a very early stage of
development. One condition in which retinal pericytes are preferentially lost is
diabetes. This was first suggested by Cogan and colleagues who evaluated retinas of
diabetic patients and observed that loss of pericytes appeared to be the initial stage
in diabetic retinopathy and may underlie the pathogenesis of microaneurysms
[Cogan, Toussaint and Kuwabara, 1961; Kuwabara and Cogan, 1961], This was
soon confirmed by Speiser et al. who compared the retinas of diabetic patients to
retinas of healthy controls and reported that the endothelial celhpericyte ratio was
greater in the diseased retinas (this increase in ratio was due to a reduction in
pericyte number and not an increase in endothelial cell number), and that the
greatest loss took place in the central retina [Speiser, Gittlesohn and Patz, 1968],
In the retinal vasculature of the Edinburgh model, the extent of the pericyte coverage
could not be commented on because unlike smooth muscle cells, pericytes did not
form a continuous layer along the retinal vessels. However, it appeared that there
was a decrease in the number of pericyte precursor cells in younger animals and a
decrease in the number of differentiated pericytes in the older animals. Thus,
pericytes were present on the vasculature, but were fewer in number. To confirm
that there was a reduction in the number of pericytes, Western blotting was
performed. However, no desmin expression was detected at any point during
development, despite using different desmin antibodies at various concentrations.
The only parameter that remained unchanged was the amount of protein loaded for
separation, but more than 75pg of total protein could not be loaded as it would have
exceeded the recommended loading volume. As an alternative, images of the central
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and peripheral retina from five control and five oxygen exposed retinas were taken,
and using computer thresholding techniques, the percentage of vasculature covered
by pericytes was calculated. The results indicated that there was indeed a significant
reduction in pericyte coverage of the oxygen treated retinas.
There are, however, several drawbacks of using this method of quantification. First,
as mentioned above, Texas red streptavidin produced significant background
labelling. It is possible that when setting the gain and off-set of the confocal
microscope to eliminate all background staining some of the true labelling was also
eliminated. This may be overcome by using other fluorescent molecular probes.
Second, due to time constraints, a very small number of samples were evaluated, and
although the results clearly showed that there were less pericytes in the model,
increasing the sample numbers would be useful. Third, only retinas of P14 animals
were used because retinas fixed in acetone were fragile, and the retinas of younger
animals were more vulnerable to damage during dissection. Thus, finding a more
suitable fixative would allow the investigation of younger animals. In addition,
instead of threshold analysis an alternative method of analysis would be very
valuable. A possibility would be to stain the cell nuclei using the trypsin digestion
technique employed by Speiser and colleagues [Speiser, Gittlesohn and Patz, 1968],
This would allow me to measure and compare the endothelial celkpericyte ratio of
controls and experimental retinas.
The electron microscope results showed that pericyte structure was altered in some
retinal blood vessels of the oxygen treated animals. The interactions between the
endothelial cells and pericytes were also compromised; the cells were no longer
within close proximity to each other. In addition, degradation of the basement
membrane was observed and some vessels lacked a basement membrane completely.
It is possible that the effect of variable oxygen on endothelial cell and pericyte
structure was due to the degradation or absence of the basement membrane.
Conversely, the abnormal pericyte and endothelial cell interactions may have caused
the degradation of the basement membrane. The data, unfortunately, cannot
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distinguish between the two possibilities. Only two control and two experimental
retinas were analysed due to time and financial restraints. Although structural
changes of the retinal vessels were observed in the oxygen treated rats, increasing
the sample number would be beneficial.
In summary, the results presented in this chapter suggest that there is a reduction in
the number of both smooth muscle cells and pericytes in a clinically relevant model
of ROP. The decrease in smooth muscle cells is most likely a result of reduced
remodelling of the vasculature, whereas the decrease in pericyte coverage may be
the result of reduced recruitment of pericyte precursor cells or apoptosis of the
pericytes in response to the oxygen regime. In addition, the differentiation of both




Factor in the EdinburghModel of ROP
3.1 Introduction
In the mid-1970s a protein capable of inducing cell proliferation was identified in
whole blood serum [Kohler and Lipton, 1974; Ross et al., 1974; Rutherford and
Ross, 1976; Westermark and Wasteson, 1976; Scher, Stone and Stiles, 1979], It was
later purified from human platelets [Antoniades, Scher and Stiles, 1979; Heldin,
Westermark and Wasteson, 1979; Deuel et al., 1981], where it was predominantly
stored in the a-granules [Kaplan et al., 1979], The protein was subsequently named
platelet-derived growth factor (PDGF). Along with promoting cell proliferation
[Kohler and Lipton, 1974; Ross et al., 1974; Rutherford and Ross, 1976; Westermark
and Wasteson, 1976; Scher, Stone and Stiles, 1979], PDGF was also found to
promote the migration of certain cell types [Bernstern, Antoniades and Zetter, 1982;
Grotendorst et al., 1982; Hosang et al., 1989; Koyama et al., 1992; Shure et al.,
1992],
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3.1.1 Ligands
PDGF is a basic glycoprotein that consists of two polypeptide chains joined by
disulfide bonds [Heldin, Westermark and Wasteson, 1979], The polypeptides are
denoted chain A and chain B and are estimated to have molecular weights of 11-
18kDa and 15-16kDa, respectively [Johnsson et al., 1982; Waterfield, 1983;
Hammacher et al., 1988a]. Thus, the molecular weight of PDGF ranges between 28
and 35kDa [Heldin et al., 1979; Antoniades, 1981; Deuel et al., 1981; Johnsson et al.,
1982, 1984; Waterfield et al., 1983], Both chains are synthesised as precursor
molecules that undergo proteolytic processing prior to secretion; the A chain is
cleaved at the N-terminal whereas the B chain is cleaved at both the N- and C-
termini [Ostman et al., 1991], Due to incomplete purification and lack of
overlapping sequences, the precise sequence of both precursors has not been fully
established. The two mature polypeptide chains, which share around 60% homology
[Johnsson et al., 1982], give rise to three possible dimeric isoforms; PDGF-AA,
PDGF-AB and PDGF-BB [Hammacher et al., 1988a], This dimeric structure of
PDGF seems to be essential for biological activity [Hammacher et al., 1988a],
Recently, two additional PDGF molecules were identified and named PDGF-CC and
PDGF-DD [Kazlauskas, 2000; Li et al., 2000; Bergsten et al., 2001], The C and D
chains are structurally related to each other, but rather distantly related to the A and
B chains; hence, they do not form heterodimers with A or B. The receptor binding,
signalling and biological functions of the C and D chains are still to be elucidated.
3.1.2 Receptors
The A and B chains of PDGF exert their effects by activating two cell surface
receptors called PDGF receptor-a and PDGF receptor-/? [Yarden et al., 1986;
Claesson-Welsh et al., 1989a, 1989b; Matsui et al., 1989], Both receptors are
transmembrane glycoproteins with tyrosine kinase activity [Claesson-Welsh et al.,
1988, 1989a, 1989b]. The a-receptor is synthesised as a 140kDa precursor that is
processed to a mature size of 170kDa, whereas the /1-receptor is synthesised as a
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160kDa precursor that matures to around 180kDa [Keating and Williams, 1987; Hart
et al., 1988; Claesson-Welsh et al., 1989a, 1989b], Because PDGF isoforms are
dimeric molecules, they simultaneously bind two receptors, and therefore dimerise
receptors upon binding [Bishayee et al., 1989; Heldin et al., 1989]. The a-receptor
binds both the A and B chains with equal affinity, whereas the /^-receptor binds only
the B chain. Thus, PDGF-AA induces aa-receptor homodimers, PDGF-AB induces
both aa-receptor homodimers and a/freceptor heterodimers, and PDGF-BB binds all
three receptor combinations [Hammacher et al., 1988a; Kanakaraj et al., 1991],
3.1.3 Biological Effects of PDGF
PDGF was initially discovered as a factor that promoted the replication of cultured
mouse fibroblasts [Kohler and Lipton, 1974] and monkey arterial smooth muscle
cells [Ross et al., 1974], Since then the proliferative effect of PDGF on both
fibroblasts [Rutherford and Ross, 1976; Westermark and Wasteson, 1976; Scher,
Stone and Stiles, 1979; Shure et al., 1992] and smooth muscle cells [Rutherford and
Ross, 1976; Grosendorst et al., 1982] have been confirmed in several reports.
Studies on retinal glial cells (astrocytes and Miiller cells), however, have produced
conflicting results; PDGF was mitogenic for the retinal glial cells of rats [De Juan,
Dickson and Hjelmeland, 1988] and humans [Westermark and Wasteson, 1976;
Uchihori and Puro, 1991], but did not stimulate the proliferation of those of the
rabbit retina [Burke, 1982; Scherer and Schnitzer, 1994], In most of these early
studies PDGF was predominantly obtained from human platelet-rich plasma, 70% of
which was found to consist of A and B chain heterodimers and 30% of B chain
homodimers [Hammacher et al., 1988a], Thus, both the a-receptor and ^-receptor
are capable of mediating cell proliferation.
To understand the mechanisms of PDGF-induced cell proliferation, Scher and
colleagues exposed cultured fibroblasts to PDGF and suggested that the protein acts
during the late stages of the cell cycle; it stimulates cells to enter the S phase,
progress through Gq/Gi, synthesise DNA and then divide. In addition, PDGF
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prevents any replicating cells from entering the Go (quiescent) phase [Scher, Stone
and Stiles, 1979],
PDGF also induces the migration of several cell types, including fibroblasts [Hosang
et al., 1989; Koyama et al., 1992] and smooth muscle cells [Bernstein, Antoniades
and Zetter, 1982; Grotendorst et al., 1982], The migratory role of PDGF is thought
to be mediated by the B chain only; when PDGF-AA, -AB and -BB were added to
cultures of rat aortic smooth muscle cells, the PDGF-AB and -BB isoforms induced
migration of the cells, but PDGF-AA inhibited the migration induced by the other
isoforms [Koyama et al., 1992], PFGF-AA, however has been shown to induce the
migration of other cell types, namely fibroblasts, monocytes and neutrophils [Shure
et al., 1992], In comparison to the proliferative effect of PDGF, the chemotactic
response of the cells is more rapid and occurs at a lower concentration of ligand
[Grotendorst et al., 1982],
Therefore, upon activation, both the a- and ^-receptors of PDGF transduce potent
mitogenic signals by promoting cells to enter the S phase of the cell cycle. Although
it is firmly established that the /^-receptor stimulates chemotaxis, the migratory
response of the a-receptor is cell type dependent; it stimulates the chemotaxis of
certain cell types whilst inhibiting that of others.
3.1.4 PDGF Transgenics
Most PDGF-A knockouts die within the first few days of birth, however some
survive until around six weeks of age. The transgenic mice are only slightly smaller
than normal mice at birth, but the difference in size increases with age and by three
or four weeks, the mutants are half the weight of normal mice. The knockout mice
develop a range of defects including reduction in the number of oligodendrocytes in
the brain, lack of alveolar smooth muscle cells, and defects of the mesenchyme
[Bestrom et al., 1996],
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The phenotype of PDGF receptor-a knockouts is more severe (perhaps because none
of the three PDGF isoforms are able to bind), and the mice die in utero [Soriano,
1997], The mice have a cleft face, skeletal and vascular defects, and suffer from
spina bifida, all resulting in death between embryonic days 8 and 16 (E8 and El6).
Mice carrying a null mutation in the gene encoding the B chain of PDGF, and
therefore deficient with regards to PDGF-BB and PDGF-AB, were generated by
Leveen and colleagues [Leveen et al., 1994], Although some of the mutant mice die
one or two days prior to birth (E17-E18.5), most survive to term and die soon after
due to subcutaneous haemorrhaging. The mice also display enlarged and deformed
hearts and abnormal kidney glomeruli. The larger arteries are also dilated, for
example, the aorta is enlarged to twice the normal size, but there is no sign of
hyperplasia since smooth muscle cells are present in normal numbers.
PDGF receptor-/? null mice also die at birth, due to their inability to breathe [Soriano,
1994], Like the PDGF-B null mice, these mice exhibit abnormalities in the kidneys;
the capillary tufts of the glomeruli and the number ofmesangial cells are reduced or
even absent. In addition, some mice also suffer from oedema and anaemia. These
defects are presumably caused by a lack ofPDGF-B signalling to the //-receptor.
3.1.5 Roles in the Vasculature
Normal vesselformation
Early in vitro studies found that 1) PDGF is secreted by endothelial cells [Barette et
al., 1984; Collins et al., 1985], 2) their receptors are expressed by both endothelial
and smooth muscle cells [Smits et al., 1989; Beitz et al., 1991], and 3) it promotes
the proliferation and migration of smooth muscle cells [Ross et al., 1974; Rutherford
and Ross, 1976; Bernstein, Antoniades and Zetter, 1982; Grosendorst et al., 1982].
Despite these findings, the formation of blood vessels during the early stages of
embryonic development is not affected in mice lacking the PDGF or the PDGF
receptor genes [Leveen et al., 1994; Soriano, 1994, 1996; Bestrom et al., 1996],
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However, some abnormalities in vessel formation are observed during the later
stages of development.
Lindahl and colleagues investigated the effects of PDGF-B deficiency on pericyte
formation [Lindahl et al., 1997], The authors crossed heterozygous mice with mice
lacking the Lac Z promoter gene, and found that in the wild types and heterozygotes
the capillaries were straight and of a uniform diameter, but those of the homozygotes
were tortuous, variable in diameter and had numerous microaneurysms. Their main
finding was that the brains of El6.5 mice homozygous for the mutation lacked
microvascular pericytes, which suggests that PDGF-B produced by the capillary
endothelial cells signalled neighbouring vascular smooth muscle cell and pericyte
progenitors (carrying the PDGF receptor-/?) to promote their co-migration along the
vessels. The researchers then investigated PDGF-B expression in the normal
developing embryo [Hellstrom et al., 1999], In the brain, PDGF-B was detected in
the endothelial cells of the capillaries and the arterioles, but not in the endothelial
cells of the venules. The developing pericytes and arterial smooth muscle cells were
positive for both PDGF receptor-/? and BrdU labelling. In comparison, PDGF-B and
PDGF receptor-/? knockout mice showed reduced BrdU labelling (indicative of
reduced proliferation). Thus, the lack of pericyte coverage in both transgenic mice
was a combined effect of reduced proliferation [Hellstrom et al., 1999] and migration
of pericyte progenitor cells [Lindahl et al., 1997],
Further evidence for a role of PDGF in pericyte recruitment came from quantitative
analysis of brains from PDGF-B and PDGF receptor-/? knockout mice. When the
number of endothelial cell nuclei were counted in wild type and transgenic brain
sections, it was found that in both transgenics there was a marked increase in
endothelial cell number (around 60%). This endothelial hyperplasia was most likely
a secondary effect of reduced pericyte coverage along the vessels [Hellstrom et al.,
2001], This study is consistent with previous published studies which suggest that
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one function of pericytes is to inhibit endothelial cell proliferation [Orlidge and
D'Amore, 1987; Sato and Rifkin, 1988].
Regarding recent in vitro studies Hirschi and co-workers assessed the effects of
PDGF on the migration of 10T1/2 cells (a multipotent cell line used as presumptive
mural cell precursors) [Hirschi, Rohovsky and D'Amore, 1998], When plated in the
presence of PDGF, the 10T1/2 cells exhibited a random movement in response to all
three dimers; PDGF-BB produced the greatest chemotactic affect, followed by
PDGF-AB and then PDGF-AA. The authors also investigated the effects of 10T1/2
cell migration in the presence of endothelial cells. In these co-cultures, the 10T1/2
cells migrated towards the endothelial cells in a directional manner, suggesting that
the endothelial cells secreted some kind of chemoattractant. When a neutralising
antibody against PDGF-B was added to the culture, the endothelial cell-induced
migration was completely inhibited. In contrast, cell migration was unaffected in the
presence of a neutralising antibody to PDGF-A.
In summary, the above mentioned studies all demonstrate that PDGF-B has an
important role in vessel formation; that of recruiting smooth muscle cells and
pericytes to the vasculature.
Wound healing
It is suggested that PDGF-B released at the site of injury is involved in the process of
wound healing. Firstly, PDGF-B causes the proliferation of fibroblasts and smooth
muscle cells to proliferate adjacent to the wound site [Kaplan et al., 1979],
Secondly, fibroblast and smooth muscle cell expression of the /i-receptor, which is
normally low in resting tissue, is up-regulated in the skin from chronic wounds and
lesions [Krane et al., 1991] and during inflammation [Terracio et al., 1988], Thirdly,
PDGF has been shown to stimulate neutrophil and macrophage migration [Shure et
al., 1992], and the production of extracellular matrix proteins [Blatti et al., 1988;
Canalis et al., 1993], all of which are involved in the process ofwound repair.
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Cancer
A large number of tumour cell types have been studied with regards to their
expression of PDGF isoforms and receptors, and although both the A and the B
chains are commonly expressed in such cell lines [Langerak et al., 1996a, 1996b],
PDGF-AA is usually predominantly secreted [Hammacher et al., 1988b], PDGF
receptor-a positive cells are found in all grades of human gliomas, but the highest
density of a-receptor is seen in the high grade tumours [Hermanson et al., 1988],
Expression of the A chain is also dramatically increased from undetectable levels in
low grade to high levels in high grade tumours suggesting that the A chain is
involved in tumour growth progression.
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3.2 Aims and Hypothesis
The aims of the work detailed in this chapter were:
• to establish the pattern of PDGF-B protein expression during normal
development
• to determine the expression of PDGF-B protein in relation to the
endothelial cells and mural cells by staining retinal flatmounts
• to investigate if the expression levels of PDGF-B were altered in the
Edinburgh model of retinopathy of prematurity (ROP).
During normal retinal development, it is postulated that the protein expression levels
of PDGF-B would increase during early retinal development, but decrease once the
vasculature has established a complete mural cell coverage. Because PDGF-B is
known to induce mural cell proliferation and migration, it is expected that PDGF-B
expression would occur near the advancing peripheral edge of the vasculature where
mural cell coverage is underway.
It is suggested that retinal vessels of infants with ROP lack coverage by pericytes
[Patz, 1982], or at least have reduced pericytes coverage [Hirschi and D'Amore,
1997], thus it is hypothesised that the expression ofPDGF-B would be reduced in the
Edinburgh model ofROP.
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3.3 Methods
3.3.1 Experiments
The experiments were conducted as described in Chapter Two. Briefly, litters of 12
or more pups were exposed from birth to postnatal day 2 (P2), P7 and P14 to the
lOkPa variable oxygen profile of the Edinburgh ROP model. The pups were killed
immediately upon removal from the oxygen chamber. Some litters were raised in
room air and sacrificed on P2, P7, P14 and P21. Both eyes from the pups were
enucleated; the right eye was used for the immunohistochemical staining of pericytes
and smooth muscle cells (Chapter Two) and the left was used for Western blot
analysis. In addition, four control retinas at P7 and P14 were stained with PGDF-B
antibody.
3.3.2 Western Blot Analysis
Protein extraction and assays
Retinas from each control and experimental litter were dissected fresh in 1M PBS
(phosphate buffered saline), pooled and stored at -70°C. At a later stage, the retinal
proteins were extracted by homogenising the retinas in extraction buffer containing a
proteinase inhibitor (Sigma). The samples were then centrifuged at 14,000g for
lOmins after which the supernatant was removed and spun for a further 30mins. The
resulting supernatant was then transferred into eppendorf tubes and stored at -70°C.
The protein content of the samples was measured using the BCA protein assay
method according to the manufacturer's instructions (Perbio). Briefly, 5pi of each
sample was added to the extraction buffer, followed by 95pi of BCA protein assay
reagent. All samples were incubated at 37°C for 30mins after which the OD562 of
each sample was measured. Bovine serum albumin was used as standard.
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Protein separation and transfer
A biotinylated molecular weight marker (Bio-Rad Laboratories) and 75jag of total
retinal protein for each control and experimental timepoint were loaded onto a 12%
acrylamide gel. 75pg of each sample was used since it allowed the greatest quantity
of protein to be loaded without exceeding the recommended volume. The proteins
were separated by SDS-PAGE electrophoresis for around 2 hours and then
transferred onto PVDF membranes (Bio-Rad Laboratories) using a semi-dry transfer
cell (Bio-Rad Laboratories).
Blotting
The membranes were washed twice (1M PBS/0.1% Tween) for 5mins with gentle
shaking and blocked overnight at 4°C in 5% non-fat dry milk prepared in the wash
solution. The next morning, the membranes were washed twice with gentle shaking
for 5mins each, and incubated in PDGF-B primary antibody (Santa Cruz), diluted to
1:200 using the blocking solution, for 1 hour at room temperature with gentle
shaking. The membranes were then washed three times for 5mins followed by two
15mins washes, and incubated in horseradish peroxidase conjugated anti-goat
secondary antibody (1:5000, Dako) prepared in the blocking solution containing
additional streptavidin horseradish peroxidase (Amersham Bioscience, 1:2000) for
detection of the molecular weight marker. The membranes were then washed again
and incubated in ECL-Plus Western blotting developer (Amersham Bioscience) for
5mins. Finally, the membranes were exposed to X-ray film for around 2mins.
To ensure that any difference in expression between control and experimental retinas
was genuine and not due to loading variable quantities onto the gel, the membranes
were stripped for 15mins at 37°C using Restore Western Blot Stripping Buffer
(Pierce), and then reprobed for actin. Briefly, the membranes were blocked
overnight in non-fat dry milk and then incubated in actin primary antibody (1:1000,
Santa Cruz). The membranes were incubated in anti-goat secondary antibody
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(1:5000, Dako). After the washing stage, developer solution was applied to the
membranes which were then exposed to X-ray film.
Analysis
An image of the X-ray film was captured using the computer software, 'Quantity-
One' (Bio-Rad Laboratories). The bands that had developed on the X-ray film were
manually selected and the software calculated the amount of PDGF-B protein
expressed by taking the area and the intensity of each band into consideration.
3.3.3 Immunofluorescent Labelling
PDGF-B single-staining
P7 and P14 retinas were dissected as described in Chapter Two and then stained for
PDGF-B antibody as follows. The flattened retinas were first permeabilised in 1M
PBS/1% Triton X-100 (wash solution) for 30mins and blocked using 5% goat serum
for 20mins. The retinas were then incubated in PDGF-B antibody prepared in 5%
serum (1:100, Santa Cruz) overnight at 4°C. The following morning, the retinas
were first washed three times for lOmins each, and then incubated in biotinylated
goat anti-rabbit secondary antibody (1:200, Dako) for 2 hours at room temperature,
with gentle shaking. The retinas were washed again and Alexa Fluor 647 (1:200,
Molecular Probes) was applied for 2 hours with gentle shaking at room temperature.
The retinas were washed for the final time, mounted in PBS:glycerol (1:1) and the
coverslip sealed with nail varnish.
PDGF-B, desmin/a-SMA and lectin triple-staining
The retinal flatmounts were first stained for PDGF-B labelling as described above.
After the incubation in Alexa Fluor 647, the flatmounts were washed in 1M PBS/1%
Triton X-100. The tissues were then blocked using avidin and biotin (Vector
Laboratories) and then incubated in 5% rabbit serum (Diagnostic Scotland) diluted in
1M PBS/1% Triton X-100 for 20mins each. The retinas were incubated in either
desmin (1:50, Dako) or a-SMA (1:400, Sigma) antibody overnight at 4°C to label the
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pericytes or smooth muscle cells, respectively. The next day, the tissues were
washed in 1M PBS/1% Triton X-100, and incubated in biotinylated rabbit anti-
mouse secondary antibody (1:200, Dako) for 2 hours at room temperature (with
gentle shaking). The retinas were washed and Texas red streptavidin (1:100, Vector
Laboratories) applied for 2 hours at room temperature with gentle shaking. After
washing, the flatmounts were blocked again using avidin and biotin for 20mins each
before incubating with biotinylated G. simplicifolia (Bandeiraea) isolectin B4 (1:50,
Vector Laboratories) overnight at 4°C to stain the endothelial cells. The following
day the washes were repeated and the retinas incubated in fluorescein streptavidin
(1:100, Vector Laboratories) for 2 hours with gentle shaking at room temperature.
The wholemounts were washed one last time, mounted in PBS:glycerol (1:1) and
sealed with nail varnish.
For the PDGF-B negative control, a retinal wholemount was incubated in 5% serum
instead of the primary antibody solution. The above protocol was then continued;
the secondary antibody was applied followed by Alexa Fluor 647.
Analysis
The retinal flatmounts were viewed using a Leica TCSNT confocal system with a
mixed gas argon/krypton laser. Cells stained using fluorescein were labelled green
and excited at 488nm (filter BP 525/50), cells stained with Texas red were labelled
red and excited at 568nm (filter LP 590), and PDGD-B staining detected by Alexa
Fluor 647 was labelled blue and excited at 647nm. Representative images were
taken and digitally stored for later analysis.
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3.4 Results
3.4.1 Western Analysis
In the Western blot analysis, the polyclonal PDGF-B antibody recognised 4 peptides
on all days examined (Figure 3.1). 5 (out of 9) molecular weight markers were
identified; these were soya bean trypsin inhibitor at 21.5kDa, carbonic anhydrase at
31kDa, ovalbumin at 45kDa, bovine serum albumin at 66.2 kDa and phosphorylase 6
at 97.4kDa. The distance migrated by each marker was measured and a graph of
molecular weight against distance migrated was plotted (Figure 3.2). The molecular
weights of the bands detected by the PDGF-B antibody were then estimated: Band 1
at 52.5kDa; Band 2 at 46.0kDa; Band 3 at 30.5; and Band 4 at 27.5kDa.
The expression of the higher molecular weight proteins, Bands 1 and 2, followed a
similar pattern of expression. During normal development, the expression levels of
the proteins increased from P2 to PI4, but there was no increase between P14 and
P21. The expression of both peptides was reduced in the oxygen treated samples;
although there was not much difference in expression on day 2, the reduction on days
7 and 14 was evident.
The expression of the lower molecular weight peptides (Bands 3 and 4) also
increased progressively from P2 to PI4, however, the effects of oxygen exposure on
these peptides differed from Bands 1 and 2. The expression on P2 and P7 was
around the same for both the control and oxygen treated groups; but on PI4, the
expression in the oxygen treated retinas was reduced in comparison to the PI4
controls.
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Figure 3.1: Western blot of retinal PDGF-B expression in control and oxygen
treated rat pups.
The blot compares control litters to oxygen treated litters at P2, P7 and PI4. The lower
blot of actin shows that the same quantity of protein was loaded for all samples.
C - control litter; O2 - litter exposed to the Edinburgh model; P - postnatal day.
Figure 3.2: Graph of distance migrated by bands against molecular weight.
The molecular weight markers were plotted and the molecular weights of the bands
detected by the PDGF antibody were estimated.
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These results were confirmed by quantitative analysis using the computer software
called 'Quantity-One':
P2 C P2 02 P7 C P7 02 P14C P14 02 P21 C
Band 1 3621.88 3198.27 4462.47 3448.49 4625.64 3644.06 4632.44
Band 2 3703.06 3312.38 4308.46 3534.78 4561.14 3601.89 4234.14
Band 3 2880.67 2792.48 3464.18 3487.19 4230.89 3214.85 3835.87
Band 4 2651.97 2582.21 4261.42 4132.37 5084.29 4268.33 4992.95
Table 3.1: Retinal PDGF-B expression of control and oxygen treated rat pups.
Using the 'Quantity One' software the bands from the Western blot were highlighted
and the total volume of each band was calculated by multiplying the area of the band by
its intensity to give the densitometric values.
02 - oxygen treated litter; P - postnatal day.
3.4.2 Immunofluorescent Labelling
Retinal flatmounts were labelled with PDGF-B to determine if its expression was
associated with the vasculature. Figure 3.3 shows the expression of the growth factor
in relation to lectin (endothelial cells) and a-SMA (smooth muscle cells); the pattern
ofPDGF-B staining was almost identical to that for lectin.
Likewise, in Figure 3.4, in which the flatmounts were stained with desmin instead of
a-SMA, the PDGF-B labelling was identical to lectin staining. This pattern of
labelling was seen across the entire vasculature; from the arteriole to the venule and
from the centre to the periphery. However, when the laser signal for lectin (488nm)
and desmin (568nm) were set to 0, and the signal for PDGF-B (647nm) was
increased to its maximum level, no staining was observed (Figure 3.4 C). Thus, the
staining detected in the triple-labelled flatmounts was entirely a result of cross-talk.
The lack of PDGF-B labelling was confirmed by staining flatmounts with PDGF-B
antibody alone (Figure 3.5, page 111). Thus, the PDGF-B antibody, although
produced results in Western blotting, failed to produce any staining of the retinal
flatmounts.
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Figure 3.3: Triple-labelled retinal flatmount of a P14 room-air raised pup.
The flatmount was stained using lectin/endothelial cells (green) a-SMA/smooth muscle
cells (red) and PDGF-B (blue). (A) Image of central retina. (B) Image of arteriole cross
section.
Scale bar: (A) 100pm; (B) 32pm.
Figure 3.4: Triple-labelled retinal arteriole of P7 pup.
The flatmount was stained using lectin/endothelial cells (green), desmin/pericytes (red)
and PDGF-B (blue). (A) Image of arteriole. (B) Image of advancing peripheral edge.
(C) Image B with green (488nm) and red (568nm) lasers eliminated. This image shows
that the PDGF-B staining observed in image B was due to crosstalk.
Scale bar: 32pm.
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Figure 3.5: P7 retinal flatmount stained for PDGF-B only.Scale bar: lOO^m.
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3.5 Discussion
3.5.1 PDGF-B in the Vasculature
PDGF is a glycoprotein produced by platelets [Heldin, Westermark and Wasteson,
1979; Antoniades, 1981; Deuel et al., 1981], although cells such as endothelial cells
have also been reported to express the protein [Barette et al., 1984; Collins et al.,
1985], The spatial and temporal expression patterns of PDGF-B and its receptor,
PDGF-/?, suggest that PDGF-B released from endothelial cells promotes the
proliferation of adjacent pericyte or smooth muscle cell precursors [Leveen et al.,
1994; Soriano, 1994, 1996; Bestrom et al., 1996], This has been confirmed by
analysis of mice lacking either the PDGF-B or PDGF-/? gene where both transgenics
showed a reduction in the proliferation and thus a reduction in the number of mural
cells [Leveen et al., 1994; Soriano, 1994], Therefore, the PDGF-B binding to its
receptor signals the recruitment of pericytes to the endothelial tubules. Taking these
studies into consideration the PDGF-B protein expression in the retina of rat pups
was measured and compared to the expression in the retinas of pups raised in the
fluctuating oxygen regime of the Edinburgh ROP model.
3.5.2 PDGF-B Protein Expression in the Retina
A polyclonal antibody raised against a recombinant piotein corresponding to amino
acids 136 to 190 at the carboxyl terminal ofmature human PDGF-B was used for the
Western analysis. This antibody recognised four proteins expressed in the rat retina.
The molecular weights of these proteins were estimated at 52.5, 46.0, 30.5 and
27.5kDa. The expression of all four peptides increased from P2 to P14, when the
vasculature was forming and remained elevated even once the vasculature was fully
matured at P21. In response to the variable oxygen regime, the expression of Bands
1 and 2 (52.5 and 46.0kDa) decreased on all days examined, but the levels of Bands
3 and 4 (30.5 and 27.5kDa) were reduced only on PI4.
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The mature B chain of PDGF has a molecular weight of between 15 and 16kDa,
making the homodimer around 30-32kDa [Johnsson et al., 1982; Waterfield, 1983;
Hammacher et al., 1988a], In the Western blots, Band 3 was calculated at
approximately 30.5kDa, which suggests that this Band may correspond to the PDGF-
BB isoform. The PDGF-B precursor expressed by endothelial cells has been
reported to be 241 amino acids long and has a molecular weight of 27,281kDa
[Collins et al., 1985], Thus, the band detected at 27.5kDa (Band 4) may be the
PDGF-B precursor peptide. The other possibility is that Band 4 was the AB
heterodimer; however this is unlikely since it is unknown whether endothelial cell
derived PDGF is a heterodimer or if endothelial cells even synthesize the A chain
[Collins et al., 1985], The other source of PDGF-AB would be the platelets
[Flammacher et al., 1988a], but all control and experimental animals were perfused
before killing.
Although there was no difference in expression of the presumed precursor and
mature PDGF-B proteins between control and oxygen exposed retinas at P2 and P7,
on P14 the levels of PDGF-B expression were reduced in the oxygen treated retinas
compared to the controls. This would suggest that PDGF-B expression was altered
only with a prolonged exposure to the variable oxygen regime, or that the greater
variability in oxygen levels during the second week of the profile produced the
decrease in PDGF-B expression (see Figure 1.2, page 25).
What caused the down-regulation of the presumed PDGF-B precursor and the mature
B chain in the Edinburgh model? Currently there is limited literature available on
the direct influence of oxygen concentration on the expression of PDGF, but the few
studies that have been conducted have shown that in vitro PDGF-B levels rise in
response to hypoxia. In one such study, human umbilical vein endothelial cells were
exposed to hypoxic conditions and the transcription rate of the PDGF-B gene
increased significantly [Kourembanas, Hannan and Faller, 1990], This increase was
inversely proportional to oxygen tension and was reversed upon reoxygenation at
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room air. Consistent with this report, the pups exposed to the oxygen regime of the
Edinburgh model used here spent very little time (8%) in hypoxic conditions (below
21% O2) [McColm et al., 2004], Thus, it is possible that the protein expression of
both PDGF-BB and its precursor decreased as a result of the hyperoxic environment
(above 21% O2) experienced by the pups.
At first I thought that the higher molecular weight bands were the result of sample
contamination. However, this explanation was rejected for several reasons. Firstly,
the samples were obtained and processed at difference times, therefore it is unlikely
that contamination of all samples would have occurred. Secondly, contaminants
would have produced diffuse bands, not distinct bands as observed here. Thirdly, the
expression pattern of both bands was rather specific, if the samples contained
contaminants a greater variation in the levels of expression would have resulted.
These bands were also not the result of non-specific binding because the membranes
were blocked overnight and all antibodies were prepared in the blocker solution,
neither was it due to non-specific binding of the secondary antibody because the
same secondary antibody was used for transforming growth factor-/)11 protein
detection (Chapter Four) and only one band was detected in the blots.
Because the two bands followed a very similar pattern of expression, it is likely that
these two proteins are closely related. It is plausible that the antibody recognised
another protein, where one band was the precursor molecule and the other the
mature, secreted molecule. On-the-other-hand, the antibody may have recognised
two different isoforms of the same protein. What can be said regarding these higher
molecular weight proteins is that their expression increased as the retinal vasculature
was developing and remained high once the vasculature had fully formed. In
addition, the expression of the peptides was reduced in fluctuating oxygen
conditions. It could simply be that a poor antibody was used; the polyclonal
antibody was raised against a recombinant protein and it is possible that other
proteins were indeed being detected. Perhaps using a different (monoclonal) PDGF-
114
Chapter Three: Expression ofPlatelet-Derived Growth Factor
in the Edinburgh Model ofROP
B antibody would produce more acceptable results. I have been in touch with the
suppliers of the antibody, Santa Cruz, regarding this problem, but as yet have not
received a reply.
3.5.3 Immunofluorescent Labelling by PDGF-B
Unfortunately our immunohistochemical staining for the detection ofPDGF-B in the
retinal flatmounts was unsuccessful despite attempts at changing the fixative used
(from paraformaldehyde to acetone) and increasing the concentrations of the
antibody (from 1:200 to 1:50). It is possible that the expression of PDGF-B was too
low for detection by this method, but if that was the case then only faint bands would
have been detected in the Western blots.
Previously researchers who investigated the expression of PDGF-B and PDGF
receptor-/? found both to be associated with retinal blood vessels. One study looked
at frozen sections of the rat retina and detected mRNA expression using in situ
hybridisation techniques [Mudhar et al., 1993], The other study preformed
immunohistochemical staining on frozen and wax sections of the human retina using
both polyclonal and monoclonal antibodies [Robbins et al., 1994], In the wax
sections, high non-specific binding was observed when using the monoclonal
antibody whereas on frozen sections, PDGF-B staining was seen in the neural retina
and the choroidal vessels. In comparison, the polyclonal antibody did not stain the
wax or the frozen sections. A polyclonal antibody was used in my study, thus it is
possible that the lack of staining here was due to a poor quality antibody. This could
be simply determined by using a monoclonal antibody on frozen retinal flatmounts.
In summary, the PDGF-B antibody recognised four proteins expressed in the rat
retina, two of which were identified as the PDGF-B chain precursor (27.5kDa) and
the PDGF-B homodimer (30.5kDa). The retinal expression levels of these two




The Effects of Oxygen on Transforming
Growth Factor-/? Protein Expression
4.1 Introduction
Transforming growth factor-/? (TGF-/?) is a growth factor which is capable of playing
different and often opposite roles on a number of cell types. Besides being
multifunctional, TGF-/? is part of a large superfamily of growth factors that includes
the inhibins, activins and Mullerian inhibiting substance [reviewed in Massague,
1990],
TGF-/? is synthesised as a large precursor protein of about 390 amino acids in size
[Derynck et al., 1985], but undergoes intracellular modification where proteolytic
digestion cleaves the precursor between amino acids 278 and 279 [Dubois et al.,
1995; Blanchette et al., 1997] to yield two separate products prior to secretion. The
peptide from the N-terminal region is called latency-associated peptide (LAP),
whereas that from the C-terminal is called mature TGF-/? [Brown et al., 1990; Gentry
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and Nash, 1990; Blanchette et al., 1997], The mature form of the protein has a
molecular weight of 25kDa and is composed of two identical 12kDa chains held
together by disulfide bonds [Assoian et al., 1983],
4.1.1 Ligands
Of the five TGF-/? isoforms identified so far, three are mammalian and designated
TGF-/?i, TGF-/?2 and TGF-/A TGF-/?i was first isolated from human and porcine
blood platelets, the richest source of TGF-/?i [Assoian et al., 1983], TGF-/?2 was
identified as one of two naturally occurring peptides in bone tissue and was named
C1F-B (cartilage-inducing factor-B) based on its cartilage-inducing activity [Seyedin
et al., 1985], CIF-A (the other peptide in bone tissue) was then realised to be
identical to TGF-/A consequently CIF-B was renamed TGF-/?2 [Seyedin et al., 1987],
Later TGF-/?2 was also isolated from procine blood platelets [Cheifetz et al., 1987],
Human TGF-/L was identified at the cDNA level [ten Dijke et al., 1988], and
expressed in the recombinant form [ten Dijke et al., 1990], All three isoforms often
display similar activities and share considerable sequence homology; around 70% of
the amino acids of TGF-/?i are identical to those of TGF-/?2 [Cheifetz et al., 1987;
Seyedin et al., 1987], and both isoforms share around 80% homology with TGF-/?3
[ten Dijke et al., 1988],
4.1.2 Receptors
Three cell surface receptors for TGF-/? have been identified using receptor affinity-
labelling methods [Massague, 1985], Transforming growth factor-/? receptor I is a
glycoprotein with a molecular weight of 65kDa [Massague, 1985], whereas
transforming growth factor-/? receptor II, also a glycoprotein, varies greatly in size
from 70-85kDa in most mammalian cells to around lOOkDa in the chick embryo
[Massague, 1985; Cheifetz, Like and Massague, 1986], Both receptor types are
transmembrane serine-threonine kinases [Lin et al., 1992; Franzen et al., 1993] and
display a higher affinity for TGF-/?i than TGF-/?2 [Cheifetz et al., 1987], The third,
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and most widely expressed, TGF-/? receptor type is betaglycan. Depending on the
species, this receptor has a molecular weight of between 280 and 330kDa [Massague,
1985], Betaglycan differs from receptors I and II in that it is a membrane anchored
proteoglycan with a large extracellular domain [Lopez-Casillas et al., 1991] and is
capable of binding all three TGF-/? ligands with high affinity [Cheifetz et al., 1987],
It is suggested that rather than being directly involved in signal transduction,
betaglycan might act to control the access of the ligand to the signalling receptor,
TGF-/? receptor I [Lopez-Casillas et al., 1991],
4.1.3 Signalling
The most important regulation of TGF-/? signalling is based on whether or not the
ligand is biologically active or latent. As mentioned above, prior to its secretion
from the cell, TGF-/? is cleaved to produce mature TGF-/? from the N-terminal region
[Dubois et al., 1995; Blanchette et al., 1997], Despite cleavage of the precursor,
however, LAP often remains non-covalently associated with the mature ligand
[Brown et al., 1990; Gentry and Nash, 1990; ten Dijke et al., 1990], The presence of
LAP facilitates the transit of the ligand from the cell, but makes it biologically
inactive (called latent TGF-/?), hence the ligand is unable to interact with its receptor
and evoke a biological effect [Brown et al., 1990; Gentry and Nash, 1990], For
latent TGF-/? to become biologically active and bind to the receptor it must be
released from its association with LAP. The conversion of latent to active ligand can
be accomplished by changes in the extracellular environment, by exposure to
extreme pH levels, or by exposure to high temperatures [Brown et al., 1990; Gentry
and Nash, 1990],
Although TGF-/? receptors I and II bind TGF-/? [Cheifetz et al., 1987], the ligand is
not recognised by receptor I, it instead binds to receptor II which is highly
phosphorylated by cellular kinases in the absence of TGF-/?, and therefore readily
binds free ligand [Wrana et al., 1994], However, receptor II fails to elicit a response;
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it is suggested that receptor I recognises the ligand bound to receptor II to form a
very stable ternary complex, called the signal receptor complex, at which point
receptor I is phosphorylated and propagates the signal to substrates within the cell
[Wrana et al., 1994], Only a small number of the TGF-/? receptor II population binds
the ligand with high affinity. This limitation is overcome by the action of
betaglycan, since receptor II binds TGF-/? tethered to betaglycan better then it binds
free TGF-/? [Lopez-Casillas et al., 1991; Lopez-Casillas, Wrana and Massague,
1993], Thus, it is proposed that all three receptor types are involved in efficient
TGF-/? signalling: first, betglycan binds and presents the ligand to receptor II,
forming a high affinity stable ternary complex; second, receptor I recognises the
ligand bound to receptor II, displaces betaglycan, and binds the ligand to form the
signal receptor complex [Lopez-Casillas, Wrana and Massague, 1993], Therefore,
betaglycan increases binding of the ligand to the signalling receptor, an effect that is
particularly evident with TGF-/?2, which has low affinity for both receptor types I and
II.
4.1.4 TGF-/? in the Developing Embryo
The first study on the functions of TGF-/? in the embryo was conducted by Fleine et
al. They reported that in the embryonic day 11 (Ell) mouse, blood cells of the liver
were positive for TGF-/?i protein, implicating this growth factor in the control of
haematopoiesis [Heine et al., 1987], Akhurst et al. detected TGF-/?! mRNA in the
extraembryonic blood islands of the yolk sac and in cardiac mesoderm cells [Akhurst
et al., 1990], Within the embryo proper, TGF-/?i transcripts were observed in the
endothelial cells of major blood vessels, suggesting that this growth factor is also
involved in vasculogenesis.
To further elucidate the functions of TGF-/?i in embryonic development, mice
lacking the TGF-/?! gene were generated by cross breeding mice heterozygous for the
TGF-/?i gene [Shull et al., 1992; Kulkarni et al., 1993; Dickson et al., 1995], All
mice generated from the mating appeared normal at birth. However, statistical
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analysis of the genotype of the mice showed a wild type:heterozygous:homozygous
ratio of 1:1.5:0.5 [Kulkarni et al., 1993; Dickson et al., 1995], deviating significantly
from the expected Mendelian ratio of 1:2:1. This indicated that approximately 25%
of the heterozygous and 50% of the homozygous null mice died in utero [Dickson et
ah, 1995], Examination of the litters showed that between E9.5 and E10.5, the
embryos suffered abnormalities in yolk sac development that ranged from a simple
delay in vasculogenesis and the development of disorganised and delicate vessels to
more severe abnormalities where regions of the yolk sac were completely devoid of
vessels. In control pups the layers of the yolk sac were closely apposed, with blood
cells within the endothelial tubes; however in the TGF-/?, null mice the cellular
adhesion between the two endothelial layers of the yolk sac was disrupted and in
some cases, blood cells appeared to have leaked into the yolk sac cavity, indicating
instability of the endothelial tubes, and inadequate endothelial cell differentiation
[Dickson et al., 1995].
In support of these roles of TGF/?i, Oshima and colleagues demonstrated that when
mice heterozygous for the TGF-/? receptor II gene were intercrossed, only wild type
or heretozygous mice survived to birth [Oshima, Oshima and Taketo, 1996], The
TGF-/? receptor II null mice displayed defects almost identical to mice lacking the
gene for TGF-/?i. Their yolk sac at E9.0 showed severe anaemia and slight
embryonic growth retardation that worsened by El0.5-El 1.5. Defects in
haematopoiesis and vascular development were also observed and the endothelial
cells never formed capillary-like tubes, with tight junctions. It is most likely that
these defects in the TGF-/? receptor II null mice were due to defective TGF-/)j
signaling.
4.1.5 Cellular Responses to TGF-/?
TGF-/? affects many cellular processes, which are highly dependent on cell type,
culture conditions, state of cell differentiation, extracellular matrix conditions and
dosage of TGF-/?. Thus, TGF-/? can have either a stimulatory or inhibitory effect on
120
Chapter Four: The Effects ofOxygen on
Transforming Growth Factor-f Protein Expression
the same cell depending on the cellular environment. Most studies that have
investigated the role of TGF-/? have used the [1\ isoform probably because it was the
first of the family to be discovered.
The concept that TGF-/? is a dual factor emanated first from studies on cell
proliferation. Under certain conditions the growth of mesenchymal cells, such as
fibroblasts [Moses et al., 1981; Roberts et al., 1981; Tucker et al., 1984] and
osteoblasts [Moses et al., 1985] is stimulated by TGF-/?. However, in most cells
TGF-/? acts as a potent growth inhibitor. These cell types include normal as well as
transformed epithelial cells [Tucker et al., 1984], endothelial cells [Frater-Schroder et
al., 1986; Heimark, Twardzik and Schwartz, 1986], haematopoietic cells [Ohta et al.,
1987], preadipocytes [Ignotz and Massague, 1986] and smooth muscle cells [Owens
et al., 1989]. It is suggested that this anti-proliferative effect of TGF-/? is the result of
arrested progression of the cell cycle in the Gi phase [Heimark, Twardzik and
Schwartz, 1986], The response of a cell to TGF-/? is also affected by cell attachment
(or lack thereof) to a solid substrate. For example, TGF-/? inhibits anchorage-
dependent growth of fibroblasts and tumour cell lines and anchorage-independent
growth of many human tumour cells, however, it promotes anchorage-independent
growth of transformed rat kidney fibroblasts [Roberts et al., 1985], Once the ligand
is removed from the culture medium, the cells continue to proliferate as normal
[Tucker et al., 1984; Massague et al., 1986], Thus, the growth inhibitory effect of
TGF-/? is usually reversible and non-toxic to cells [Frater-Schroder et al., 1986],
The effects of TGF-/? on cell differentiation are also cell type dependant. Although,
the growth factor favours chrondogenesis and osteogenesis [Seyedin et al., 1985] and
promotes the differentiation of epithelial cells [Mausi et al., 1986] and smooth
muscle cells [Shah, Groves and Anderson, 1996], it fails to elicit the differentiation
of embryonic myoblasts (skeletal muscle) [Massague et al., 1986],
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TGF-/? is also involved in extracellular matrix production; it stimulates the syntheisis
of many extracellular matrix components including collagens and fibronectin
[Seyedin et al., 1985; Massague et al., 1986; Centralla, McCarthy and Canalis, 1987],
and suppresses matrix degradation by down-regulating the expression of proteinase
but inducing that of proteinase inhibitors [Edwards et al., 1987; Laiho, Saksels and
Keski-Oja, 1987],
4.1.6 TGF-jg as an Immunosuppressor
TGF-/?i null mice that survive to birth appear normal and continue to gain weight as
normal pups [Shull et al., 1992; Kulkarni et al., 1993J. About 3 weeks after birth,
however, the animals begin to exhibit an acute wasting syndrome, resulting in death.
The mice display a variable degree ofmixed inflammatory cell infiltration and tissue
necrosis in several organs, mainly the heart, stomach, liver and lungs [Shull et al.,
1992; Kulkarni et al., 1993], The infiltration contains lymphocytes and neutrophils,
and cytokine mediators of inflammation, such as interferon-}', tumour necrosis factor-
a and macrophage inflammatory protein-la, are increased in the liver and lungs of
the mutants [Shull et al., 1992], Thus, TGF-/h deficiency results in death associated
with dysfunction of the immune and inflammatory systems. It is suggested that
TGF-/h deficient animals that survive to birth are in fact rescued by their mother; in
utero by placental transfer of the growth factor and postnatally by transmission in
milk [Shull et al., 1992],
In vitro studies are consistent with an immunosuppressant action of TGF-/?. First, B-
lymphocytes and T-cells synthesise and secrete TGF-/?, and express the three
receptor types [Kehrl et al., 1986a, 1986b]. Second, the ligand inhibits the
proliferation of B-lymphocytes [Kehrl et al., 1986a], and T-lymphocytes [Kehrl et
al., 1986b]. Third, in cultures of resting monocytes, TGF-/? activates inflammatory
cytokine production such as interleukin-1, tumour necrosis factor-a, basic fibroblast
growth factor and macrophage inflammatory protein-la [Wahl et al., 1987], Lastly,
it is reported to act as a chemattractant for monocytes, T-lymphocytes and fibroblasts
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to the site of tissue injury [Wahl et al., 1987], Hence, TGF-/7 functions as a potent
regulator of the immune and inflammatory system.
4.1.7 TGF-/7 in Cancer
Transgenic studies have provided evidence that one of the physiological roles of
TGF-/? signalling is to provide protection against malignant transformation. For
example, transgenic mice that produce a constitutively active form of TGF-/?i are
resistant to mammary tumour formation [Pierce et al., 1995b]. Conversely, the
absence of TGF-/?i appears to promote tumour formation in skin keratinocytes
isolated from TGF-/?]-/- embryos [Glick et al., 1994], In some cases, loss of TGF-/?
expression may represent an early step in tumour progression [Wu et al., 1992],
However, many human carcinoma cell lines in vitro [Roberts et al., 1983] and human
tumours in vivo [Kong et al., 1995; Tsushima et al., 1996; Perry, Anthony and
Steiner, 1997] appear to express high levels of TGF-/? than corresponding normal
tissue. For example, TGF-/?i and TGF-/?2 are both detected in a majority of primary
breast cancers [MacCallum et al., 1994],
It is proposed then, that TGF-/? acts predominantly as a potent tumour suppressor
during the early stages of cancer. However, at some point during development and
progression of malignant neoplasia, the cells escape from the growth arrest induced
by TGF-£ Although the molecular mechanisms remain to be elucidated, tumour
cells somehow switch from a TGF-/? sensitive to TGF-y? resistant state.
4.1.8 TGF-jg in Vascular Development
Thus far, several roles of TGF-/1 have been discussed and much of the experimental
work mentioned above is also supportive of a role for TGF-/? in the development of
the vasculature:
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• the mesenchyme of the mouse embryo is strongly positive for TGF-/T
when it interacts with the adjacent epithelium during remodelling [Heine
et al., 1987]
• the yolk sac of TGF-/?i and TGF-/? receptor II knockout mice develop
disorganised and delicate vessels; some areas are devoid of vessels [Shull
et al., 1992; Kulkarni et al., 1993; Oshima, Oshima and Taketo, 1996]
• TGF-y? inhibits the proliferation of smooth muscle cells [Owens et al.,
1989], but induces their differentiation [Shah, Groves and Anderson,
1996]
• TGF-/? up-regulates the expression of fibronectin and collagen to increase
extracellular production and enhance both cell-matrix and cell-cell
adhesion [Seyedin et al., 1985; Massague et al., 1986; Centralla,
McCarthy and Canalis, 1987],
In addition to the above studies, two research groups have investigated the role of
TGF-/?i on single and co-cultures of endothelial cells, smooth muscle cells and
pericytes.
Sato and colleagues demonstrated that when a confluent endothelial cell monolayer
is wounded by a razor blade, the endothelial cells move rapidly into the denuded
space to repair the damage [Sato and Rifkin, 1988], This movement is inhibited by
the addition of neutralising antibodies to TGF-/?i [Sato and Rifkin, 1989] and by
growing endothelial cells in the presence of pericytes or smooth muscle cells [Sato et
al., 1990], They also found that depending on the length of time the two cell types
are together, 1-10% of the latent TGF-/T species is rapidly converted into the active
form, reaching a maximum by about 12 hours [Sato et al., 1990], After the initial 12
hours, the conversion of latent to active TGF-/?i decreases due to the stimulation of
plasminogen activator inhibitor, which is synthesised by the ligand. The
plasminogen activator inhibitor in turn inhibits the generation of plasmin that
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activates latent TGF-/i. Therefore, TGF-/? in vascular development may be self-
regulated.
The second group, lead by D'Amore, began by investigating the effects of pericytes
and smooth muscle cells on endothelial cells, and showed that when endothelial cells
are cultured alone they tripled in number over a 14 day period. However, when the
cells are co-cultured with pericytes or smooth muscle cells, their growth is
completely inhibited [Orlidge and D'Amore, 1987], This inhibition requires that
either the two cell types make direct contact with each other or that the two cell types
lie in close proximity. Like others researchers [Frater-Schroder et al., 1986;
Heimark, Twardzik and Schwartz, 1986; Sato and Rifkin, 1988] Antonelli-Orlidge et
al. also found that endothelial cell growth is inhibited by the addition of TGF-/?i to
the culture medium, and reported that the latent TGF-/?i secreted by endothelial cells
and pericytes is activated only when both cells come into contact [Antonelli-Orlidge
et al., 1989], Next, they found that the endothelial cells in three-dimensional co-
cultures become tightly associated in cord like structures that resemble the early
stages of capillary formation in vivo, and that the 10T1/2 cells (presumptive
mesenchymal cells) become elongated and either stretch along or wrap around the
endothelial cells [Darland and D'Amore, 2001a]. However, when soluble TGF-/?
receptor or TGF-/5 antibody is added to the culture, the cells do not elongate nor form
cords, but instead form large aggregates of rounded cells. In addition, a decrease in
the expression levels of NG-2 and a-smooth muscle actin (presumed markers for
pericytes and smooth muscle cells, respectively) in the co-culture is detected,
suggesting that TGF-/? is required for smooth muscle differentiation during capillary
formation [Darland and D'Amore, 2001a],
TGF-/i, therefore, appears to play a critical role in vascular development by
mediating differentiation of mesenchymal cells towards smooth muscle cells and/or
pericytes, and in maintaining vascular quiescent by acting as a direct inhibitor of
endothelial cell proliferation.
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4.2 Aims and Hypothesis
The aims of the work described in this chapter were:
• to determine the expression pattern of TGF-/h protein during normal
development of the rat retina
• to study the distribution ofTGF-/?i protein within the retina
• to investigate the expression of TGF-/?i in relation to the retinal
vasculature
• to determine if the expression of TGF-/?i protein was affected by the
oxygen regime of the Edinburgh model of retinopathy of prematurity
(ROP).
It is hypothesised that during normal development the expression of TGF-/?i protein
would increase progressively from birth to postnatal day 21 (P21). The reason for
this is that as the endothelial tubules spread across the two layers of the retina, the
vessels become encapsulated by pericytes and smooth muscle cells, thus from PO to
P21 the number of cells on which TGF-/?i would exert an effect will increase.
Based on current knowledge, it is expected that rats raised in the Edinburgh model of
ROP would have a decreased expression of retinal TGF-/?i protein when compared to
rats raised in room air because pups raised in the oxygen regime have a reduced
retinal vascular area [Cunningham et al., 2000] and a reduced coverage of pericytes
and smooth muscle cells [Chapter Two],
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4.3 Methods
4.3.1 Experiments
The experiments were conducted as described in Chapter Two. Briefly, litters of 12
pups or more were exposed to the lOkPa minute-by-minute variable oxygen profile
from birth to P2, P7 and PI4, and killed immediately. Control litters, raised in room
air, were sacrificed on P2, P7, P14 and P21. Both eyes from each pup were
enucleated; the right eye was used for immunohistochemistry (Chapter Two) and the
left was dissected fresh for Western blot analysis. A few additional eyes from day 14
control pups were obtained to examine the distribution of TGF-/f protein in the
retina.
4.3.2 Western Blot Analysis
Protein extraction and assays
Retinas from each control and experimental litter were dissected fresh in 1M
phosphate buffered saline (PBS), pooled and stored at -70°C. At a later stage, the
samples were homogenised in extraction buffer containing proteinase inhibitor
(Sigma). The samples were then centrifuged at 14,000g for lOmins, after which the
supernatant was transferred into a new tube. The samples were spun for a further
30mins and the resulting supernatant, which contained the total retinal protein, was
transferred into clean tubes and stored at -70°C.
To determine the protein content of the samples, 5pi of each sample was added to
95pl of extraction buffer, followed by 2mls of BCA protein assay reagent (Perbio).
All samples were incubated at 37°C for 30mins, and the OD562 of each sample was
measured. Bovine serum albumin was used as standard.
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Protein separation and transfer
75]ug of total retinal protein for each control and experimental timepoint was loaded
onto a 12% acrylamide gel. A biotinylated molecular weight marker (Bio-Rad
Laboratories) was also loaded. The proteins were then separated by SDS-PAGE
electrophoresis and then transferred onto PVDF membranes (Bio-Rad Laboratories)
using the semi-dry transfer cell (Bio-Rad Laboratories).
Blotting
The membranes were washed twice in 1M PBS/0.1% Tween for 5mins while shaking
gently and then blocked overnight at 4°C in 5% non-fat dry milk prepared in the
wash solution. The next morning, the membranes were washed twice and incubated
in TGF-/?i primary antibody (1:200, Santa Cruz), prepared in the blocking solution,
for 1 hour at room temperature with gentle shaking. The membranes were then
washed; three times for 5mins each and twice for 15mins each. The membranes
were incubated in horseradish peroxidase conjugated goat anti-rabbit secondary
antibody (1:5000, Dako) which contained additional horseradish peroxidase (1:2000,
Amersham Bioscience) for the detection of the molecular weight marker. The
membranes were washed again and then developed by applying ECL-Plus, a
chemiluminescent reagent (Amersham Bioscience) to the membrane for 5mins. The
membranes were then exposed to X-ray film for around 90secs.
To ensure that any difference in expression between control and experimental retinas
was genuine and not due to loading errors, each membrane was stripped and
reprobed for actin. Briefly, the membranes were first stripped for 15mins at 37°C
using Restore Western Blot Stripping Buffer (Pierce), washed and blocked again in
5% non-fat dry milk overnight. The following morning, the membranes were
incubated in actin primary antibody (1:100, Santa Cruz) and then in secondary
antibody containing horseradish peroxidase. After the washing step, developer
solution was applied and the membranes exposed to X-ray film.
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Analysis
An image of the X-ray film was captured using 'Quantity-One' software designed by
Bio-Rad Laboratories. Individual bands that had developed on the X-ray film were
manually selected. The software then calculated the amount of TGF-/?i protein
expressed in each sample by taking the area and the intensity of each band into
consideration.
4.3.3 Immunohistochemistry
Whole eye wax sections
Eyes from pups raised in room air until P2, P7, P14 and P21 were fixed in 10%
formalin overnight and then transferred to 70% alcohol. The eyes were later
dehydrated through a graded series of ethanol solutions (70%, 90%, 100%) followed
by xylene, and then embedded in wax. 5pm serial sections were cut and mounted
onto poly-L-lysine coated slides and left overnight to dry at 60°C.
The sections were deparaffinised and hydrated by first immersing the slides in
xylene, then decreasing alcohol concentrations (100%, 90%, 70%) and finally tap
water. To prevent the binding of endogenous peroxidase, the sections were treated
with 0.3% hydrogen peroxide for 20mins followed by a 5min wash in 1M PBS. The
sections were then incubated in 5% normal goat serum for 20mins to block non¬
specific binding. TGF-/h antibody (1:100, Santa Cruz) was applied for 30mins, after
which the sections were washed. Goat anti-rabbit biotinylated secondary antibody
(1:200, Dako) was applied for 30mins and then washed. The sections were then
incubated in horseradish peroxidase (1:100, Vector Laboratories) for 30mins and
washed again. Finally, the sections were incubated in DAB reagent (Vector
Laboratories) until the staining developed. The sections were counterstained using
thionine (blue stain) for 15secs, dehydrated and mounted. For the negative control
the above protocol was followed, except that the primary antibody incubation was
replaced with an incubation in 5% serum/lM PBS. The sections were viewed using
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a conventional light microscope (Leica) with a colour video camera attached (JVC)
and digital images were obtained.
Retinal whoiemounts
Four eyes from 7 and 14 day old pups, raised in room air, were fixed in 75% acetone,
dissected (as described in Chapter Two) and the retinas stained to determine the
distribution TGF-/?i protein expression in the vasculature. The protocols detailed
below were used where, unless otherwise stated, each wash stage consisted of three
lOmins incubations in 1M PBS/l%Triton X-100, and the antibodies/fluorescent
markers were prepared in the wash solution and applied for 2 hours at room
temperature with gentle shaking.
The flattened retinal whoiemounts were first permeabilised in 1M PBS/1% Triton X-
100 for 30mins and blocked using 5% rabbit serum (Diagnostic Scotland) diluted in
1M PBS/Triton X-100 for 20mins. The whoiemounts were then incubated in TGF-/h
antibody (1:100, Santa Cruz) overnight at 4°C. The next day, the whoiemounts were
washed and incubated in biotinylated goat anti-rabbit secondary antibody (1:200,
Dako). The whoiemounts were washed again and Alexa Fluor 647 (1:200,
Molecular Probes) was applied. The whoiemounts were given a final wash and then
mounted in PBS:glycerol (1:1) and the coverslip sealed with nail varnish.
For the triple-labelling, the retinal whoiemounts were incubated overnight at 4°C in
either anti-a-smooth muscle actin (a-SMA) primary antibody (1:400, Sigma) or
desmin primary antibody (1:50, Dako) prepared in 5% serum/lM PBS/1% Triton X-
100 to stain the mural cells. The following day, the tissues were washed and then
incubated in biotinylated rabbit anti-mouse secondary antibody (1:200, Dako),
followed by Texas red streptavidin (1:100, Vector Laboratories). The retinas were
then blocked using avidin and biotin for 20mins each (Vector Laboratories) before
applying biotinylated G. simplicifolia (Bandeiraea) isolectin B4 (1:50, Vector
Laboratories) overnight at 4°C to stain the endothelial cells. The next day, the retinas
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were incubated in fluorescein streptavidin (1:100, Vector Laboratories), blocked
using avidin, biotin and then 5% goat serum each for 20mins, and incubated
overnight in TGF-/?i antibody (1:100, Santa Cruz) at 4°C. On the fourth day, the
retinas were washed and incubated in biotinylated secondary antibody, followed by
Alexa Fluor 647. The retinas were washed for the final time and mounted.
For the negative control labelling, retinas were treated as above, however, each
primary antibody incubation was replaced with an incubation of 5% serum/1M
PBS/1% Triton X-100.
The retinal flatmounts were viewed using a Leica TCSNT confocal system with a
mixed gas argon/krypton laser. The endothelial cells stained using fluorescein were
labelled green and excited at 488nm (filter BP 525/50), mural cells stained with
Texas red were labelled red and excited at 568nm (filter LP 590), and TGF-/?i
expression, detected by Alexa Fluor 647, was labelled blue and excited at 647nm.
Representative images at xlO, x20 and x63-oil magnification were taken and
digitally stored.
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4.4 Results
4.4.1 Western Blots
The retinas from each litter of rat pups raised in room air or in variable oxygen were
pooled, the proteins were extracted and then separated by SDS-PAGE
electrophoresis. The membranes onto which the proteins were transferred were then
probed using a polyclonal antibody for TGF-/?i. As shown in Figure 4.1, the
antibody recognised a peptide with a molecular weight of around 25kDa.
Group 1 Group 2
I | | | Mwt.













Figure 4.1: Western blot of retinal TGF-/?j expression in control and oxygen
treated rat pups.
The lower blot shows actin (43kDa) expression as a loading control.
C - control litter; 02 - oxygen treated litter; numbers correspond to age of pups.
In normal development, very little TGF-/?i was expressed in the retina at P2. There
was a marked increase by P7, which remained high at PI4. On P21, however, the
expression of TGF-/?i had decreased. In comparison to the controls, rats exposed to
the variable oxygen regime of the Edinburgh ROP model had a reduced expression
of the protein at each developmental timepoint; the greatest decrease occurred in the
retinas exposed to oxygen for 14 days.
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These results were confirmed by quantitative analysis (densitometric values):
Mean Weight (g) TGF-/?ivalues
% decrease
in 02 group
Group 1 P2 Control 8.8 1245.81
P2 02 7.9 * 1044.16 16.2
P7 Control 15.3 3317.53
P7 02 13.9 * 2726.30 17.8
P14 Control 22.3 1836.08
P14 02 24.5 * 1257.91 31.5
P21 Control 37.6 1428.05
Group 2 P2 Control 9.1 749.25
P2 02 8.5 ** 696.07 7.1
P7 Control 15.7 2601.37
P7 02 16.3 2453.74 5.7
P14 Control 24.1 2001.38
P14 02 26.9 * 1316.61 34.2
P21 Control 35.7 847.56
Table 4.1: The percentage decrease of retinal TGF-/?i expression in oxygen treated
rat pups.
Using the 'Quantity One' software, the bands from the Western blot were highlighted
and the total volume of each band was calculated by multiplying the area of the band by
its intensity.
O2 - oxygen treated litter; P - postnatal day; * - p < 0.005 (t-test); ** - p < 0.05 (t-test)
The values obtained show that the highest expression of TGF-/?i in normal
development occurred at around day 7, falling slightly by day 14 and dramatically by
day 21. From Table 4.1 it can also be seen that 14 days of the variable oxygen
exposure resulted in a greater decrease in TGF-/?i protein expression than 2 or 7 days
of exposure; for example, in Group 1, on day 2 and day 7 the percentage decrease in
the oxygen treated rats was around 17%, but on day 14 the reduction in expression
was almost twice as much at 32%. These results suggest that TGF-/?i expression was
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regulated by oxygen and that the duration of the oxygen exposure was an important
factor.
The membranes were stripped and reprobed using polyclonal goat actin which acted
as a loading control. The expression levels of actin were similar for all samples
(Figure 4.1), thus similar quantities of protein were loaded for each sample.
4.4.2 Immunohistochemistry
To determine if the observed decrease in TGF-/?i expression was a direct effect of
oxygen on the cells of the vasculature, and not other cells of the retina, TGF-/?i
immunohistochemistry was conducted.
Wax sections
The first stage involved determining the distribution of TGF-/?i protein expression
within the retina. 5pm paraffin wax sections of whole eyes from P2, P7, P14 and
P21 control animals were stained using the same TGF-/?i antibody used in the
Western blots. Figure 4.2 (page 136) shows that both the vitreous and the choroid
stained strongly for TGF-/?i protein. On P2, no staining was detected within the
neural retina. On P7, positive staining was present in the ganglion cell layer (GCL),
but only around the optic nerve area. By PI4, scattered cells stained positive for the
protein; these cells were located in the GCL and the posterior edge of the inner
nuclear layer (INL). This labelling pattern was also observed on P21. Upon further
examination (Figure 4.3, page 137), it seemed that these scattered cells may be blood
vessels, suggesting that the Western results were reflective of TGF-/?i acting on the
vascular cells, and not other retinal cells. In the negative controls, where only serum
was applied to the sections instead of primary antibody, no staining was observed.
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4.4.3 Immunofluorescent Labelling
Finally, the expression of TGF-/?i in relation to the vascular cells was briefly
investigated. Retinas of a few pups raised in room air until 14 days of life were
triple-labelled for endothelial cells, mural cells and TGF-/?i. Previously, in Chapter
Two, it was suggested that desmin and a-SMA were suitable markers for pericytes
and smooth muscle cells, respectively. As illustrated in Figure 4.4 (page 137),
positive TGF-/?i labelling was observed around the vessels; all vessels were stained
from the centre of the retina to the periphery.
It was expected that the positive labelling would be observed between the endothelial
and mural cells, since TGF-/? has been reported to act on both cells types [Frater-
Schroder et al., 1986; Heimark, Teardzik and Schwartz, 1986; Antonelli-Orlidge et
al., 1989; Owens et al., 1989; Sato and Rifkin, 1989; 1990], Figure 4.5 (page 138)
shows arterioles triple-labelled for endothelial cells, smooth muscle cells or
pericytes, and TGF-/?i. The positive staining for the growth factor was very close to
that of the three cell types. This is illustrated best in Image D, where it can also be
seen that TGF-/?i staining occurred on the inner surface of the smooth muscle cells.
The negative controls showed no positive staining, except those for desmin and a-
SMA; which had high background labelling (Chapter Two). Whilst examining these
images it was observed that the staining pattern of TGF-/?i was almost identical to
that of the endothelial cells (lectin). Indeed, this is seen in the images showing each
individual stain for Figure 4.5 A and Figure 4.5 C.
Thus, flatmounted retinas were stained for TGF-/?i protein expression alone. Positive
TGF-/?i labelling was detected on the arterioles and venules; as illustrated in Figure
4.6 A (page 138), staining of the venule was markedly weaker than that of the
arteriole. In Figure 4.6 B, which shows an arteriole at a higher magnification, there
was a little staining on either side of the arteriole; it is possible that this staining was
of the primary capillary branches. These results suggest that TGF-/?i predominantly
exerts its effects on the vascular cells of the main retinal vessels.
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Figure 4.2: Immunohistochemical staining for TGF-/?i expression in wax sections
of normal rat eyes.
Positive labelling for the protein was detected using DAB (brown). The sections were
then counterstained using thionine (blue).
GCL - ganglion cell layer; INL - inner nuclear layer; ONL - outer nuclear layer;
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Figure 4.3: Enlarged image of P14 retinal section in Figure 4.2.
Arrows indicate positive labelling of what may be blood vessels.
GCL - ganglion cell layer; INL - inner nuclear layer; ONL - outer nuclear layer
Scale bar: 50pm
Figure 4.4: Fluorescent triple-labelling of the retinal vasculature at PI 4.
Image of the central retinal vasculature stained for lectin/endothelial cells (green),
desmin/pericytes (red) and TGF-/?, (blue).
Scale bar: 100pm.
137
Chapter Four: The Effects ofOxygen on
Transforming Growth Factor-fl Protein Expression
Figure 4.5: Fluorescent triple-labelling of the retinal arterioles at PI 4.
(A) Arertiole stained with lectin/endothelial cells (green), a-SMA/smooth muscle cells
(red) and TGF-/?, (blue); projected focus stack of 10 optical sections at 0.94pm.
(B) Cross-section of image A. (C) Arteriole stained with lectin/endothelial cells
(green), desmin/pericytes (red) and TGF-ft, (blue); projected focus stack of 15 optical
sections at 0.49pm. (D) Cross-section of image C.
Scale bar: (A) 32pm; (B) and (C) as A; (D) 15pm.
Figure 4.6: Fluorescent labelling for TGF-//] expression on P7.
(A) Labelling of the two arterioles (a) is strong in comparison to the venule (v).
(B) Labelling of an arteriole at a higher magnification than A. Positive labelling
appears to have begun on the primary branches (arrows).
Scale bar: (A) 200pm; (B) 100pm.
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4.5 Discussion
4.5.1 Evidence for a Role of TGF-/7i in Vascular Development
Genetic studies on mice have revealed a role for TGF-/?i in embryonic vascular
assembly and in the establishment and maintenance of vessel wall integrity [Shull et
al., 1992, Kulkarni et al., 1993; Dickson et al, 1995; Oshima, Oshima and Taketo,
1996], In addition, immunohistochemical analysis of the mouse embryo showed that
the endothelial cells of major blood vessels are positive for TGF-/? mRNA [Akhurst
et al., 1990], and that the mesenchyme per se or tissues derived from the
mesenchyme are positive for protein expression [Heine et al., 1987],
Indeed, in vitro studies also support a role for TGF-/?i in vessel formation. First,
aortic endothelial cells cultured in media are growth inhibited in the presence of
TGF-/? [Frater-Schrdder et al., 1986; Heimark, Twardzik and Schwartz, 1986], as are
endothelial cells of capillaries from bovine adrenal cortex [Antoneli-Orlidge et al.,
1989], Second, when smooth muscle cells, which express all three TGF-/? receptors
[Goodman and Majack, 1989], are plated at subconfluent densities their growth is
inhibited by TGF-/?i in a dose-dependent manner [Majack, 1987; Owens et al., 1989;
Schor et al., 1995], Third, neural crest stem cells in culture differentiate into smooth
muscle cells in response to TGF-/?i [Shah, Groves and Anderson, 1996], Finally, the
level of a-SMA and active TGF-/? vary similarly along the length of arteries in vivo
[Granger et al., 1998],
In comparison to endothelial cells and smooth muscle cells, studies on the effects of
TGF-/?i on pericytes are limited. One reason for this is that pericytes are difficult to
positively identify and therefore to isolate and grow in vitro. Thus far, TGF-/?i is
reported not to have an effect on pericyte proliferation [Verbeek et al., 1994; Schor et
al., 1995], but promote in vitro differentiation of human brain pericytes to smooth
muscle cells [Verbeek et al., 1994] and differentiation of presumptive mesenchymal
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cells to the perictye/smooth muscle cell lineage [Hirschi, Rohovsky and D'Amore,
1998], The differential potential of TGF-/?i, however, is disputed; Schor et al. found
that TGF-/i, did not affect a-SMA synthesis by bovine retinal pericytes [Schor et al.,
1995], but a-SMA, as discussed in Chapter Two, is not a suitable marker for the
identification of pericytes.
One of the main functions of TGF-/? is to promote vessel stability by inhibiting the
proliferation and migration of endothelial cells; it is suggested that pericytes express
the active form of TGF-/? once they come into contact with endothelial cells [Sato
1988, 1989; Antonelli-Orlidge et al., 1989], Thus, I investigated if the expression of
TGF-/?i in the retina would differ between rats raised in room air and rats exposed to
a minute-by-minute oxygen regime that induces features ofROP [Cunningham et al.,
2000; McColm et al., 2004],
4.5.2 The TGF-/7i Antibody
A polyclonal antibody raised against the carboxyl terminus of the TGF-/?i precursor
purified from human platelets was obtained from Santa Cruz. From the Western
analysis it can be seen that this antibody recognised a component of around 25kDa
that corresponds to the mature form of TGF-/h [Assoian et al., 1983], This detected
TGF-/?i was biologically active; if the ligand was inert, the LAP protein would be
bound to the mature ligand and a band at around 90-100kDa would have been
detected instead [Brown et al., 1990; Gentry and Nash, 1990; Blanchette et al.,
1997],
Physiologically activated TGF-/?i within the retina would be readily recognised by
the receptors, and once the ligand is bound to the receptor it would not be detected in
the Western blots. In the wax sections, on-the-other-hand, activated ligand bound to
any cell surface receptors would be readily detected. Extreme pH (less than 3 or
above 10), high temperatures (above 100°C) and chaotophic agents can convert the
latent form of the ligand to the activated state [Lawrence, Pircher and Jullien, 1985;
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Wakefield et al., 1988; Brown et al., 1990], Although the samples for the Western
blots were never exposed to extreme pH conditions, the proteins were extracted in
buffer containing SDS, a chaotrophic agent that coats the molecules and allows their
migration during electrophoresis, and later the samples were heated at 90-100°C for 3
minutes to denature the proteins before electrophoresis. It is therefore possible that a
high proportion of latent TGF-/? could have been converted into the active form
during the processing of the tissues.
4.5.3 Retinal TGF-/7i Expression During Normal Development
On P2, TGF-/?i was barely detected in the Western blots and none was detected in
the immunohistochemically stained sections. At this point, the superficial
vasculature was in the initial stages of development; the endothelial cells were
forming into tubules and were still required to proliferate for further vessel
formation, and there was very little mural cell coverage (Chapter Two). Thus, the
low level of TGF-/?i expression observed in the Western blots was probably due to
secretion of the latent ligand by mural cells and endothelial cells; in vivo, none of the
secreted protein was probably converted into the active form. Vessels of the
superficial layer had progressed much further to the periphery by day 7, the central
vasculature had undergone remodelling and extensive mural cell coverage was
apparent. The Western blots showed a marked increase in TGF-/?i expression
compared to P2, however in the sections, positive staining was only observed around
the optic nerve area. Although the activated ligand was acting on a few cells at this
stage, the number of cells secreting the ligand had increased greatly. Thus, in the
Westerns it may be assumed that the high TGF-/?i levels detected was the result of an
increase in the presence of both latent and active TGF-/?i. At day 14, the formation
of the superficial vasculature came to an end, and the expression of TGF-/?i in the
Westerns although still high, was slightly reduced in comparison to day 7. In the
wax sections, positive labelling was noted in the GCL and the INL from the centre to
the periphery of the retina. TGF-/?i was now acting on a greater number of cells to
promote the differentiation of mural cells [Shah, Groves and Anderson, 1996;
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Hirschi, Rohovsky and D'Amore, 1998] and inhibit the proliferation of endothelial
cells [Frater-Schroder et al., 1986; Heimark, Twardzik and Schwartz, 1986; Sato and
Rifkin, 1988, 1989; Antonelli-Orlidge et al., 1989], Since many TGF-/? receptors on
the cells of the vasculature were occupied by the ligand, there may have been a slight
decrease in the level of ligand secreted and consequently a decrease in the amount
detected in the Western blot. The formation of the whole retinal vascular network
was completed by day 21; both layers had undergone remodelling and maturation
with sufficient mural cell coverage. Although there was a decrease in the level of
expression detected in the Western blot, in the wax sections positive staining was
still observed as on PI4. Perhaps, basal levels of TGF-/?i were expressed to maintain
vascular integrity by promoting the contact between endothelial cells and between
endothelial cells and pericytes/smooth muscle cells.
The purpose of the immunohistochemical staining of wax sections was to identify
which retinal cells expressed the mature activated ligand and therefore which cells
were affected by oxygen exposure. Positive TGF-/?i labelling in the retina was
mainly noted on postnatal days 14 and 21 in some cells of the GCL and INL; cells
which appeared to be blood vessels of the superficial and deep vascular layers.
These results differ from previous studies which have shown TGF-/A
immunoreactivity within the photoreceptors. Firstly, Pfeffer et al. detected positive
staining around the outer segments of photoreceptors of monkeys. However, the
antibody used was raised against the TGF-/?i precursor molecule [Pfeffer et al.,
1994], Secondly, Anderson and colleagues detected labelling in the choroid, the
photoreceptors, the outer plexiform layer (OPL) and GCL in human and monkey
retinas using an antibody raised against the mature form of TGF-/?i [Anderson et al.,
1995], Immunohistochemical results should be interpreted cautiously, since labelling
patterns vary significantly from species to species and under different conditions of
fixation and tissue processing. For example, Heine et al. found that the distribution
of TGF-/? was dependant on the fixative used; paraformaldehyde (neutral pH) stained
only the cartilage whereas Bouin's solution (pH2) stained cartilage and strongly
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stained the mesenchymal cells in many areas of the mouse embryo [Heine et al.,
1987], It is possible that in that study the acidic pH of the Bouin's solution altered
the latent:active ratio of TGF-/7. Although Anderson et al. claimed that the retinas
fixed in Bouin's solution produced the same extent of immunohistochemical staining
as retinas fixed in paraformaldehyde, their results only contained images of stained
tissues that were fixed using Bouin's solution. Thus, their tissue processing
techniques may have induced the conversion of TGF-/? from the latent to the active
state.
In support of the findings reported here, that TGF-/h was only acting on retinal
vascular cells, is a study by Yamada and colleagues. This group investigated the
expression of the type I and type II TGF-/? receptors in the rat retina and found that
receptor II was expressed in the GCL, INL, ONL, and within the photoreceptors and
retinal pigmented epithelium from late embryonic stages to adulthood, whereas type
I was observed in the GCL and single nuclear layer at El7, but not in the adult
photoreceptor layer [Yamada et al., 1999], The type II receptor is incapable of
producing a response when occupied by the ligand, however it presents the ligand to
the type I receptor which then propagates a cellular response [Wrana et al., 1994],
Hence, active TGF-/?i labelling would be observed where it could induce a response;
in the GCL and INL.
In addition to staining the retinal cells, the antibody also stained the vitreous and
choroid. However the expression of TGF-/L by these tissues had no effect on the
results of the Western blots; the vitreous although difficult to remove in fixed tissue
lifts off the surface of the retina easily in fresh tissue, and the choroid comes away
when separating the retina from the sclera. Thus, TGF-/?i detected in the Western
was that expressed by scattered cells of the GCL and INL.
In the triple-labelled flatmounted retinas, positive labelling occurred across the whole
of the superficial vasculature, however when the tissues were labelled with TGF-/?i
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alone, positive labelling was only noted on the main vessels. The extensive labelling
of TGF-/?i in the triple-labelled retinas may have resulted if insufficient blocking
solution was applied after lectin staining. Due to time constraints the triple-labelling
could not be repeated, but would be worth further investigation. In Chapter Two, it
was shown that smooth muscle cells encapsulated the arterioles, its branches and
possibly venules, while pericytes were observed to line the endothelial tubules of the
entire vasculature. Looking at the single stained flatmounts, it would appear that
TGF-/?i acted only on the smooth muscle cells, which contradicts the findings of
other researchers that differentiated pericytes also express TGF-/?i [Antonelli-Orlidge
et al., 1989], and that TGF-/?i induces the differentiation of pericytes into smooth
muscle cells [Verbeek et al., 1994], It also contradicts the findings of the
immunohistochemical staining of the wax sections; positive labelling was detected in
the deeper layer where smooth muscle cells were not present. A possible explanation
is that the quantity of TGF-/?} secreted by the pericytes was too low for detection by
the fluorescent immunohistochemical technique employed here.
4.5.4 The Effects of Oxygen Fluctuations on Retinal TGF-/7i Expression
Raising pups in the Edinburgh model of ROP caused a decrease in the expression of
TGF-/?i protein at all timepoints examined, although the greatest reduction was
observed with 14 days of oxygen exposure. In Chapter Two, it was found that the
variable oxygen regime resulted in a significant decrease in pericyte coverage and a
slight reduction in a-SMA expression which stained smooth muscle cells, thus the
reduction in TGF-/?i could be a reflection of the decrease in the number of mural
cells. Another explanation is that because the retinal vasculature spreads at a slower
rate when pups are exposed to oxygen, the number of endothelial and mural cells is
further reduced, thus in comparison to the retinas of room air raised pups, less active
TGF-/?i is required. This though seems unlikely because in the Edinburgh model
when pups were exposed to the lOkPa oxygen regime, the percentage of the retinal
area that remained avascular was only 4.6% (average) [McColm et al., 2004], If the
reduction was only due to less endothelial and mural cells as a result of decreased
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spread of the vasculature, then a similar decrease in TGF-/?i at P14 would have been
expected, but here a much greater difference was observed, of around 30%.
The next step would be to establish whether the decrease in TGF-/?i protein was the
result of the hypoxic or hyperoxic periods, or if it was in response to the constant
switching between the two (where the genes may be switching 'on' and 'off
repeatedly). This could be investigated by exposing pups to each of the following
oxygen regimes: room-air (as control); constant hyperoxia (70-80% oxygen)
[Ashton, Ward and Serpell, 1954; Ashton and Blach, 1961; Smith et al., 1994]; the
conventional hyperoxic/hypoxic cycle [Penn, Tolman and Lowery, 1993; Penn,
Henry and Tolman, 1994; Penn et al., 1995], and constant hypoxia (around 15%
oxygen). The expression of retinal TGF-/?i protein could then be compared by
various methods for each group. This may give an indication of how oxygen
regulates TGF-/h in vivo.
The percentage reduction in the experimental samples on P2 and P7 was greater in
Group 1 than in Group 2. This may have been due to a difference in the weights of
the pups since weight directly effects development. In Group 1 the p-value for
weights of control and experimental was less than 0.005 (t-test) for both P2 and P7.
However, in Group 2 the p-value on P2 was reduced to less than 0.05 and the
difference in the weights of the P7 controls compared to the experimental pups was
not significant. In comparison, the p-value obtained for P14 in both groups was less
than 0.005.
From all timepoints examined, the greatest decrease in the level of TGF-/?i
expression occurred with 14 days of fluctuating oxygen exposure. This decrease
may have been due to a longer duration of oxygen exposure. If that was the case,
then in comparison to P2, a further decrease in protein levels should have been
observed on P7. It is possible that instead of the duration of exposure, the variability
of oxygen was more important. As illustrated in Figure 4.7, the oxygen profile in the
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second week is more variable than the first week making the extent of relative
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Figure 4.7: The change in oxygen variability on days 2, 7,10 and 14.
Two studies have investigated the effects of oxygen on TGF-/?i expression. Khaliq
and colleagues grew solo cultures of endothelial cells and pericytes, reduced the p02
from 135mmHg (18kPa) to 18mmHg (2.4kPa), and found that total TGF-/?, in
particular TGF-/?2, was decreased in both cultures, although endothelial cells were
more effected [Khaliq et al., 1995], However, this contrasts with previous work by
Falanga et al., where TGF-/?i secretion and synthesis were shown to be elevated in
response to hypoxia and TGF-/?2 to be unaffected [Falanga et al., 1991]. This study
was conducted on human dermal fibroblasts and as discussed earlier, TGF-/?,
response differs with cell types.
The Western blot data reported here does not ascertain whether the observed
decrease in TGF-/?i expression in the retinas of experimental pups was the result of
its decreased secretion by the cell or a reduction in its synthesis (either decreased
mRNA expression or rate of transcription). This could be answered very simply by
measuring (by Western or ELISA analysis) the amount of TGF-/?i precursor protein
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in control and experimental retinas using an antibody that recognised only the
precursor molecule. If less precursor protein was detected in the experimental
samples, then the reduction in TGF-/?i levels would have been due to a reduction in
its synthesis. If no change was observed in the experimental retinas, then the oxygen
may have caused a reduction in the secretion of the protein. It is possible that
oxygen had a direct effect on the conversion of latent to active TGF-/?i. This could
be deduced by investigating the occupancy of the TGF-/? receptors using a technique
called immunoprecipitation. The samples are first homogenised in protein extraction
solution containing TGF-/?i antibody and Protein-A/G Sepharose (which would bring
all structures forming a complex with TGF-/?i to the bottom of the tube when
centrifuging); the proteins are then separated by electrophoresis, and transferred onto
a membrane which is blotted using an antibody for the TGF-/?i receptor.
A major drawback of the Western analysis is that the retinas of each litter were
pooled, thus TGF-/?i protein expression was studied in only two control and two
experimental groups which does not allow for statistical analysis. The retinas were
grouped and then the proteins extracted since sufficient protein for loading onto the
acrylamide gel would not be obtained from individual retinas. Using the 'Quantity-
One' software which calculated the amount of protein expressed by multiplying the
intensity of the band with the area it occupied, was not the most reliable method for
determining the level of expression between the control and experimental groups
since errors can easily occur when selecting the band areas. Therefore, in order to
quote any difference in expression with confidence, all retinas should not be pooled,
but stored in groups of two or three and then the proteins extracted. This would
allow up to as many as six samples (compared to only one) from each litter. The
protein expression would then be measured in all samples and the statistical
significance determined.
To further understand the roles of TGF-/?i in retinal vessel development,
investigating the retinas of the TGF-/? null mice that survived postnatally to 3 weeks
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of age may prove valuable; would the endothelial cells migrate normally and would
the tubules gain a smooth muscle cell or pericyte coverage? For this, double-labelled
immunohistochemistry would be conducted as in Chapter Two. Granger et al.
investigated the aorta of mice heretozygous for the TGF-/?i gene and found that
active TGF-/? in these mice was lower compared to wild type mice, and that a-SMA
levels were also depressed in the heterzygotes [Granger et al., 1998], Hence, smooth
muscle cell differentiation was reduced as a consequence of the reduction in TGF-/?i
levels.
Thus, during normal development, the retinal expression of TGF-/?i increased from
P2 to PI4. The levels of expression, however, were reduced in the Edinburgh ROP
model. It is possible that the oxygen environment of the model directly modulated
the production of TGF-/?i and in turn affected mural cell coverage of the vessels.
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5.1 Introduction
Recently another family of growth factors specific for the vascular endothelium was
identified. To date, this family consists of two receptors, called Tie-1 and Tie-2
(tyrosine kinase with immunoglobulin and epidermal growth factor homology
domains) [Sato et al., 1993], and four ligands, named angiopoietin-1 [Davis et al.,
1996], angiopoietin-2 [Maisonpierre et al., 1997], angiopoietin-3 and angiopoietin-4
[Valenzuela et al., 1999], The angiopoietins are structurally divided into three
domains; an N-terminal region, an a-helical rich coiled-coil segment and a
fibrinogen-like domain [Davis et al., 1996; Maisonpierre et al., 1997; Valenzuela et
al., 1999], All four ligands bind to the Tie-2 receptor, but it is unclear as to whether
or not they utilise the Tie-1 receptor. It is possible that other proteins for this
receptor will be identified at a later date.
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5.1.1 The Angiopoietins
The first member of the angiopoietins was discovered using a novel cloning
technique called 'secretion-trap expression cloning' [Davis et al., 1996],
Angiopoietin-1 (Ang-1) is a 70kDa protein consisting of 498 amino acids. Unlike
other vascular growth factors that induce proliferation of endothelial cells, Ang-1
binds and phosphorylates the Tie-2 receptor, but it is incapable of inducing a
mitogenic response [Davis et al., 1996],
Angiopoietin-2 (Ang-2) was identified by homology screening in the mouse and in
human [Maisonpierre et al., 1997]; the proteins of these two species share around
85% homology. Ang-2 is reported to be slightly smaller than Ang-1, consisting of
496 amino acids, and both ligands share around 60% identity [Maisonpierre et al.,
1997], Like Ang-1, Ang-2 also binds to the Tie-2 receptor; however, unlike Ang-1,
it fails to induce receptor phosphorylation. In fact, Ang-1 induced phosphorylation
of cultured endothelial cell lines is completely inhibited by Ang-2 [Maisonpierre et
al., 1997], Thus, Ang-2 is the naturally occurring antagonist for Ang-1/Tie-2
binding.
Valenzuela and co-workers identified mouse angiopoietin-3 (Ang-3) and human
angiopoietin-4 (Ang-4) using homology based cloning techniques. Whereas Ang-3
appears to be an antagonist, Ang-4 is an agonist [Valenzuela et al., 1999], Currently,
literature on both of these angiopoietin isoforms is very limited, thus the biological
roles ofAng-1 and Ang-2 only will be discussed in this chapter.
5.1.2 Biological Functions of the Ang/Tie-2 System
In vivo studies
Many of the functions of the Tie receptors and the angiopoietins were elucidated by
investigating their embryonic expression patterns and by in depth analysis of mice
with targeted gene mutations. The following is an overview of the findings from
such studies.
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In mice, expression of both receptor types is relatively abundant during the early
stages of embryogenesis, when it is detected only in cells associated with the
vascular system such as the aorta and endocardium [Sato et al., 1993], Homozygous
mice deficient for Tie-1 die between embryonic day 13.5 (E13.5) and birth due to
haemorrhaging and oedema [Sato et al., 1995], The mice have smaller hearts
compared to normal mice and the alveoli of the lungs fail to expand. Ultrastructural
analysis of the blood vessels indicated that the mice have poor endothelial integrity
causing the leakage of interstitial fluid (oedema) and blood (haemorrhaging) through
the vessels. In contrast, Tie-2 homozygous mutants die earlier, at E10.5 when the
mice are severely growth retarded in comparison to the controls [Sato et al., 1995],
The mice also display abnormalities of the vascular network; although endothelial
cells are present in normal number and assemble into tubules, the vasculature fails to
organise into large and small vessels and lacks encapsulation by mural cells.
Embryonic Ang-1 expression is predominantly found in the heart myocardium
surrounding the endocardium [Suri et al., 1996], However, later in development its
expression becomes much more widely distributed, most often in the mesenchyme
surrounding developing vessels in close association with Tie-2 expressing
endothelial cells. Lack of the Ang-1 gene results in death at around E12 [Suri et al.,
1996], a day or two after Tie-2 knockouts [Sato et al., 1995], The primary capillary
plexus, which is normally a highly branched and intricate vascular network, appears
relatively immature in the knockout mice. Endothelial cells are present in normal
number, but the organisation of the vasculature is compromised in that the
vasculature does not consist of large and small vessels, instead most of the vessels
are of a similar size and diameter. Ultrastructural analysis showed that the
endothelial cells are poorly associated with the underlying matrix and fail to recruit
and associate with mural cells. Thus, lack of the Ang-1 gene results in defects
reminiscent of, but slightly less severe, than mice lacking the Tie-2 receptor gene.
Transgenic mice overexpressing Ang-1 generally appear normal, however their skin
is markedly different from normal mice; the skin appears very red and has more
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larger blood vessels than normal [Suri et al., 1998], Transmission electron
microscopy confirmed that the vessels of these mice exhibit normal cell-to-cell
contact between endothelial cells and adjacent pericytes, but the number, size and
branching pattern of the blood vessels is increased dramatically, suggesting that Ang-
1 promotes sprouting and branching in vivo.
Ang-2 expression is not readily detected in the heart of the mouse embryo, but it is
abundant in the smooth muscle layer beneath the vessel endothelium [Maisonpierre
et al., 1997], The distinct but overlapping expression patterns of Ang-1 and Ang-2
suggests that Ang-2 might regulate Ang-1 function at particular sites and stages of
vascular development. Although mice lacking the Ang-2 gene have not been
generated, transgenic mice overexpressing Ang-2 have been studied [Maisonpierre et
al., 1997], The vascular defects of these mice are very similar, but more severe, than
mice homozygous for Ang-1 [Suri et al., 1996] or Tie-2 gene mutation [Sato et al.,
1995], consistent with the concept that Ang-2 is an antagonist for Ang-l/Tie-2
binding.
In vitro studies
When added to cultured endothelial cells, Ang-1 fails to elicit a significant growth
response of the cells [Davis et al., 1996; Koblizek et al., 1998; Witzenbichler et al.,
1998], nor does it induce tubule formation [Davis et al., 1996], Ang-1, however, is
capable of promoting a dose-dependent migration of endothelial cells, but not
smooth muscle cells [Witzenbichler et al., 1998], indicating that it may also function
in angiogenesis, as previously suggested by in vivo studies. Indeed, when Ang-1 is
added to a confluent monolayer of endothelial cells, the cells migrate and form long
capillary sprouts [Koblizek et al., 1998], When Ang-1 and VEGF (vascular
endothelial growth factor, a potent endothelial cell mitogen and chemoattractant)
[Ferrara and Henzel, 1989; Millauer et al., 1993] are added to the culture together,
there is a further increase in the number of sprouts. This suggests that VEGF and
Ang-1 can act synergistically to induce sprout formation [Koblizek et al., 1998],
Consistent with this, in the mouse cornea micropocket assay neither Ang-1 nor
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Ang-2 are seen to induce neovascularisation, but when administered with VEGF,
Ang-1 enhances the capillary density and the luminal diameter of the vessels while
Ang-2 produces longer vessels. Thus, Ang-1 promotes the maturation of the
vasculature but Ang-2 initiates a neovascular response [Ashara et al., 1998],
It is reported that the Tie-2 receptor is associated with the p85 subunit of
phosphatidlyinositol 3-kinase (PI3-kinase), a second messenger that is activated upon
Tie-2 receptor phosphorylation. Further downstream in the signalling pathway, Tie-
2 and PI3-kinase activation also causes phosphorylation of Akt, a critical survival
messenger [Kontos et al., 1998], This finding triggered several studies on the effects
of the Tie-2 system on endothelial cell survival. When endothelial cells are cultured
they became organised into a network consisting of tubules and cords, however some
of the tubules regress in the later stages of the culture. In the presence of Ang-1, the
endothelial networks survive for a longer period of time [Papapetropoulos et al.,
1999], Similarly, when endothelial cells are cultured in the absence of serum, many
of the cells undergo apoptosis, but this cell death is reduced significantly in the
presence of Ang-1 [Papapetropoulos et al., 1999; Kwak et al., 1999], The
involvement of the Tie-2/PI3-kinase/Akt pathway in cell survival has also been
investigated; when endothelial cells are stimulated with Ang-1, an up-regulation in
both Akt and PI3-kinase phosphorylation is observed [Papapetropoulos et al., 2000;
Kim et al., 2000a]. This effect is antagonised by the addition of Ang-2 antibody,
Tie-2 soluble receptor [Papapetropoulos et al., 2000], and completely blocked by
wortmannin, a PI3-kinase inhibitor [Kim et al., 2000a], In addition to causing
activation of Akt, Ang-1 also induces a rapid increase in the mRNA levels of
survivin, an antiapoptotic agent [Papapetropoulos et al., 2000], Recently, Kim et al.
also reported that Ang-2 can promote cell survival by utilising the same pathway as
Ang-1, but in order to produce this response a concentration four times that for Ang-
1 is required [Kim et al., 2000b],
In summary, the above mentioned studies have established that the Ang-1/Tie-2
system functions in the later stages of vasculogenesis, namely vessel maturation and
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stabilisation by mainly promoting the associations between endothelial cells and
mural cells. The angiopoietins also have some function during angiogenic growth
since Ang-2 antagonises the effects of Ang-1 by competitively binding to the Tie-2
receptor. However, the exact roles and mechanisms of the angiopoitein/Tie-2 system
in vessel formation have yet to be elucidated.
5.1.3 The Ang/Tie-2 System in Postnatal Life
Basal levels of Ang-1 and Tie-2 continue to be expressed once the vasculature is
established and quiescent [Wong et al., 1997], Ang-2 levels though are quite
restricted in the adult, but increase dramatically (along with Tie-2) in organs of the
female reproductive system [Maisonpierre et al., 1997], and during the processes of
wound repair [Wong et al., 1997] and tumour formation [Stratman, Risau and Plate,
1998; Holash et al., 1999; Tanaka et al., 1999],
In early follicle development within the ovary, the vasculature is quiescent, thus
Ang-1, but little Ang-2, is expressed. In the late pre-ovulatory follicle and the post-
ovulatory corpus luteum, angiogenesis is quite active and the Ang-2 gene appears to
be up-regulated while Ang-1 expression remains unchanged [Maisonpierre et al.,
1997], In the non-productive follicles, which regress, Ang-2 expression is strong
[Maisonpierre et al., 1997], as it is in the endometrium during the proliferative and
secretory phases of the menstrual cycle [Krikun et al., 2000],
To establish if there is a role of the Ang/Tie-2 system in the process of wound repair,
Wong and colleagues studied biopsy punch wounds on the dorsal skin of the rat
[Wong et al., 1997], In the initial stages of tissue repair following injury, Tie-2
mRNA and protein expression are increased in the dilated ecstatic vessels
surrounding the wound. Newly formed vessels then invade the injured tissue and
Tie-2 expression is further increased. Towards the later stages of the healing
process, when the wound edges are contracted and many microvessels have
regressed, Tie-2 is limited to the blood vessels of the wound edge. Thus, Tie-2
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mRNA levels are rapidly increased after injury, but down-regulated as the repair
process is completed.
Because the angiopoietin/Tie-2 system is essential for angiogenesis, several studies
have investigated the roles of the angiopoietins in tumour formation, but they have
produced conflicting results. For example, in Kaposi sarcoma the expression of
Ang-2, Tie-1 and Tie-2 is reported to be strong, but that of Ang-1 is low [Brown et
al., 2000], Likewise, in breast cancer cell lines, high levels of Ang-2 are detected,
but Ang-1 is rarely expressed [Stratmann et al., 2001], In contrast, samples of
human glioblastoma have increased levels of Ang-1 as well as Ang-2 and Tie-2
mRNA expression [Startmann, Risau and Palate, 1998], Consistent with a role for
Ang-2 in cancer, is the finding that when rat lung and mammary carcinoma cells are
injected with Ang-2, the formation of metastatic tumours is inhibited and survival of
the rats is prolonged [Yu and Stamenkovic, 2001], In contrast, administration of
Ang-1 has no effect on tumour growth and animal survival. Also, the administration
of Tie-2 soluble receptor into rat mammary tumours results in a marked reduction in
the growth and the vascular density of the tumour [Lin et al., 1997], Hence, both
Ang-2 and Tie-2 are believed to be up-regulated in cancerous cells, but the
expression ofAng-1 in tumours is debated. It may be that the expression ofAng-1 is
dependent on the developmental stage of the tumour.
Although the above mentioned studies are somewhat difficult to interpret, Holash et
al. have put forward the following theory on how the angiopoietins are involved in
tumour formation. Although most natural tumours begin as small avascular masses,
many start as well-vascularised tumours and grow by co-opting existing host vessels
[Holash, Weigand and Yancopoulos, 1999; Holash et al., 1999], Soon after tumour
co-option, host vessels express high levels of Ang-2 (which is now considered the
earliest marker of tumour development [Holash et al., 1999]) and respond by
regressing [Holash, Weigand and Yancopoulos, 1999; Holash et al., 1999], As a
result, the tumour becomes hypoxic, which in turn stimulates a rapid increase in
VEGF expression. The high VEGF and Ang-2 expression induce new sprouting
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from pre-existing vessels [Maisonpierre et al., 1997; Asahara et al., 1998] and allow
survival and further growth of the tumour [Holash et al., 1999],
To summarise, in the adult vasculature VEGF, Ang-1 and Ang-2 collaborate to elicit
angiogenesis. When Ang-2 expression is up-regulated (for example during
menstruation or in tumour formation) the interaction of Tie-2 and Ang-1 is disrupted
and vessels are destabilised. Once the endothelial cells separate from the
perivascular cells and the endothelial cell matrix, vessels appear particularly
vulnerable. In the presence of VEGF, Ang-2 promotes angiogenesis, but in its
absence, Ang-2 causes the regression of the destabilised vessels.
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5.2 Aims and Hypothesis
The primary objective of this study was to investigate the mRNA expression of both
Ang-1 and Ang-2 during normal development of the rat retina. Because Ang-2
antagonises the effects of Ang-1, the balance of Ang-1 and Ang-2 expression is
considered critical for establishing a mature and stable vasculature. Therefore, the
successful measurement of the mRNA of both angiopoietins would allow the ratio of
Ang-1:Ang-2 in normal development to be determined. The second objective was to
investigate if this ratio was affected by the fluctuating oxygen regime of the
Edinburgh model of retinopathy of prematurity (ROP).
Ang-1 is a stabilising factor for the endothelium, whereas Ang-2 induces vessel
instability, thus initiating angiogenesis. Therefore, it is expected that basal levels of
Ang-1 mRNA will be detected throughout the period of retinal formation. In
contrast, the expression of Ang-2 mRNA is predicted to be high during the
development of the lower retinal vasculature, which forms as an extension of the
superficial vasculature. Hence, Ang-2 expression is expected to be high during mid-
vascular development (around days five to 12).
In the ROP model, it is postulated that the Ang-1:Ang-2 ratio would be altered as
lower levels of Ang-1 mRNA and higher levels of Ang-2 mRNA may be expressed
either as a direct result of the oxygen regime or as a result of the reduced association
of endothelial cells and pericytes.
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5.3 Methods
5.3.1 Animals & Tissue Preparation
Litters of Sprague-Dawley rat pups were raised in room air and sacrificed, without
perfusion, on all days from 0 to 14. The eyes were enucleated and processed for
either frozen or wax sections.
Frozen sections
The eyeballs were pierced by a needle and fixed for 2 hours in 4% paraformaldehyde
prepared in 1M phosphate buffered saline (PBS). The eyes were then embedded in
1.5% agarose prepared in 1M PBS and supplemented with 5% sucrose. Once set, the
solid agarose blocks were trimmed and left in 30% sucrose at 4°C until the blocks
sank. Using dry-ice, the blocks were slowly frozen and stored at -70°C.
The frozen agarose blocks were sectioned using a freezing microtome set between
-26°C and -30°C. Thick sections of the eye were cut until close to the centre (just
prior to reaching the optic nerve where all retinal layers are visible). 10pm serial
sections were then obtained and mounted onto superfrost glass slides. The sections
were stored at -70°C until the in situ hybridisation was performed.
Wax sections
The eyes were fixed in 10% formalin overnight and transferred to 70% alcohol. The
eyes were later dehydrated through a graded series of ethanol solutions (70%, 90%
and 100%) followed by xylene and then embedded in wax.
The wax blocks were sectioned using a bench-top microtome (Heidelberg). 5 pm
serial sections near the optic disc region were cut and mounted onto superfrost glass
slides. The sections were then left to dry overnight at 60°C.
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5.3.2 Probe Preparation
The complementary DNA for mouse Ang-1 and Ang-2 were the generous gift of Dr.
G. D. Yancopoulos, Regeneron Pharmaceuticals (NY, USA). These DNA constructs
were transformed into E.coli and stored as glycerol stocks at -70°C.
A minute quantity of the E-coli was smeared onto an agar plate containing lOOpg/ml
ampicillin and grown overnight at 37°C. A single colony was selected and added to
50ml Luria Broth base containing lOOpg/ml ampicillin and cultured overnight at
37°C with vigorous shaking. The culture medium was then centrifuged at 6,000g for
15mins, the supernatant discarded and the pellet containing the DNA plasmid frozen
at-20°C.
The plasmid was purified using the HiSpeed Plasmid Midi Kit and protocol supplied
by Qiagen, LTD. Briefly, the pellet was resuspended in buffer containing RNase A,
lysed and then precipitated in acetate buffer (pH 5.5). After centrifugation, the
supernatant was transferred to a QLAGEN-tip which caused the DNA to bind to its
column. The DNA was then eluted and stored at -20°C.
Using restriction enzymes (Roche Molecular Biochemicals) the DNA plasmid was
linearised; 2.5units of enzyme was added per pg of DNA and incubated for an hour
at 37°C. The linearised plasmid was then purified using Elutip columns (Schleicher
& Schuell). Briefly, the column was loaded with the DNA and all the nucleic acids
bound to the column. The column was then washed in buffer, and the sample was
eluted and stored at -20°C.
Finally, using the DIG RNA Labeling Kit (Roche), the DNA was labelled with
digoxigenin-UTP by in vitro transcription with T3 and T7 RNA polymerase. Both
sense and antisense probes were prepared. Briefly, the following reagents were
added to 1 pg of purified DNA template and then incubated at 37°C for 2 hours: NTP
labelling mixture, transcription buffer, RNase inhibitor and RNA polymerase. The
probe was now fully prepared and stored at -70°C.
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5.3.3 In situ Hybridisation
Solutions
All solutions were prepared using autoclaved double distilled water:
• SSC x20 was prepared using sodium chloride and sodium citrate dihydrate. The
solution was pH adjusted to 7.0.
• lOx Salts was prepared using sodium chloride, tris sodium chloride, tris base,
disodium hydrogen orthophosphate monohydrate, sodium hydrogen phosphate
and ethylenediaminetetraacetic acid.
• Hybridisation buffer consisted of lx salts, 50% deionised formamide, 10%
dextran sulphate (at 50%), lmg/ml yeast RNA and lx Denhardts.
• Solution A consisted of lx SCC, 50% deionised formamide and 0.1% Triton X-
100.
• TBST contained 0.14M sodium chloride, 0.003M potassium chloride, 0.025M
tris hydrogen chloride (pH 7.5) and 0.1% Triton X-100.
• NTMT solution was prepared using 0.1M sodium chloride, 0.1M tris-hydrogen
chloride at (pH 9.5), 0.05M magnesium chloride hextrahydrate and 0.1% Triton
X-100.
• Colour development solution consisted of TBST solution containing 0.34mg/ml
NBT (4-nitro blue tetrazolium chloride, Roche Molecular Biochemical) and
0.18mg/ml BCIP (5-bromo-4-chloro-3-indolyl-phosphate, Roche Molecular
Biochemical).
Digoxigenin-labelled hybridisation
15 slides (one for each developmental day) were defrosted at room temperature for at
least an hour and stained together under the same conditions to determine the
expression pattern ofAng-2.
The probe was prepared in the hybridisation buffer at a concentration of lOOng/ml or
150ng/ml. The probe mix was then denatured by heating it at 70°C for 5 to lOmins.
lOOpl of this probe mix was applied to each slide and a thin plastic coverslip placed
on top. The slides were hybridised in a humidified chamber overnight at 45°C.
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The following morning, the slides were transferred into a slide rack and washed three
times in Solution A at 45°C; the first wash was for 15mins, followed by two 30min
washes. The slides were then washed in TBST solution at room temperature for 1
hour with a change of solution after 30mins. The slides were blocked using 10%
heat inactivated sheep serum prepared in TBST for at least 1 hour at room
temperature. The slides were dried around the edges and lOOpl of anti-digoxigenin
coupled alkaline phosphatase-Fab was added to each slide. The slides were again
covered with thin plastic coverslips and incubated in a humidified chamber overnight
at 4°C.
The coverslips were removed again and the slides washed at room temperature in
TBST solution five times for 20mins each, followed by a 20min wash in NTMT
solution. The slides were then stained overnight at 4°C in the dark using the colour
development solution. The next morning, the reaction was stopped by washing the
slides in distilled water. The sections were then fixed in 4% paraformaldehyde/0.1 %
gluteraldehyde for 20mins and counterstained: 5mins in tap water; 5mins in 10%
nuclear fast red; 5mins in tap water. Finally, the sections were dehydrated through a
graded alcohol series (30%, 50%, 70%, 95% and 100% for 30secs each) followed by
xylene (lOmins) before they were mounted using Vectamount (Vector Laboratories).
Radiolabelled hybridisation
Radiolabeled in situ hybridisation was performed by Helen Wilson working with Dr.
Hamish Fraser in the Medical Research Council, Human Reproductive Sciences Unit
(Edinburgh). The following is a brief outline of the method used in their laboratory
(a more detailed methodology can be found in Wulff et al., 2000):
The complementary DNA for Ang-1 and Ang-2 were provided by Dr. G. D.
Yancopoulos (Regeneron Pharmaceuticals, USA) and that for VEGF was provided
by Dr. S. Charnock-James (University of Cambridge, UK). Sense and antisense
35
probes were prepared using an RNA transcription kit and were labelled with [ S]-
UTP and then purified from free bases using Chroma Spin columns.
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Paraffin wax sections of eyes from 7 and 14 day-old pups were deparaffinised in
xylene and hydrated through an alcohol series. The sections were then incubated in
hydrogen chloride solution followed by digestion in proteinase K. The sections were
washed in SCC and then incubated in prehybridisation buffer at 55°C for 2 hours.
Hybridisation was preformed overnight at 55°C with either the sense or antisense
probe. After hybridisation, the slides were rinsed in SCC and treated with RNase A
to remove excess probe. The slides were then dehydrated through another alcohol
series, dried and dipped in liquid emulsion and exposed for either 4 weeks (VEGF)
or 9 weeks (Ang-1 and Ang-2). The slides were developed and counterstained with
haematoxylin and eosin, dehydrated and mounted.
Analysis
The digoxigenin-labelled slides were viewed under lightfield conditions and the
radio-labelled slides under both lightfield and darkfield conditions. Digital images
were obtained using a Leica microscope with an attached colour video camera (JVC).
162
Chapter Five: The Angiopoietins in the Developing Rat Retina
5.4 Results
5.4.1 Formation of the Retinal Layers
In the rat, the retinal layers were not completely differentiated until P14 as
previously described [Stone et al., 1995; Yamada et al., 1999], Briefly, as illustrated
in Figure 5.1 (page 165), on day 0 the retina was comprised of only two layers called
the ganglion cell layer (GCL) and the neuroblast layer (NBL). By postnatal day 6
(P6), the NBL began to differentiate, and by P10 the central NBL had developed into
the inner nuclear layer (INL), the inner plexiform layer (IPL), the outer nuclear layer
(ONL) and the outer plexiform layer (OPL). This differentiation of the NBL
progressed towards the periphery until P14 at which point the entire retina had
differentiated into several layers.
5.4.2 Digoxigenin-Labelled in situ Hybridisation
From PO to P5, very faint labelling for Ang-2 mRNA expression was observed in the
GCL and the anterior edge of the NBL which later differentiated into the INL (Figure
5.1, page 165). This labelling increased slightly on P6 to P9. On P10 to P14, the
signal within the GCL and the INL was stronger in comparison to the earlier days,
with maximum expression observed on P14. Hence, Ang-2 mRNA levels increased
steadily from PO to PI4.
5.4.3 Radio-Labelled in situ Hybridisation
In comparison to digoxigenin-labelled probes, radio-labelled probes are more
sensitive for the detection ofmRNA. Thus, to confirm the results obtained with the
digoxigenin-labelled probe in situ hybridisation was performed on wax sections of
o c
day 7 and day 14 retinas using a [ S]-labelled probe. First radio-labelled VEGF
probe was used as a positive control (Figure 5.2, page 166). VEGF expression was
high in both the GCL and the INL on P7, when the vasculature of both the superficial
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and deep layer was forming. On day 14, VEGF expression was very low because
retinal vessel formation of both layers was complete.
Ang-1 mRNA expression, as shown in Figure 5.3 (page 167), was low on day 7 but
high on day 14, suggesting that Ang-1 exerted an effect during the later stages of
retinal development. However, the sections stained with the sense probe (as a
negative control) also showed high Ang-1 expression on day 14, indicating that the
expression seen with the antisense probe was a result of high background or non¬
specific staining. The low signal observed on day 7 may simply be due to
insufficient probe applied to the slide.
Ang-2 labelling was similar on day 7 and day 14 (Figure 5.4, page 168). Again the
sense probe showed high staining, therefore, the signal observed was mostly, if not
entirely, non-specific.
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Figure 5.1 Expression ofAng-2 mRNA during formation of the rat retina.
10pm frozen sections stained with digoxigenin-labelled Ang-2 probe (purple) and
counterstained with nuclear fast red (pink),
GCL - ganglion cell layer; INL - inner nuclear layer; NBL - neuroblast layer; ONL -
outer nuclear layer; P - postnatal day.
Magnification: x20.
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Figure 5.2 Expression of VEGF mRNA in the rat retina.
5pm wax sections of the rat retina stained with [35S]-labelled VEGF probe and
counterstained with hematoxylin and eosin. (A) P7 retina viewed under light-field
conditions to show retinal morphology. (B) Image A viewed under dark-field
conditions to show labelling with VEGF probe. (C) PI4 retina viewed under light-field
conditions. (D) Image C viewed under dark-field conditions.
ch - choroid; GCL - ganglion cell layer; INL - inner nuclear layer; NBL - neuroblast
layer; ONL - outer nuclear layer.
Magnification: x20.
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Figure 5.3 Expression of Ang-1 raRNA in the rat retina.
5pm wax sections of the rat retina stained with [35S]-labelled Ang-1 probe and
counterstained with hematoxylin and eosin. (A) P7 retinal section viewed under light-
field conditions to show retinal morphology. (B) Image A viewed under dark-field
conditions to show labelling with Ang-1 probe. (C) P14 retinal section viewed under
light-field conditions. (D) Image C viewed under dark-field conditions. (E) Negative
control. P14 retinal section labelled with Ang-1 sense probe and viewed under dark
field conditions.
ch - choroid; GCL - ganglion cell layer; INL - inner nuclear layer; NBL - neuroblast
layer; ONL - outer nuclear layer.
Magnification: x20.
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Figure 5.4 Expression of Ang-2 mRNA in the rat retina.
5pm wax sections of the rat retina stained with [35S]-labelled Ang-2 probe and
counterstained with hematoxylin and eosin. (A) P7 retina viewed under light-field
conditions to show retinal morphology (B) Image A viewed under dark-field
conditions to show labelling with Ang-2 probe. (C) P14 retina viewed under light-field
conditions. (D) Image C viewed under dark-field conditions. (E) Negative control
P14 retinal section labelled with Ang-2 sense probe and viewed under dark field
conditions.
ch - choroid; GCL - ganglion cell layer; INL - inner nuclear layer; NBL - neuroblast
layer; ONL - outer nuclear layer.
Magnification: x20.
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5.5 Discussion
5.5.1 The Ang/Tie-2 System
In vesselformation
Targeted disruption of the Ang-1 and Tie-2 gene in the mouse revealed that this
ligand-receptor system is not required for the early stages of vasculogenesis (which
involves endothelial cell differentiation and proliferation), but is essential for correct
vascular assembly, maintaining endothelial cell and matrix associations and for the
recruitment ofmural cells [Sato et al., 1995; Suri et al., 1996], In comparison, Ang-2
is a naturally occurring antagonist for Ang-1 [Maisonpierre et al., 1997], and
therefore, may counteract Ang-1 mediated blood vessel stability and maintain the
endothelium in a more plastic state to promote angiogenesis.
The effects ofoxygen
In vitro studies have reported that the angiopoietins and the Tie-2 receptor are
regulated by oxygen concentration. Exposure of cultured endothelial cells to
hypoxic conditions resulted in a time-dependent increase in Ang-2 mRNA
expression [Mandriota and Pepper, 1998; Oh et al., 1999] and Tie-2 expression
[William et al., 2000], The up-regulation of Tie-2 was reversible upon
reoxygenation of the cells. Although Ang-1 mRNA expression was also
investigated, the effects of oxygen tension on Ang-1 expression could not be
commented on since Ang-1 was neither detected in the control nor in the treated
cultures [Mandriota and Pepper, 1998],
Further support for the regulation of the angiopoietins by oxygen came from in vivo
studies that used the Smith model of oxygen-induced retinopathy [Oh et al., 1999;
Hackett et al., 2000], In this model mice were exposed to 75% oxygen from P7 to
P12 and then transferred to room air to induce neovascularisation [Smith et al.,
1994], During the ischemic period, the retinal Ang-2 mRNA levels were increased
[Oh et al., 1999; Hackett et al., 2000], In contrast, Ang-1 was down-regulated on the
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first day of the hypoxic period, up-regulated for the following two days and then
down-regulated again [Oh et al., 1999], In another study adult rats were exposed to
10% oxygen for 12 or 48 hours [Abdulmalek et al., 2001] and it was found that the
expression levels of Ang-1 mRNA in the cerebellum had decreased, and Ang-2
mRNA had risen in the hypoxic compared to the control group.
The data from the above mentioned studies suggest that the ratio of Ang-1 :Ang-2
may be critical for establishing vascular integrity and that this ratio may be altered in
response to oxygen changes. It is proposed that in ROP the vessels either have a
reduced pericyte coverage (Chapter Two) or completely lack a pericyte coverage
[Patz, 1982], To establish if the Ang-1 :Ang-2 ratio is altered in ROP I decided to
investigate the retinal mRNA expression of both ligands in normal rats and rats
raised in the Edinburgh ROP model.
5.5.2 Ang-2 mRNA Expression in Retinal Development
Using a digoxigenin-labelled Ang-2 probe, in situ hybridisation was performed on
whole eye sections of the rat. When the probe was prepared at a concentration of
lOOng/ml, no staining was detected, except in the choroidal vessels. The
concentration of the probe was then increased to 150ng/ml and the results illustrated
in Figure 5.1 were obtained (page 165). Ang-2 expression was noted on all days; the
signal was low during the early stages of development and increased as retinal
formation progressed.
These results differ from those reported previously. Oh et al. looked at the
expression of Ang-2 mRNA on PI2, PI7 and P21 in the mouse. Using a
digoxigenin-labelled probe at a concentration of 50ng/ml, a low signal was observed
in the GCL and INL on all three days [Oh et al., 1999]. In another study, Hackett
and co-workers generated mice with targeted disruption of the Ang-2 gene where the
gene expressed /?-galactosidase under control of the Ang-2 promoter. In these mice,
Ang-2 mRNA labelling was low during the early stages of vascular development, but
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intense in the INL on day 8 (when the deep capillary bed was forming). This
expression decreased again by day 12 and further still by day 14 [Hackett et al.,
2000],
The conflicting results may simply be the result of species difference, however this is
unlikely because retinal formation is very similar in rats and mice. The next
possibility is that my in situ hybridisation technique was flawed. Therefore, the
methodology used here was compared to that in the literature, but no obvious
discrepancies were noted. In addition, the digoxigenin-labelled in situ hybridisation
method used in this study had been performed in this laboratory on several
occasions; primarily for detection of VEGF, which is abundantly expressed in the
retina. Figure 5.5 (page 172) shows that on P14 VEGF was detected only in the INL
towards the periphery where the formation of the deep plexus is almost complete. In
comparison, VEGF levels in the retina of the P14 pups exposed to the 8kPa regime
of the Edinburgh Model were markedly increased.
Finally, it is possible that the staining which developed was the result of applying a
very high probe concentration. Other researchers have found that the use of
digoxigenin-labelled probes in conjunction with alkaline phosphatase coupled anti-
digoxigenin antibodies is a relatively insensitive in situ hybridisation method
(personal communication, Stan Weigand, Regeneron Pharmaceuticals, NY, USA).
While it is quite suitable for detection of precise localisation of abundantly expressed
mRNAs, it is less useful for in situ localisation of mRNAs which are expressed at
low to moderate levels. This method is prone to produce artefact when it is 'pushed'.
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Figure 5.51 Expression of VEGF mRNA on P14.
10pm frozen sections of the rat retina stained with digoxigenin-labelled VEGF probe
(purple) and counterstained with nuclear fast red (pink). (A) P14 retina of a control
pup. (B) P14 retina of a pup exposed to the 8kPa oxygen regime of the Edinburgh ROP
model. Arrows indicate staining in inner nuclear layer.
Magnification: x20.
1
Taken, with permission, from Jean Wade
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Thus, in situ hybridisation was performed using Ang-1 and Ang-2 probes labelled
with [33S]-UTP 2, a more sensitive technique for the detection of mRNA. Positive
Ang-2 expression was not observed on either P7 nor on PI4, which showed that the
digoxigenin-labelling (which was most intense on PI4) may indeed be incorrect.
Additionally, the expression of Ang-1 was looked into with the hope that its
expression levels may be detected instead. Unfortunately, any staining that resulted
was non-specific. These findings suggest that retinal expression of the angiopoietins
is too low for detection using in situ hybridisation methods.
5.5.3 Alternative Detection Methods for the Angiopoietins
Studies in the literature that investigated the mRNA expression of the angiopoietins
have used either reverse transcriptase-polymerase chain reaction (RT-PCR) or
Northern blotting, presumably due to the relatively low abundance of these
transcripts in retinal tissue. In an attempt to investigate the Ang-1:Ang-2 ratio in
normal development, Northern blot analysis was first considered. In a study
conducted by Hackett and colleagues, Ang-2 expression was detected using lOpg of
total RNA, but Ang-1 expression remained undetected. Thus, I decided to use 20pg
of total retinal RNA with the hope that Ang-1 expression may also be detected. The
total retinal RNA of a few rat pups was extracted using an RNA extraction kit
(Qiagen, LTD) according to the manufacturer's instructions. Less than lOgg of total
RNA was obtained from a single retina. Therefore, because too many animals would
be required, this method ofmRNA extraction was abandoned. One technique which
would overcome this problem of animal numbers is RT-PCR. In brief, this involves
using a reverse transcriptase enzyme that catalyses the conversion of RNA to DNA.
Next using a PCR thermocycler the DNA sequence is amplified by repeatedly
'running off copies of the sequence using a Tag DNA polymerase. Thus, from a
small quantity of tissue, adequate amounts may be easily obtained. Unfortunately,
the laboratory was not equipped with the appropriate apparatus for this technique. In
addition to these difficulties, Northern blotting is a very complicated technique to
2 As mentioned in the Methods, this was conducted by Helen Wilson because our laboratory was not
equipped for use of radioactive isotopes.
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establish and would, therefore, be very time consuming. Finally, this technique
involves high costs. Thus, detection of the levels of Ang-1 and Ang-2 expression by
Northern blot analysis was not considered any further.
The remaining possibility was the investigation of the protein expression of Ang-1
and Ang-2 which has an advantage over mRNA detection in that contamination of
samples is not a problem. When this study was conducted (in 2000) the availability
of antibodies for the angiopoietins was limited. For example, Santa Cruz offered an
antibody for Ang-1 that was reactive with human, rat and mouse tissue, but also
detected the expression of the other angiopoietin isoforms. An Ang-2 specific
antibody was also available, but it was only weakly reactive with tissues of rat origin.
However, recently this company has produced type-specific antibodies that are
reactive with rat material and can be used in many procedures including Western
blotting and ELISA analysis. Therefore, this study could have been conducted now,
but due to time limitations it was not possible.
Thus, because attempts to detect the mRNA expression by in situ hybridisation were




Testing the Edinburgh ROP Model
6.1 Introduction
6.1.1 Retinopathy of Prematurity and the Clinical Situation
In the 1950s, extreme prematurity together with high concentrations of supplemental
oxygen during the first few weeks of life were firmly established as risk factors for
retinopathy of prematurity (ROP) [Campbell, 1951; Patz, Hoeck and Cruz, 1952], In
an attempt to reduce the incidence of this disease, the use of oxygen therapy on
neonates was restricted. Although this resulted in a reduction in the number of
infants developing the retinal disorder [Cross and Evans, 1952; Ryan, 1952; Guy,
Lanman and Dancis, 1956], the limited use of supplemental oxygen led to an
increase in infant mortality [Avery and Oppenhiemer, I960], Thus, in the 1970s the
use of oxygen was reintroduced with a reoccurrence of ROP [reviewed in Weakley
and Spencer, 1992; and in Ziavras and Javitt, 1995],
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Today, in high income countries because more immature babies are surviving due to
advanced neonatal care, the incidence of ROP has remained high. This is despite the
ability of neonatal intensive care units to control more carefully the levels of oxygen
at which the infants are maintained [Cunningham et al., 1995; The STOP-ROP
Multicenter Study Group, 2000], Fortunately, in most cases the disease
spontaneously regresses without scarring or causing visual impairment. In America
around 85% of premature survivors born at less than 28 weeks gestation develop the
disorder. Around 20% of these infants develop loss of vision [Palmer et al., 1991;
Cryotherapy for Retinopathy of Prematurity Cooperative Group, 1994], Using the
Oxford Register of Early Childhood Impairment, Crofts and colleagues gathered
information on all babies with severe visual impairment born between 1984 and
1988. This sample was considered representative of the United Kingdom. Of the
166 children with severe vision loss diagnosed by the age of 5 years (1.25 per 1000
births), 5.4% suffered from blindness due to ROP [Crofts, King and Johnson, 1998],
Others have reported a slightly higher incidence of the disorder in the UK [Rogers,
1996; Dezateux and Rahi, 1998],
In comparison to high income countries, the incidence of severe ROP and blindness
due to retinal detachment is markedly higher in middle income countries, such as
Latin America [Sirtautiene, 1997] and Eastern Europe [Gilbert et al., 1997], In these
countries, although advanced neonatal care permits the increased survival of preterm
babies, the health resources are relatively limited and neonatal care is less than ideal.
As a result, around 40% of infants with severe ROP develop some degree of visual
impairment.
In low income countries, no cases of blindness due to ROP were reported by Gilbert
et al. [1997], Unfortunately, such countries have a low health care provision and
lack the facilities to support the survival of babies born prematurely. Hence, few
preterm babies survive to develop the disease.
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6.1.2 Conventional Animal Models of Oxygen-Induced Retinopathy
Preterm infants with severe ROP, which is characterised by retinal
neovascularisation, develop the disorder whilst still receiving supplemental oxygen
therapy. As discussed earlier, upon transfer to room air the disease usually regresses
and the retinal vasculature appears normal, but in some cases the neovascularisation
can progress further to cause retinal detachment and blindness.
In animal models of oxygen-induced retinopathy, hyperoxia alone does not result in
retinal neovascularisation, rather a short room air recovery period (relative hypoxia),
after the hyperoxic exposure is essential for inducing the profuse growth of the
retinal vessels into the vitreous. This was first demonstrated by Ashton and
colleagues [Ashton, Serpell and Ward, 1954; Ashton, 1966; Ashton, Garner and
Knight, 1971], Their studies found that animals subjected to extreme concentrations
of oxygen developed complete vaso-obliteration of the retinal vessels. When the
animals were returned to room air, the obliteration was irreversible in a majority of
the vessels and a profuse outgrowth of vessels took place. This outgrowth comprised
of numerous corkscrew (endothelial cell) proliferations extending from the retinal
surface into the vitreous, mimicking the human disease.
Several animal models of oxygen-induced retinopathy have since been developed
[Flower and Blake, 1981; Chan-Ling et al., 1992; Penn, Tolman and Lowery, 1993;
Penn, Henry and Tolman, 1994; Penn, Tolman and Henry, 1994; Smith et al., 1994],
As discussed in detail in Chapter One, each of these models use a different oxygen
regime to halt the normal process of retinal vascularisation, and depend on a relative
hypoxic period (room air recovery) to induce neovascularisation. The duration of
this relative hypoxic period is crucial as shown by Smith and by Penn. The Smith
model involves placing mice at postnatal day 5 (P5) in constant 75% oxygen until
P12 to induce sufficient vaso-obliteration. The animals are then returned to room air
where maximum neovascularisation occurs between P17 and P21 (five to nine days
of hypoxia). With a longer period in room air, the neovascularisation eventually
regresses and the vasculature essentially appears normal [Smith et al., 1994], In one
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of Penn's model of oxygen-induced retinopathy, newborn rat pups are switched
between 80% and 40% oxygen every 12 hours until PI4. When the animals are
killed immediately on removal from oxygen, no neovascularisation is observed.
With two days of room air recovery, some neovascularisation is noted, but the
greatest incidence occurs with a period of four days in room air. By the seventh day,
the neovascularisation decreases possibly due to spontaneous resolution of the
pathology [Penn, Tolman and Lowery, 1993],
6.1.3 Neovascularisation in the Edinburgh Model?
The Edinburgh model of ROP was developed since the typical models of oxygen-
induced retinopathy did not represent the oxygen environment experienced by a
premature ventilated infant. Infants are no longer maintained in high oxygen (70-
80%) nor does their oxygen environment switch between high and low levels on a
regular basis. Instead the arterial oxygen levels of the babies are constantly
fluctuating between clinically 'safe' limits [Cunningham et al., 1995], Thus, the first
14 days of the transcutaneous oxygen profile of a preterm infant who developed
severe ROP was selected and translated into percentage inspired oxygen to produce
equivalent arterial oxygen levels in the rat. Rat pups exposed to this clinically
relevant profile, which had a mean oxygen concentration of 21.3%, developed
features ofROP [Cunningham et al., 2000],
The drawback of the Edinburgh model is that, unlike the conventional oxygen-
induced retinopathy models, the retinas of this model do not develop
neovascularisation. Instead lectin-positive tufts, called abnormal terminal vessels,
form at the vascular/avascular junctions (Figure 6.1, page 180).
When the profile is set to fluctuate around a mean of 8kPa, only 21% of the retinas
are identified as having abnormal terminal vessels, but when the oxygen fluctuated
around a mean of lOkPa, 42.5% of the retinas are affected [McColm et al., 2004],
Thus, a higher mean oxygen level results in an increase in the number of retinas with
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abnormal terminal vessels. It is suggested that these tufts represent the initial stages
of neovascularisation (precursors) or that they are simply the proliferating
endothelial cells at the leading edge of the retinal vasculature. The origin and role of
these tufts may be better understood by either exposing pups to the oxygen profile
for a longer period of time, or by placing the pups into room air after oxygen
treatment.
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Figure 6.1 Abnormal terminal vessels.
P14 retina exposed to the 8kPa minute variable oxygen profile.
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6.2 Aims and Hypothesis
The lack of neovascularisation in the Edinburgh model may be seen as indicating a
poor model of ROP. Therefore, the aim of the work discussed in this chapter was to
establish whether the Edinburgh model simply delays retinal vascularisation, or if the
model is capable of inducing retinal neovascularisation. In order to determine this,
two additional regimens were used; newborn pups were either exposed to the
variable oxygen for a longer period of time (until PI 8) or returned to room air after
14 days of oxygen exposure.
Since the oxygen regimen of the Edinburgh model consists of frequent small
fluctuations in inspired oxygen levels, it does not produce severe retinopathy as in
the traditional models. Thus, it is proposed that with 18 days of variable oxygen
exposure retinal vascular changes of the Edinburgh model would still be observed,
namely altered capillary density, increased peripheral avascularity and the formation
of abnormal terminal vessels; however, the extent of these vascular changes may be
reduced in comparison to the pups exposed to the variable oxygen profile for 14 days
alone. With a period of room air recovery, retinal neovascularisation may be
observed. On-the-other-hand, this period in room air may result in the resolution of
the disease.
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6.3 Methods
6.3.1 Experiments
Five animal groups were analysed, two of which were reared in room air and three
raised in the minute-to-minute variable oxygen profile set at 8kPa [described in
Chapter One and in Cunningham et al., 2000]:
• P14 control1 - pups were raised in room air until postnatal day 14
• PI8 control - pups were raised in room air until postnatal day 18
• P14 8kPa' - pups were exposed to the variable oxygen regime from birth
to postnatal day 14
• PI8 8kPa - pups were exposed to the variable oxygen regime which had
been extended to run until postnatal day 18. This was accomplished by
running the profile from day 0 to day 10 without interruption, and then
running the oxygen profile form day 11 to day 14 twice
• P14 8kPa + 4d RA - pups were raised in the variable oxygen regime from
birth until postnatal day 14 and then transferred to room air for four days.
A minimum of 12 Sprague-Dawley pups was required per litter and three litters were
analysed per group. The rat pups were first weighed and then anaesthetised, perfused
and killed as described in Chapter Two. Both eyes were enucleated; the right was
fixed in 2% paraformaldehyde for 2 hours, the retinas dissected and stained for
endothelial cells, whilst the left was dissected fresh and stored at -70°C for any
possible future studies.
6.3.2 Lectin Staining
Endothelial cells were visualised by incubation with G. simplicifolia (Bandeiraea)
isolectin B4 as follows. The flattened wholemounted retinas were fixed in 70%
1 These experiments had been conducted earlier by the ROP research group at the Department of
Child Life and Health.
182
Chapter Six: Testing the Edinburgh ROPModel
ethanol for 20mins (-20°C), and then permeabilised in 1M PBS/1% Triton X-100 for
30mins. Biotinylated G. simplicifolia (Bandeiraea) isolectin B4 (Vector
Laboratories) was prepared in 1M PBS/1% Triton X-100 at a 1:50 dilution, and
applied to the wholemounts overnight at 4°C. The following day, the retinas were
washed three times in 1M PBS/1% Triton X-100 for lOmins each. The tissues were
then incubated at room temperature in streptavidin-conjugated flourescein (Vector
Laboratories) at a dilution of 1:100 prepared in 1M PBS/1% Triton X-100 for 2
hours. The tissues were again washed three times in 1M PBS/1% Triton X-100 for
lOmins each. Finally, the wholemounts were mounted in PBS:glycerol (1:1) and the
coverslip sealed with nail varnish.
6.3.3 Analysis
Confocalmicroscopy
The stained, flatmounted retinas were viewed using an argon krypton laser confocal
microscope (Leica Microsystems, Germany) excited at 488nm (filter BP 525/50).
Images of each retinal quadrant were taken at x2.5 and xlO magnification and
digitally stored for later analysis.
Capillary density
Capillary bed areas were chosen within the mid-periphery of the retina, and where
possible major vessels (arterioles and venules) were not included in the field of view.
Because each retina was divided into four quadrants, an image of each quadrant was
scanned at xlO magnification. Using the Image Tool Software (designed by the
University of Texas, Health Sciences Center, San Antonio), the retinal capillary
branches of each quadrant were marked and counted. An average was then
calculated for each retina which represented the capillary density. Some retinas were
recounted to validate the results.
183
Chapter Six: Testing the Edinburgh ROPModel
Avascular area
Images of the whole retinal quadrant (at 2.5x magnification) were saved and the total
retinal area and peripheral avascular area were measured using Scion Image Software
(Scion Corporation, USA). The avascular area of each retina was then expressed as a
percentage of the total retinal area.
Abnormal terminal vessels
Each retina was carefully examined for abnormal terminal blood vessels at the
vaseular/avascular junction and simply graded 0 or 1 for the absence or presence of
these vessels, respectively2. The number of retinas with abnormal terminal vessels
within each experimental group was then expressed as a percentage.
Statistics
Summary statistics are presented as median (interquartile range). Comparisons
between the groups were made by Mann Whitney U correlation using the SPSS
statistics package (SPSS, Inc., Chicago, USA).
2 This analysis was conducted by Dr. Brian Fleck, an ophthalmologist and a member of the ROP
research group.
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6.4.1 Capillary Density
The retinal capillary density of pups raised in room air until P14 was greater than
those raised in room air until PI8. The difference between these two groups was
statistically significant (p<0.001). Although the number of capillary branches per
mm2 in the retinas of the P14 8kPa group was less than that of the P14 control group,
the difference was not statistically significant. This was also the case when the
capillary density of the PI8 8kPa group was compared to that for the PI8 control
group.
Representative images of the retinal capillary beds from each group are shown in
Figure 6.2 (page 188). The retinas of the P14 8kPa + 4d RA pups had a median
capillary density less than the P14 control (significant at P<0.05), but greater than the
PI8 control (not significant). The capillary density value calculated for this group
was very close to that for the P14 8kPa group.
6.4.2 Peripheral Avascularity
As expected, retinas of the PI8 control pups were fully vascularised (Figure 6.3,
page 188). Flowever, a small proportion of the P14 control group had a slight
peripheral avascular area (average 0.22%, median 0%). In comparison, most retinas
(20 out of 28) of the P14 8kPa group had some extent of peripheral avascularity. On
average 4.6% of the total retinal area was non-vascularised (median 1.7%). Fewer
retinas of the PI8 8kPa group had an avascular area, with an average of 0.3% and a
median of 0%. Thus, the peripheral avascularity of both the P14 8kPa and PI 8 8kPa
retinas were significantly greater than the 14 controls and PI8 control retinas,
respectively. In the P14 8kPa + 4d RA group only 7 of the 32 retinas examined had
peripheral avascularity. The average of this group was 0.2% and the median was
0%, values very similar to the P14 controls, but significantly greater than the PI8
controls (p<0.005).
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6.4.3 Abnormal Terminal Vessels
As in the original Edinburgh model study [Cunningham et al., 2000], no
neovascularisation was noted in any of the groups investigated here. However,
abnormal terminal vessels were observed in both the PI4 8kPa (21%) and PI8 8kPa
(11%) groups. Abnormal terminal vessels were not present in any of the control and
P14 8kPa + 4d RA retinas.
187
Chapter Six: Testing the Edinburgh ROPModel
Figure 6.2 The retinal capillary bed of all groups.
(A) PI4 Control. (B)P14 8kPa. (C) PI8 Control. (D)P18 8kPa. (E) P14 8kPa + 4d RA.
Scale bar: 200pm.
Figure 6.3 Extent of peripheral avascularity of all groups.
(A) P14 Control (B) P14 8kPa. (C) PI8 Control. (D) P18 8kPa. Abnormal terminal
vessels were also observed in this retina (arrow). (E) P14 8kPa + 4d RA.
Scale bar: 800pm.
188
Chapter Six: Testing the Edinburgh ROPModel
6.5 Discussion
6.5.1 Normal Retinal Vessel Development
Under normal conditions retinal vascular development of the rat is usually complete
by day 14 [Penn, Tolman and Lowery, 1993; Holmes, Duffner and Kappil, 1994],
however, the results of this study suggest that some further vascular development
occurs between P14 and PI 8. Firstly, all of the retinas of the PI 8 control group were
fully vascularised, whereas a few of the P14 controls still had a small peripheral
avascular area. Secondly, there was a significant reduction in the capillary density of
the PI8 controls compared to the P14 controls suggesting that the capillary network
underwent some further remodelling.
6.5.2 Neovascularisation in the Model
It is suggested that the abnormal terminal vessels in the P14 8kPa group may either
be proliferating endothelial cells at the advancing edge of the vasculature or may
represent precursors of pathologic neovascularisation [Cunningham et al., 2000], If
the former is true, then the small tufts would be observed at the vascular/avascular
junction at all stages of retinal development. However, in the P2 and P7 retinas that
were double stained for endothelial cells and mural cells (Chapter Two), no such
structures were observed. There is, however, some support for the suggestion that
the tufts may be precursors of neovascularisation. Firstly, the tufts occurred at the
vascular/avascular junction where neovascularisation develops in other rat models
[Penn, Henry and Tolman, 1994; Penn, Tolman and Henry, 1994], Secondly, the
proportion of retinas with abnormal terminal vessels increased as the insult increased
(21% in 8kPa and 42% in lOkPa [McColm et al., 2004]). Thirdly, in a model where
the oxygen concentration cycled between 80% and 20% every 12 hours (oxygen-
induced retinopathy), 73% of the retinas were affected with abnormal terminal
vessels [Cunningham et al., 2000], This value is very similar to that quoted by Penn
for the 80/40% model where neovascularisation developed in 72% of the retinas
[Penn, Henry and Tolman, 1994],
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If the small tufts are neovascular precursors, then this model would have greater
clinical relevance since infants develop neovascularisation whilst still ventilated.
Therefore, the aim of the experiments described in this chapter was to establish if
these tufts developed into neovascular vessels with a prolonged oxygen treatment or
with post-exposure room air maintenance (relative hypoxia).
6.5.3 Effects of Prolonged Oxygen Treatment
The 14 day profile of the model was extended to run for 18 days. This was
accomplished by repeating the oxygen data of days 11 to 14. Thus, from birth to
P10, the pups were exposed to the 24 hour data corresponding to the equivalent days,
i.e. days 0 to day 10. But from PI 1 to PI8, the oxygen profile of days 11 to 14 ran
for 48 hours each, i.e. on PI 1 and PI 2 the pups were exposed to the data of day 11,
on P13 and P14 the pups were exposed to that of day 12, and so on.
Raising pups in this regime resulted in a slight reduction in the capillary density in
comparison to PI 8 controls. Some of the retinas also had a peripheral avascular area,
although markedly less than the P14 8kPa group. There was also a fall in the
proportion of retinas with abnormal terminal vessels; only 11% of the retinas had
abnormal vessels. If the abnormal terminal vessels are precursors of neovascul¬
arisation, then the pathology spontaneously regressed in 89% of the retinas, a
proportion similar to that of infants in developing countries who develop ROP but is
naturally corrected. Hence, the extended variable oxygen profile still produced
features of ROP, suggesting that the Edinburgh model is not simply a model of
delayed retinal vessel development.
6.5.4 Effects of Transfer to Room Air
In the original experiments of the Edinburgh model, the pups were not transferred to
room air after oxygen exposure [Cunningham et al., 2000], Ventilated infants are not
abruptly switched from a high oxygen environment to normoxia, instead they are
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gradually reintroduced to room air by withdrawing them from oxygen. Thus, it was
felt that post-exposure room air maintenance would not reflect the clinical set up.
Animal studies investigating 'oxygen weaning' have produced conflicting results.
Phelps and Rosenbaum induced retinopathy in kittens and then gradually lowered the
oxygen concentration within the chamber to room air over a period of a few weeks.
They reported that the retinas of the kittens raised in this regimen were not
appreciably different to those exposed to high oxygen and then transferred to room
air [Phelps and Rosenbaum, 1987]. Chan-Ling and colleagues also exposed kittens
to high oxygen for several days and then gradually lowered the oxygen concentration
until the kittens were four weeks of age. Some of the regimes tested by the
researchers actually offered some degree of protection in the long term and the
formation of the pre-retinal vessels was effectively prevented by supplemental
oxygen therapy [Chan-Ling, Gock and Stone, 1995],
In the experiments described here, it was felt that 'oxygen weaning' was not
necessary since the profile fluctuated at a mean of 21% and the minute-to-minute
changes between day 12 and day 14 were very small in comparison to the changes
during the earlier days. Thus, animals were transferred directly into room air on P14
to investigate if the retinal vasculature 'normalised' or developed neovascularisation.
The animals were given four days of recovery after 14 days of oxygen exposure in
keeping with other animal models [Penn, Tolman and Lowery, 1993; Penn, Henry
and Tolman, 1994; Penn, Tolman and Henry, 1994; Chan-Ling et al., 1992],
The retinal vasculature of the pups exposed to this regimen appeared no different to
PI4 control retinas; the capillary density and extent of avascularity were very similar
in both groups and no abnormal terminal vessels were observed. Thus, four days of
room air exposure may have resulted in 'normalisation' of the retinal vasculature.
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In conclusion, the Edinburgh model of ROP does not produce the same extent of
avascularity as the conventional models nor does it induce neovascularisation with a
longer exposure to the oxygen regime or with a period of relative hypoxia. It is
possible that neovascularisation did occur in both of the groups analysed in this
study, but an extended period of four days of oxygen or room air was too long and
the retinal vasculature normalised. A shorter duration of 12 or 24 hours may instead
result in neovascularisation. Thus, the Edinburgh model would benefit from further
manipulation of the data in order to induce neovascularisation, but still keeping the




7.1 Vessel Stability in the EdinburghModel of ROP
During the early stages of vasculogenesis, angioblasts differentiate into endothelial
cells that proliferate to form a primary vascular network [reviewed in Risau, 1997],
During the later stages, this network matures by rapidly remodelling into large and
small vessels [reviewed in Risau, 1997], and develops a coverage by mural cells
[Rhodin, 1968], Mural cell coverage has been suggested to signal the stability of
blood vessels [Kuwabara and Cogan, 1963; Speiser, Gittelsohn and Patz, 1968;
Crocker, Murad and Geer, 1970; Tilton et al., 1985; Orlidge and D'Amore, 1987],
Several growth factors, including platelet-derived growth factor (PDGF) [Lindahl et
al., 1997], transforming growth factor-/? (TGF-/?) [Antonelli-Orlidge et al., 1989a],
and the angiopoietins [Suri et al., 1996], are implicated in regulating vessel
stabilisation. In retinopathy of prematurity (ROP), the retinal vessels either lack
support cells or have a limited coverage of support cells. Consequently, the retinal
capillaries are susceptible to injury by hyperoxia and prone to leakage [Patz, 1968],
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The first purpose of the work detailed in this thesis was to investigate blood vessel
stability during the normal development of the rat retina by studying the interaction
between endothelial cells and mural cells, and the retinal expression of the above-
mentioned growth factors. The second aim of this project was to determine if mural
cell coverage and the expression of PDGF-B, TGF-/? and the angiopoietins were
affected by the fluctuating oxygen regime of the Edinburgh model ofROP.
7.1.1 Mural Cell Coverage
Pericytes and smooth muscle cells have been reported to express a number of
proteins [Joyce, Haire and Palade, 1985; Nayak et ah, 1988; Skalli et ah, 1989;
Mitchell et ah, 1990; Schlingemann et ah, 1990; Nehls, Denzer and Drenckhahn,
1992; Newcomb and Herman, 1993; Ehler et ah, 1995], However, the expression of
only two mural cell markers, a-smooth muscle actin (a-SMA) and desmin, were
investigated in the work reported here.
a-SMA expression increased progressively from P2 to P21 in the control retinas, but
was seen only on the arterial vessels that had undergone remodelling. On P2, a-
SMA positive cells were flat and lacked distinct structure, but by PI4, the cells were
elongated and spindle-shaped, and arranged perpendicular to the axis of the vessels.
Thus, a-SMA stained the smooth muscle cells of the retinal vasculature. In contrast,
desmin expression was observed on all vessels of the retina. On P2, desmin labelled
very fine and long strands on the surface of the retinal vessels (which may be
immature pericytes or undifferentiated precursor cells). However, by P7 the cells
had gained the typical structure of pericytes; they were long and slender with
numerous processes. Unlike the smooth muscle cells, the structure and orientation of
the pericytes altered depending on their location. On the arterioles, the cells were
long, thin, and encircled the wall of the vessel, whereas on the venules the cells had
several processes (primary and secondary) and were arranged both perpendicular and
parallel to the axis of the vessels. Occasional cells of the arterioles expressed both
protein markers; some had the typical structure of smooth muscle cells whilst others
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appeared more like pericytes. These cells were presumably the transitional pericytes,
which may have the potential to differentiate into smooth muscle cells on demand.
In the Edinburgh model of ROP, there was a slight reduction in the expression of
a-SMA. This reduction was most likely a result of the limited remodelling of the
vasculature in response to the oxygen exposure. Desmin expression, however, was
significantly reduced in the retinas of the oxygen treated pups. This reduction may
be the result of reduced recruitment of pericyte precursor cells or apoptosis of some
pericytes. Electron microscopic analysis showed that in some retinal vessels of the
oxygen treated pups the structure of the pericytes was altered. The basement
membrane was degraded and the pericytes were no longer within close proximity to
the endothelial cells.
7.1.2 Platelet-Derived Growth Factor-B
PDGF-B released from endothelial cells promotes the proliferation of adjacent
pericyte or smooth muscle cell precursors [Leveen et al., 1994; Soriano 1994, 1996;
Bestrom et al., 1996], Thus, PDGF-B, by binding to its receptor, signals the
recruitment of pericytes to the endothelial tubules.
When Western immunoblotting of the retinal proteins was performed using a
polyclonal antibody to PDGF-B, four proteins were detected. Although the two
higher molecular weight proteins were not clearly identified, the lower molecular
weight proteins were suggested to be the PDGF-B chain precursor and the PDGF-BB
isoform. During normal development the expression of both proteins increased from
P2 to P14 and remained high at P21. The expression on P2 and P7 was unaffected
by the variable oxygen regime, however, with 14 days of exposure, the expression of




7.1.3 Transforming Growth Factor-/?)
TGF-/?i is suggested to play a role in vessel stabilisation as it inhibits the
proliferation of both endothelial cells [Frater-Schroder et al., 1986; Heimark,
Twardzik and Schwartz, 1986] and mural cells [Majack, 1987; Owens et al., 1989;
Verbeek et al., 1994; Schor et al., 1995], but promotes the differentiation of the
mural cells [Shah, Groves and Anderson, 1996; Hirschi, Rohovsky and D'Amore,
1998],
In retinal vessel development, TGF-/?i protein levels increased markedly from P2 to
P7, but fell slightly on P14 and further on P21. Much of this detected protein was
believed to be the latent form that converted into the active form during the
preparation of the tissue samples. With immunohistochemical analysis, which only
detected the active form of TGF-/?i, the expression of the protein increased from P2
to PI4.
When compared to the controls, retinas of the pups raised in the variable oxygen
regime had decreased expression of the protein at all timepoints examined,
suggesting that either the secretion or the synthesis of the protein was reduced in
response to fluctuating oxygen.
7.1.4 The Angiopoietins
The angiopoietins are critical for the maintenance of endothelial cell-matrix and
endothelial cell-mural cell interactions [Sato et al., 1995; Suri et al., 1996;
Maisonpierre et al., 1997], Thus, the angiopoietins function during both the later
stages of vasculogenesis and during angiogenesis.
Using both digoxigenin-labelled and radio-labelled probes I was unable to detect any
expression of Ang-2. Thus, further investigation of the angiopoietins was
abandoned, however, it had been previously reported that Ang-2 mRNA is low
during the early and late stages of retinal vessel formation [Oh et al., 1999; Hackett
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et al., 2000], but high during the middle period of retinal development (around P8)
[Hackett et al., 2000],
7.1.5 Clinical Implications
The results of these studies suggest that blood vessel stability may be compromised
by fluctuating oxygen levels. This compromised stability may cause the retinal
vessels to become fragile and vulnerable to rupture and leakage. It may also underlie
the process of neovascularisation since the vessels which burst into the vitreous
probably sprout from vessels that have a reduced (or a lack of) pericyte coverage.
Therefore, using the Edinburgh model a potential targeting point for ROP would be
to promote stability of the vessels by (1) increasing the recruitment of the pericyte
precursors, (2) promoting their differentiation into mature pericytes or (3) preventing
their apoptosis. Of course, further studies are required to determine which of these
mechanisms are responsible for the reduced stability of the retinal vessels in the
Edinburgh model.
As far as potential therapeutic agents are concerned, although PDGF-B and TGF-/?
induce pericyte recruitment and differentiation, respectively, the use of these may be
limited in the treatment ofROP: firstly, administration ofPDGF-B has been found to
disrupt the association between endothelial cells and pericytes by causing the
detachment of the pericytes from newly coated retinal vessels [Benjamin, Hemo and
Keshet, 1998]; secondly, to date the effects of TGF-/9 administration on blood vessels
has not been investigated. Recent studies have found that the acute administration of
Ang-1 can protect the vasculature against leakage [Thurston et al., 2000; Xu, Zhang
and Adelman, 2003] and reduce retinal neovascularisation [Nambu et al., 2003],
Although the mechanisms by which Ang-1 protects the vasculature is unknown,





Early studies found that persistent hyperoxia along with retinal immaturity are risk
factors for ROP [Campbell, 1951; Patz, Hoeck and Cruz, 1952], However, infants
are no longer exposed to continued high oxygen concentrations; instead their
transcutaneous oxygen levels fluctuate from minute-to-minute, but kept between
clinically defined limits [Cunningham et al., 1992], It has been reported that infants
experiencing a greater variability of oxygen during the first two weeks of life are at
an increased risk of developing the condition [Cunningham et al., 1995]. The
Edinburgh model ofROP was designed to mimic this clinical situation [Cunningham
et al., 2000],
7.2.1 The Profiles
The purpose of this project was to determine if vessel stability was compromised in
the Edinburgh ROP model. For these studies, pups were exposed to the lOkPa
oxygen profile since, in comparison to the other profiles, it induced a higher
incidence and greater severity of disease [Cunningham et al., 2000], Thus, it was
predicted that if vessel integrity was indeed compromised in the model, then it would
be more readily detected in the lOkPa model.
When the model was being tested for neovascularisation, two regimens were studied;
an extended duration of oxygen exposure (18 days) and a period of room air recovery
(14 days of oxygen exposure followed by four days in room air). For both of these
regimens, the 8kPa profile was used since the original study used an oxygen profile
with a mean of 8kPa [Cunningham et al., 2000], As in the original study, neither of
these two regimens induced neovascularisation. However, abnormal terminal vessels
were observed at the vascular/avascular junction in the retinas killed immediately
after oxygen exposure. In contrast, pups transferred to room air after oxygen
exposure did not appear appreciably different to the PI4 controls.
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7.2.2 Improvements to the Model
Although the Edinburgh model of ROP represents more realistically the oxygen
environment experienced by preterm infants receiving supplemental oxygen therapy,
the lack of neovascularisation in the retinas may be a weakness of this model. The
model could benefit from manipulation to induce the proliferation of vessels into the
vitreous.
Animal models have shown that hypercarbia can induce retinopathy [Flower, 1988;
Holmes, Duffner and Kappil, 1994; Holmes et al., 1997, 1998], In the Edinburgh
model, when pups were exposed to the 8kPa profile with a constant carbon dioxide
level of 5%', the retinal vasculature appeared very immature in comparison to that of
pups raised in room air or variable oxygen alone. The retinal vasculature consisted
of numerous smaller vessels and lacked capillary-free zones around the arterioles,
suggesting that the vasculature had not undergone sufficient remodelling. In
addition, the retinas had increased peripheral avascularity, and a greater number of
retinas contained abnormal terminal vessels. If these abnormal terminal vessels are
indeed neovascular precursors, then these results are in agreement with other studies
that carbon dioxide is a risk factor for ROP [Flower, 1988; Holmes, Duffner and
Kappil, 1994; Holmes et al., 1997, 1998],
Clinical studies investigating the effects of carbon dioxide on the retina have
however produced conflicting results; whilst some consider carbon dioxide to be a
risk factor [Shoat et al., 1983; Brown et al., 1987], others have failed to show any
relationship between carbon dioxide and ROP [Bauer, 1982; Gellen et al., 2001],
Thus, although in the animal model carbon dioxide along with variable oxygen
exposure induced a more severe disease, because the clinical relevance of carbon
dioxide is not fully understood the use of carbon dioxide to induce retinopathy may
be inappropriate.
1
Unpublished results of the ROP research team in the Department ofChild Life and Health.
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The lungs of preterm infants are poorly developed, thus the babies have great
breathing difficulties. During resuscitation, preterm infants commonly experience a
very short period of hypoxia, followed by a short exposure to 100% oxygen before
they are maintained in clinically 'safe' oxygen levels. It is possible that this early
insult may play a crucial role in the induction and outcome of ROP. Therefore,
exposing rat pups to 10% oxygen for 10 minutes followed by 100% oxygen for 10
minutes prior to starting the variable oxygen regime may produce more severe
retinopathy than the variable oxygen regime alone, and perhaps even induce
neovascularisation. This regime would further mimic the oxygen environment
experienced by a preterm ventilated infant. These experiments are currently
underway in the laboratory.
In the current model, a minimum of 12 pups per litter are required to induce the early
features of ROP [Cunningham et al., 2000], Using a rat model of oxygen-induced
retinopathy, Holmes and Duffner induced more frequent and more severe abnormal
retinal neovasculatisation in larger litters (25 pups) than smaller litters (10 pups)
[Holmes and Duffner, 1996], Hence, litter size can determine retinal outcome
possibly due to competition within the litter leading to malnourishment and postnatal
growth retardation. Therefore, in addition to manipulation of the oxygen regime,





Along with the further studies and improvements suggested in the individual
chapters, there is scope for a number of future studies on retinal vessel stability. In
addition, the Edinburgh model may prove very useful in establishing the effects, if
any, of variable oxygen in other tissues and systems.
7.3.1 The Angiopoietins
At the time of conducting the initial experiments on the angiopoietins, antibodies for
use in immunohistochemistry and Western analysis were not available. However,
suitable angiopoietin antibodies are now available. Thus, in order to complete this
project, the first experiments carried out would investigate the expression of the
angiopoietins during retinal development in control and oxygen treated rat pups.
Since pericyte coverage and the expression ofPDGF-B and TGF-/?i were affected by
the variable oxygen regime, it would be expected that retinal expression of Ang-1
and Ang-2 would also be altered.
7.3.2 Blood Vessel Leakiness
The work discussed in Chapter Two found that mural cell coverage was reduced in
the Edinburgh model and that the basement membrane, which forms a continuous
layer around pericytes and endothelial cells, was disrupted in the retinas of the
variable oxygen group. These factors can result in vessel destabilisation and leakage
of fluids.
Thurston and colleagues measured vascular leakage of the ear skin of VEGF
(vascular endothelial growth factor) and Ang-1 transgenic mice by injecting Evans
blue dye into the femoral vein [Thurston et al., 1999, 2000], This technique has been
adapted to measure vessel leakage of the rat retina [Xu, Quam and Adamis, 2001]
and may be easily applied to the Edinburgh model. Because leakage sites expose the
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basement membrane to the vessel lumen, Thurston et al. also investigated the leakage
sites in the ear skin of the transgenics [Thurston et al., 1999], The exposed basement
membrane was visualised by staining the vasculature with biotinylated Ricinus
comminis I lectin. This technique can also be used to establish any retinal vascular
leakiness of the oxygen treated pups and has an advantage over the Evans blue dye
methodology in that UK Home Office approval would not be required.
7.3.3 The Effects of Oxygen on the Retina
It would be interesting to establish if the reduced expression of PDGF-B and TGF-/?i
was due to hypoxic episodes alone, or to hyperoxic periods, or was a result of the
variability which may have caused the relevant genes to be switched 'on' and 'off
repeatedly.
In the Edinburgh model of ROP, the oxygen concentration does not exceed 50%.
Thus, to investigate the effect of hyperoxia alone, the pups could be maintained in
50% oxygen until 14 days of life. In order to determine if the effects were the result
of hypoxia, the pups could be exposed to 50% for seven days followed by room air
maintenance (relative hypoxia) until PI4. Alternatively, pups could be raised from
birth to postnatal day 14 in a slightly hypoxic environment (15% oxygen).
Following exposure, the pups would be sacrificed, the tissues collected and Western
analysis performed.
7.3.4 Differentiation of Pericytes into Smooth Muscle Cells
Zimmermann2 identified three types of mural cells: smooth muscle cells around
larger vessels; transitional pericytes found around the pre- and post-capillaries; and
true pericytes around the mid-capillaries. Transitional pericytes have been described
as undifferentiated smooth muscle cells [Rouget, 18733; Nicosia and Villaschi, 1995;
2 The original paper was written in German and a translation was not available. This is taken from the
review by Darland and D'Amore, 2001b.
3 The original paper was written in French and a translation was not available. This is taken from the
review by Darland and D'Amore, 2001b.
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Lindahl et al., 1997; Hellstrom et al., 1999], Since 10T1/2 cells (mesenchymal cell
precursors) have been shown to differentiate into pericytes or smooth muscle cells in
the presence of TGF-/? [Hirschi, Rohovsky and D'Amore, 1998], the theory that
pericytes are undifferentiated smooth muscle cells could be investigated by
maintaining cultures of retinal capillaries in vitro and testing the effects of TGF-/?
addition to the cultures.
It may also be worthwhile to adapt cell culture incubators so that the direct effects of
oxygen variability could be investigated in various cell types and systems. For
example, on the formation of capillary structure in three-dimensional co-cultures of
endothelial cells and 10T1/2 cells [Darland and D'Amore, 2001a],
7.3.5 Effects of Variable Oxygen on the Developing Brain
More extremely premature infants are surviving today as a result of improvements in
neonatal care. However, a large proportion (around 50%) of these babies is found to
have neurodevelopmental abnormalities later in life [Volpe, 1995], Because most
extremely premature babies are ventilated for a period of time, many of them
experience fluctuations in their blood oxygen levels similar to those used in the
Edinburgh model. Since the retina is an extension of the brain, the question has been
asked whether the brain could be affected by oxygen variability too. If oxygen
variability is indeed found to be harmful to the brain, it may account for some of the
brain injuries in preterm infants which cause neurodevelopmental disorders. Such




In summary, with 14 days of variable oxygen exposure, there was a reduction in the
mural cell coverage of the retinal blood vessels. The small decrease observed in
smooth muscle cell coverage was due to limited remodelling of the vasculature,
whereas the marked decrease in pericyte coverage was most likely the result of a
reduction in the number of precursors cells migrating onto the vasculature. This
reduction in mural cell coverage was confirmed by the reduced expression of PDGF-
B and TGF-/?i proteins which function in the recruitment and differentiation of the
mural cells, respectively.
These findings suggest that the stability of the retinal vasculature is indeed
compromised in the Edinburgh model ofROP and merits further analysis.
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A comparison of the retinal vascular changes following a short or prolonged
exposure to carbon dioxide in a variable oxygen model of retinopathy of prematurity.
Yaqoob, Z., McColm, J. R., Wade, J., Gellen, B., Fleck, B., Sharma, T., Gilmour, D.,
Cunningham, S., Sedowofia, K., Mcintosh, N.
Aims: To determine the effects of short versus long duration hypercarbia and
fluctuating oxygen on the developing rat retinal vasculature.
Methods: Newborn rats were exposed to oxygen and carbon dioxide in one of three
groups: (1) Variable oxygen exposure (VO2) (2) VO2 with 2 days 5% carbon dioxide
(2CO2 +VO2) (3) VO2 with 14 days 5% carbon dioxide (MCO2 + VO2). Following
sacrifice at day 14, the eyes were enucleated, fixed in 2% PFA and retinal
wholemounts prepared. Blood vessels were visualised by staining the endothelial
cells using G. simplicifolia (Bandeiraea) isolectin B4 and the median number of
branches and the peripheral avascular area were assessed by confocal microscopy.
Results:
Control VO2 2C02 + V02 14C02 +V02

































* p<0.05 comparec to control.
p<0.001 compared to control.
# pO.OOl compared to control and variable oxygen.
Conclusion: All experimental protocols induced features of retinopathy in rat pups.
However, pups exposed to carbon dioxide had increased capillary branching and a
greater peripheral avascular area when compared with controls. A prolonged
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Retinal vascular changes in a variable oxygen model of retinopathy of prematurity
comparing short and prolonged exposure to hypercarbia.
Yaqoob, Z., McColm, J. R., Wade, J., Gellen, B., Fleck, B., Sharma, T., Gilmour, D.,
Cunningham, S., Sedowofia, K., Mcintosh, N.
Aims: To determine the effects of short versus long duration hypercarbia and
fluctuating oxygen on the developing rat retinal vasculature.
Methods: Newborn rats were exposed to oxygen and carbon dioxide in one of three
groups: (1) Variable oxygen exposure (VO2) (2) VO2 with 2 days 5% carbon dioxide
(2C02 +VO2) (3) VO2 with 14 days 5% carbon dioxide (14C02 + VO2). Following
sacrifice at day 14, the eyes were enucleated, fixed in 2% PFA and retinal
wholemounts prepared. Blood vessels were visualised by staining the endothelial
cells using G.simplicifolia (Bandeiraea) isolectin B4 and the median number of
branches and the peripheral avascular area were assessed by confocal microscopy.
Results:
Control vo2 2C02 + V02 14C02 +VOz

































* p<0.05 comparec to control.
p<0.001 compared to control.
# p<0.001 compared to control and variable oxygen.
Conclusion: All experimental protocols induced features of retinopathy in rat pups.
However, pups exposed to carbon dioxide had increased capillary branching and a
greater peripheral avascular area when compared with controls. A prolonged
exposure to carbon dioxide produced no greater retinopathy than a short, early
exposure.
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Retinal Vascular Changes in a Variable Oxygen Model of Retinopathy of Prematurity
Comparing Short and Prolonged Exposure to Hypercarbia.
Z Yaqoob1, JR McColm2, J Wade1, B. Gellen1, BW Fleck3, T Sharma3, D Gilmour3,
S Cunningham1, K Sedowofia1, N Mcintosh1
1Child life & Health, University of Edinburgh, Scotland, UK; 2Dept of Ophthalmology, Louisiana State University,
New Orleans, LA; 3Princess Alexandra Eye Pavilion, Edinburgh, Scotland, UK
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Introduction
Prolonged treatment of preterm infants with high oxygen levels has consistently
been associated with the development of retinopathy of prematurity (ROP).
Several studies have also investigated the effects of carbon dioxide on the
development of the retinal vasculature. Although clinical studies have produced
contradictory data1'2, animal studies suggest that carbon dioxide is indeed a risk
factor34.
Most oxygen-induced retinopathy models involve the exposure of newborn animals
to large swings of oxygen over long periods of time. These models do not
represent the clinical situation of premature humans, hence, we developed an
oxygen delivery system that mimics the clinical environment5.
The aim of this project was to investigate the combination of oxygen variability with
either an early, short or a prolonged exposure to hypercarbia on the developing
retinal vasculature using our rat model.
Animal Model
The neonatal intensive care unit in Edinburgh continuously monitors the arterial
oxygen of admitted infants by a computerised monitoring system. The first 14 days
of the transcutaneous oxygen profile of an infant who developed ROP was selected
and converted into percentage inspired oxygen levels to produce the equivalent
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Rats exposed to this clinically relevant minute variable oxygen environment
developed features of ROP5.
Methods
3 groups of experimental rats were exposed to the unique Edinburgh oxygen
variability model from birth to P14 (v02). In addition to the fluctuating oxygen, 2 of
the groups were exposed to 5% C02 for either the first 48 hours of life (2d C02) or
for the whole 14 day period (14d C02). A control group consisted of animals raised
in room air.
Following sacrifice at day 14, the eyes were enucleated, fixed and retinal
wholemounts prepared. Endothelial cells were visualised by overnight incubation
with G. simplicifolia (Bandeiraea) isolectin B4 and images of sample retinal areas
were captured using a confocal microscope. These images were used to visually
assess the maturity of the vasculature and quantitatively assess the vascular
changes in 2 ways: the capillary density and the extent of avascularity.
Results
Below are graphs illustrating the results from the analysis of the lectin stained retinal wholemounts. The median and interquartile range were determined
and comparisons were made using the Mann-Whitney U test. Images of the representative retinal areas are adjacent to the appropriate graphs.
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Discussion
Although we noted no neovascularisation, two masked observers did note
abnormal terminal dilations present at the vascular/avascular interface of all
experimental groups. Since these terminal vessels were stained with lectin,
they may represent endothelial cell proliferation. The retinas of the 2d C02
group were not affected to the same extent as the retinas of the 14d C02
group, however, the 2d C02 retinas did have a distinct morphology; the
terminal vessels were enlarged and the vessels ran along the circumference
of the vascular/avascular junction.
Puos exposed to prolonged carbon dioxide had more abnormal terminal
vessels than pups exposed to an early short period of carbon dioxide,
however the extent of avascularity and the capillary density were similar in
both C02 groups.
The exact mechanism of the induction of vascular changes by hypercarbia is
unclear. Raised carbon dioxide acts as a vasodilator, causing increased
retinal blood flow. This could result in increased tissue oxygen or oxygen
variability causing a greater insult to the developing vasculature.









2d CO, 14d CO,
Animal Groups
The retinas of the control group were fully vascularised with remodelled
capillary beds and avascular areas around arteries. The capillary beds of
the v02 group looked similar to the controls, but in fact had a decreased
number of branches per mm2 and a median avascular area of 1.8%. The
vasculature of both C02 groups consisted of many smaller vessels with the
absence of capillary free zones, hence groups 2d C02 and 14d C02 had a
significantly greater capillary density than both the control and v02 groups.
Although the median peripheral avascular area was greater in comparison
to the v02 group, it was not statistically significant.
Conclusion
This study supports the view that carbon dioxide in addition to fluctuating
oxygen produces more severe retinopathy than fluctuating oxygen alone.
An early short exposure of carbon dioxide may be as clinically important as
a prolonged exposure.
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Retinal pericyte/smooth muscle cell coverage in rats exposed to a variable oxygen
model of retinopathy of prematurity (Edinburgh Model).
Yaqoob, Z., Sharp, L., Sedowofia, K., McColm, J. R, Wade, J. C., Giles, D. II, Fleck,
B. W, Cunningham, S., Mcintosh, N.
Purpose: To investigate pericyte/smooth muscle cell coverage during development
of the normal rat retinal vasculature and determine how it is affected by fluctuating
oxygen.
Methods: Litters of newborn rats were either reared in room air or exposed to a
minute-by-minute variable oxygen profile, which induces features of retinopathy
(including peripheral avascularity, vascular immaturity and abnormal terminal
vessels) for 2, 7 and 14 days. Following sacrifice, the eyes were enucleated. The
right eyes were fixed and retinal wholemounts prepared. The endothelial cells were
visualised using G.simplicifolia (Bandeiraea) isolectin B4 and the pericytes/smooth
muscle cells with a-smooth muscle actin (a-SMA) or desmin. The vasculature was
examined using a confocal microscope. The left retinas of each litter were pooled,
the protein extracted and blotted for a-SMA.
Results: In the normal rat retina, at day 2 a-SMA positive cells were found only on
the arterioles. By day 7, coverage had begun on the arterial capillaries, and
progressed further by day 14. Desmin positive cells, however, were present across
the whole retinal vasculature, including the developing peripheral edge on all
timepoints examined. Occasionally, cells were identified positive for both a-SMA
and desmin. This pattern of labelling was also observed in retinas of rats exposed to
variable oxygen. However, the retinal development in these rats was delayed and the
longitudinal coverage of the arterioles with a-SMA positive cells does not progress
as far as in controls. Desmin staining, although seen at the leading edge of the
developing vasculature, was also reduced, particularly on the arterioles. Western
blot analysis confirmed the decrease in a-SMA expression on days 7 and 14.
Conclusion: a-SMA stains smooth muscle cells; desmin stains pericytes. In normal
development pericyte coverage is very rapid, but smooth muscle cell coverage lags
significantly behind vessel formation. Smooth muscle cell coverage of the retinal
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INTRODUCTION
Mature retinal blood vessels are surrounded by a single layer of pericytes or smooth muscle cells,
collectively called mural cells. This encapsulation by mural cells has been suggested to signal
vessel stability. Smooth muscle cells are elongated, spindle shaped cells with fine tapered ends that
encapsulate larger vessels1, whereas pericytes are often elongated with multiple, long and slender
cytoplasmic process that lie parallel to the axis of capillaries or encircle the capillary wall2. It is
suggested that in retinopathy of prematurity (ROP), a potentially blinding eye disease affecting
preterm infants, the vessels of the retina lack coverage by mural cells3.
The aim of this study was to investigate the coverage of retinal vessels with pericytes/smooth
muscle cells during development in rats and determine if it was affected by the fluctuating oxygen
regime of the Edinburgh Model of ROP4.
ANIMAL MODEL
The neonatal intensive care unit in Edinburgh continuously monitors the arterial oxygen of admitted
infants by a computerised monitoring system. The first 14 days of the transcutaneous oxygen profile
of an infant who developed severe ROP was selected and converted into percentage inspired




a-SMA expression was only seen on the arterial vessels, and increased
progressively from P2 to P14 in both groups (Fig. 1). On P2, a-SMA positive
cells were very simple, flat cells lacking distinct structure. The labelling was
limited to the arterioles that had undergone complete remodelling (where
capillary-free zones had formed, arrows). By P14, a-SMA labelled elongated,
spindle-shaped cells that were arranged perpendicular to the axis of the
vessels. Thus, a-SMA stained smooth muscle cells and their precursor cells.
Fig. 1: Expression of a-SMA
Desmin expression was observed on all vessels of the retina (Fig. 2). On P2, desmin labelled very
fine and long strands on the surface of the retinal vessels (these may be immature pericytes or
undifferentiated precursor cells, arrow a). However, by P7 the cells had gained the structure of
typical pericytes; they were long and slender with numerous processes. The structure of the
pericytes altered depending on their location. On the arterioles, the cells were long, thin, and
encircled the wall of the vessel (arrow b). On the venular vessels the cells had several processes
(primary and secondary) and were not arranged in any particular manner (arrow c).
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Rat pups exposed to this clinically relevant minute-variable oxygen environment developed features
of ROP which included increased capillary density, peripheral avascularity and the formation of
abnormal vessels4.
METHODS
Litters of newborn rats were either reared in room air or exposed to the unique Edinburgh Model of
fluctuating oxygen from birth to postnatal days 2, 7 or 14. Following sacrifice, the eyes were
enucleated.
Retinal wholemounts were prepared for immunohistochemical staining; the endothelial cells were
visualised with G. simplicifolia (Bandeiraea) isolectin B4 (Vector Laboratories), and the mural cells
were stained using a-smooth muscle actin (a-SMA, Sigma) or desmin (Dako). The staining was then
viewed using a confocal microscope.
For Western blotting, proteins were extracted from freshly dissected retinas, separated by SDS-
electrophoresis and transferred onto a membrane which was probed using a-SMA antibody. The
membrane was then stripped and blotted with actin as a loading control.
To determine the extent of desmin coverage, images at x20 magnification were taken of the central
and peripheral areas of the retinas. Lectin and desmin staining were quantified using computer-
threshold analysis (Image Tool software). Desmin staining was then expressed as a percentage of
lectin staining.
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Double labelling: lectin (green) and a-SMA (red) Double labelling: lectin (green) and desmin (red)
To ensure that the entire depth of the vessels were imaged, projected focus stacks of several optical sections from the upper to the lower surface of the vessels were obtained.
Occasional cells of the arterioles expressed both markers (Fig. 3); some had the typical structure of smooth muscle cells (arrow a) whilst others appeared more like pericytes (arrow
b). It is possibly that along with a-SMA, differentiating smooth muscle cells also express desmin or that these cells are transitional pericytes and may have the potential to
differentiate into smooth muscle cells on demand.





Fig. 4: Western blot analysis of a-SMA expression
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Fig. 5: Desmin coverage of endothelial tubules
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To determine if there was a difference in smooth muscle and pericyte coverage between control pups and those raised in the Edinburgh ROP Model, Western blotting for a-SMA
staining (Fig 4) and computer thresholding for desmin staining (Fig 5) was conducted. It was found that a decrease in the expression of both markers occurred in the retinas of pups
exposed to the Edinburgh Model of ROP; a-SMA expression was only slightly reduced in the oxygen treated pups, whereas the reduction in desmin staining was marked and
significant.
CONCLUSION
a-SMA and desmin were very early markers for smooth muscle cell and pericytes, respectively. Transitional pericytes, however, expressed both proteins. In the Edinburgh Model of
ROP, there was a small reduction in the expression of a-SMA. This reduction was most likely a result of the limited remodelling of the vasculature in response to the oxygen
exposure4. Desmin expression was also reduced in the retina of oxygen treated pups. This reduction may be the result of (1) reduced recruitment of pericyte precursor cells, (2)
inhibition or delay of pericyte differentiation, or (3) apoptosis of the pericytes in response to the oxygen regime.
In conclusion, mural cell coverage is reduced in a clinically relevant model of ROP.
